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Abstract 
Smooth muscle (SM) tissue is found in many parts of the body, primarily in 
sheets or bundles surrounding hollow organs. The main function of the tissue is 
the regulation of organ tone via its contractile state. Dysfunction of SM in 
diseases such as asthma and atherosclerosis affect millions worldwide. 
Current methods for studying SM primarily rely on ex vivo animal tissues or 2D in 
vitro models. Animal models do not accurately recreate human disease states 
and 2D models are cultured on stiff surfaces lacking the elastic properties and 3D 
morphology found in natural extracellular matrix in vivo. Therefore it is desirable 
to develop both an in vitro model of SM that possesses the ability to contract and 
a method in which this contraction can be measured. 
In order to achieve this, primary rat aortic SM cells and primary human airway 
SM cells were cultured in collagen hydrogels; both free floating in the form of 
collagen disks and under uniaxial tension in order to generate aligned SM 
collagen constructs. When stimulated with contractile agonists, these constructs 
contract in a uniaxial fashion. The design of the constructs allows them to be 
attached to a force transducer allowing the physical force of contraction to be 
measured. The force of contraction was dependant on the agonist concentration 
and could be antagonised by the presence of an L-type calcium channel blocker. 
In order to improve the alignment and uniformity of the smooth muscle 
population a range of aligned electrospun scaffolds were produced from 
polyethylene terephthalate (PET), cross-linked gelatin and cross-linked gelatin 
methacrylate (GelMa). The average fibre diameter of the scaffolds ranged from 
approximately 200 nm to several micrometres. Additionally the Young’s moduli 
of the scaffolds ranged from around 1x105 to 1x108 Pa. In all cases, scaffolds were 
highly aligned; alignment was achieved by using a rapidly rotating collector 
mandrel. 
Culture of primary SM cells upon these scaffolds showed that the cells readily 
adhered to and proliferated upon the scaffolds over a 10 day culture period. The 
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cells formed a highly aligned population following the topographical cues of the 
aligned fibrous scaffolds. Additionally, the cells stained positive for SM markers 
in all cases, indicative of a contractile phenotype. When stimulated with 100 µM 
UTP, the SM cells were able to contract the gelatin and GelMa scaffolds but not 
the PET scaffolds. 
SM seeded GelMa scaffolds were cultured for 10 days prior to attachment to the 
previously mentioned force transducer apparatus. Upon stimulation the seeded 
scaffolds contracted generating forces greater than those achieved by the 
hydrogel model, and was reproducible over several experiments.
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1. Introduction 
The experiments described in this thesis represent an attempt to develop and 
characterise a tissue engineered smooth muscle model using cultured primary 
smooth muscle cells seeded upon electrospun scaffolds. The model was designed 
to be used in studies directly measuring the contractile force generated by 
smooth muscle cells and has potential for future use in studies concerned with 
smooth muscle function in disease, specifically diseases affecting airway smooth 
muscle (such as asthma). Asthma is defined in the Global Initiative for Asthma 
(GINA) Guidelines as “a chronic inflammatory disorder of the airways in which 
many cells and cellular elements play a role. The chronic inflammation is 
associated with airway hyperresponsiveness that leads to recurrent episodes of 
wheezing, breathlessness, chest tightness and coughing… episodes are usually 
associated with widespread, but variable, airflow obstruction within the lung 
that is often reversible…” (GINA 2006). Asthma classification is determined by 
the frequency severity of exacerbations and can be classified either by clinical 
features or by the level of asthma control. This classification is described in 
tables 1.1 and 1.2 respectively.  The major effector cells causing airway 
obstruction in asthma are the airway smooth muscle cells. Development of a 
model that can monitor the contractile state of smooth muscle tissue in different 
environments (e.g. in the presence of immune cells simulating an inflammatory 
response) in response to various agonists/ antagonists would enable further 
investigations into the roles of smooth muscle tissue within asthma and would 
also have the potential to be used as a test bed for new asthma therapies. This 
introduction will focus on the morphology of smooth muscle in vivo and how 
smooth muscle contraction occurs. Additionally this section will look at current 
models used to investigate smooth muscle function; both in vivo animal models 
and ex vivo tissues, as well as recently developed tissue engineered alternatives 
to these models. 
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Smooth muscle is an involuntary contractile tissue that can be found in many 
locations throughout the body, the majority of which is found in the walls of 
hollow organs such as blood vessels (named vascular smooth muscle (Wynne et 
al. 2009)) or the airways (airway smooth muscle (ASM) (Ouedraogo & Roux 
2014)). In locations such as these it occurs as either broad, thin sheets or arrays 
of bundles that surround the vessels circumferentially. Their main function is to 
control the tone of the vessels via contraction and relaxation responses, 
regulating luminal area.  Smooth muscle can also be found connecting hair 
follicles to surrounding tissues (Jahoda et al. 1991) and is even present in the 
eye, with a small ring found close to the pupillary edge of the iris (Jensen 2005).  
The name smooth muscle arose due to the lack of striations when compared to 
skeletal and cardiac muscles, as their name suggests, their primary function is to 
contract, and do so in response to chemical (Borkowski et al. 1995; Matsui et al. 
2002) and physical signals (Kirber et al. 1988; Davis et al. 1992). Smooth muscle 
contraction can be classed as either tonic or phasic; tonic smooth muscle 
contracts slowly over prolonged periods of time and is generally found in the 
vasculature, airways, the eye, urinary tract and reproductive organs. Phasic 
smooth muscle contracts quickly and for short periods, the majority of this is 
visceral smooth muscle (Thornbury 1999). Given the wide range of locations in 
the body in which smooth muscles are found, it is unsurprising that their 
contractile behaviour differ greatly to suit their purpose. Their contractile speed, 
force and duration in addition to their stiffness, shortening ability, energy 
consumption and importantly, the contraction inducing stimuli, all vary 
depending on their location in vivo. These differences partly stem from the 
chemical composition of their contractile machinery. For example, different 
isoforms of both the heavy (Babij & Periasamy 1989; Nagai et al. 1989; Rovner et 
al. 1986) and light (Nabeshima et al. 1987) chains of myosin are known to 
contribute to these differences in contractile behaviour.  
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1.1 Smooth muscle morphology 
Smooth muscle cells possess a spindle-like morphology, varying in length 
dependent on their location in vivo. The cells contain a complex network of 
structural and contractile proteins in the form of filaments (thin, thick and 
intermediate), dense bodies and dense bands that all play important roles in the 
contractile function of the tissue. Important structural features such as cell 
junctions and caveolae are found within the plasma membranes of smooth 
muscle cells. 
 Cell junctions can be classified as either intermediate (also called adherens) 
junctions or gap junctions. The former provide mechanical coupling between 
cells and represent two paired dense bands from adjacent cells, separated by 10-
20 nm whose intercellular space is occupied by rod-shaped molecules bridging 
the membranes (Hirokawa & Heuser 1981; Miyaguchi 2000). Gap junctions 
provide ionic/ electrical coupling between adjacent cells with a gap of only 2-4 
nm between parallel membranes (Alberts et al. 2002). This small gap allows for 
the pairing of connexons (a circular array of six connexins) on each cell 
membrane to form single ionic channels connecting the cytoplasm of the two 
cells. This aids in the transmission of contractile stimuli between cells. Within 
smooth muscles a single gap junction is thought to contain as many as 1400 
connexons per cell (Gabella 1981).  
Caveolae are omega shaped 50-100 nm invaginations of the cell membrane that 
occur across the cell, dispersed between dense bands (Razani et al. 2002). They 
are formed from cholesterol and sphingolipid-rich lipid rafts that bind to specific 
caveolae proteins; caveolins. The plasma membrane regions within caveolae 
contain multiple membrane receptors (including muscarinic and adrenergic 
receptors), second messenger generators (such as, phospholipase C), G proteins, 
kinases, and ion channels in close proximity. This creates a specialised area for 
the regulation of cellular activity (Ostrom & Insel 2004), including contraction. 
The presence of calcium pump ATPase within caveolae membranes (Fujimoto 
1991) and high calcium concentrations within caveolae (found by electron probe 
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studies (Popescu & Diculescu 1975)) also suggest that caveolae are involved in 
the influx of extracellular calcium. 
Intermediate filaments are more plentiful in smooth muscle tissues than other 
tissues, in some cases constituting 5% of the total protein content (Huiatt et al. 
1980). They vary in length and are approximately 10 nm in diameter. The protein 
content of intermediate filaments varies throughout the body; within visceral 
muscles, the major component is the 53.5 kDa protein (Geisler & Weber 1983) 
desmin which has been shown to reconstitute intermediate filaments in vitro (Ip 
et al. 1985). Vascular smooth muscle cells on the other hand possess little to no 
desmin with vimentin being the key constituent of intermediate filaments 
(Gabbiani et al. 1981). Few smooth muscle cells express both desmin and 
vimentin (Schmid et al. 1982). Intermediate filaments form a structural network 
throughout the cell, they associate with dense bodies (Cooke & Chase 1971; 
Tsukita et al. 1983) within the cell (forming side-to-side links) and membrane 
bound dense bands, linking the two providing 3-dimensional integrity (Small & 
Gimona 1998). In addition to providing structural support, the intermediate 
filaments are also important in mechanotransduction, converting mechanical 
stimuli into a biological response. This has been shown in several studies; for 
example, mice genetically modified to be deficient in desmin (Loufrani et al. 
2002) and vimentin (Schiffers et al. 2000)  both display alterations in vasomotor 
properties such as agonist sensitivity and impaired flow-dependent dilation. This 
suggests that the intermediate filament proteins are involved in sensing 
mechanical cues from outside the cell. A diagram of the distribution of 
intermediate filaments (in addition to thin and thick filaments) within smooth 
muscle cells is shown in Figure 1. 
Dense bodies are distributed throughout the cytoplasm of smooth muscle cells 
and are rich in α-actinin (Aguilar & Mitchell 2010). In addition to intermediate 
filaments, they associate with thin (actin) filaments; this association of actin with 
the α-actinin of dense bodies is very similar to that seen at Z lines within striated 
muscles (Fay et al. 1983). Their association to thin filaments makes them appear 
to act as anchors from which the thin filaments can exert forces during cell 
 Page 
6 
 
  
contraction. In addition to contractile actins, they also associate with the 
cytoskeletal β-actin (Aguilar & Mitchell 2010), suggesting that they are arranged 
within the cell cytoskeleton. Dense bodies are called so due to their electron 
dense appearance under an electron microscope, they elongate along the cell 
length and are variable in size. Dense bands (also known as dense plaques) are 
similar in appearance to dense bodies but appear exclusively bound to the cell 
membrane. They link contractile actin filaments to the cell membrane and in 
turn, to the ECM or neighbouring cells. Some dense bands are also linked to 
dense bodies via intermediate filaments. They are found across the whole 
membrane, covering 30-50% of the cell surface, with a greater density at the 
tapered ends of the cells. Again, α-actinin is found within dense bands although 
the focal adhesion protein vinculin is only found in dense bands. In dense bands 
that bind to the surrounding ECM, talin is also present (Drenckhahn et al. 1988). 
Thin/ actin filaments are part of the contractile machinery within smooth muscle 
cells. They are 7-8 nm in diameter and form branched fibrous networks, 
terminating within dense bodies or bands. The filaments are formed from 
polymerisation of globular actin subunits which form chains twisted into a 
double helix configuration with a rotation of 166.15° around the axis between 
subunits (Egelman et al. 1982). Associated to the actin filaments are 
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Caveolae Dense bands Dense bodies Intermediate filaments 
Thin/Actin filaments Thick/Myosin 
filaments 
Figure 1.1: Assembly of structural and contractile filamentous proteins 
within smooth muscle cells.  
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tropomyosin, calponin and/or caldesmon (Figure 2A). Within smooth muscle 
cells there are two major groups of filamentous actin. The first group is 
composed of α and γ actin and form the thin filaments described above; these 
slide along myosin filaments during contraction (Draeger et al. 1990). β-actin on 
the other hand, is a structural cytoskeletal protein found below the plasma 
membrane. It is known to polymerise in the presence of contractile agonists, 
strengthening the plasma membrane. This is thought to play an integral role in 
developing mechanical tension during contraction (Gunst & Zhang 2008). The 
ratio of actin to myosin filaments is higher in smooth muscle than in striated 
muscles (Murphy et al. 1977), suggesting that not all actin filaments interact 
directly with a myosin filament. 
Thick filaments are formed from aggregates of myosin, are around 14-18 nm in 
diameter and cylindrical in shape. The term myosin encompasses a large 
superfamily of proteins that share the ability to bind to actin and possess ATPase 
enzyme activity. Class II myosin is the predominant myosin within the contractile 
apparatus of human muscles. It is a hexamer formed from two intertwined 
myosin heavy chain (MHC) molecules and four myosin light chain (MLC) 
molecules . Each heavy chain (approximately 200kDa each) consists of a head, 
neck and tail domain; the head domains contain the globular N-terminals that 
protrude laterally from the myosin filament, they also contain the sites for actin 
binding and ATP hydrolysis. The neck domains create the angle between the 
head and tail domains and are the site of binding for the MLC molecules, the tail 
domains are made up of the C-terminal ends of the MHC molecules, and the two 
are intertwined in a helical rod that forms the major constituent of thick 
filaments. Two different MLCs exist, with molecular weights of 20 kDa (MLC20) 
and 17 kDa (MLC17) known as regulatory light chain and essential light chain 
respectively. One of each MLC binds to the neck domain of each MHC, forming 
the myosin II hexamer. A diagram of the myosin II hexamer is shown in Figure 
2B. MLC20 has a pivotal role in regulating vascular smooth muscle contraction. 
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Figure 1.2:  Structure of actin and myosin. A diagram of a thin/ actin 
filament filaments (A; adapted from http://www.ivyroses.com/). A 
diagram of a myosin II hexamer (B; adapted from (Aguilar & Mitchell 
2010)) 
A 
B 
Calponin 
Tropomyosin 
Actin Caldesmon 
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(Górecka et al. 1976; Arner & Pfitzer 2005), the role of MLC17 is unclear but is 
thought to contribute to the structural stability of the myosin heads 
Other proteins of interest associated with thick and thin filaments are 
tropomyosin, calponin, caldesmon. Tropomyosin binds to actin filaments 
spanning 7 actin monomers and is laid out end to end over the length of the thin 
filaments. Within striated muscles, it enhances actin-myosin interactions 
however its role in smooth muscles is not clear. Calponin is expressed at similar 
levels to actin and is thought to act as a load bearing protein; it also binds to 
actin and inhibits myosin ATPase activity, displaying a similar function to 
troponin in striated muscles (which is not present in smooth muscles), and 
inhibiting actin sliding. Phosphorylation of calponin with protein kinase C (PKC) 
alleviates this inhibitory effect, promoting actomyosin activity (Pohl et al. 1997). 
Caldesmon is thought to be involved in the tethering of actin, myosin and 
tropomyosin and is also thought to act as a molecular switch, inhibiting myosin 
ATPase activity depending on its phosphorylation state. 
1.2 Smooth muscle contraction 
Smooth muscle contraction is principally regulated by chemical or mechanical 
stimulation of the contractile proteins actin and myosin. In the case of chemical 
stimuli; binding of an agonist (such as histamine) to a G-protein-coupled-
receptor (GPCR) stimulates phospholipase C (PLC) activity (Figure 3). In parallel, 
this stimulates the influx of extracellular calcium into the cell through receptor 
operated calcium channels (ROCCs) and voltage dependant calcium channels 
(VDCCs). PLC is an enzyme specific for the membrane bound lipid 
phosphatisylinositol 4, 5-biphosphate (PIP2) cleaving it into two potent second 
messenger molecules; inositol-1, 4, 5 triphosphate (IP3) and diacyl glycerol 
(DAG). DAG, along with Ca2+ ions, activates PKC which phosphorylates tissue 
specific target proteins in addition to actin bound calponin, which promotes 
actin-myosin cross-bridging. IP3 stimulates the release of intracellular calcium 
from IP3 sensitive stores in the sarcoplasmic reticulum. This calcium increase 
triggers the activation of the calcium dependent cytosolic protein calmodulin,  
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Figure 1.3: Mechanism of initial and sustained ASM contraction. Schematic adapted 
from (Word & Kamm 1997) 
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which binds to four Ca2+ ions (Johnson et al. 1996). This Ca-calmodulin complex 
activates the enzyme myosin light chain kinase (MLCK), a key enzyme in the 
actin-myosin cross-bridging mechanism, which phosphorylates the regulatory 
light chain (MLC20) using ATP in the process. Phosphorylation of MLC results in 
cross-bridge attachment, cycling, and force development within the cell (Kamm 
& Stull 1986; Murphy 1994). Studies have shown that phasic smooth muscles 
develop force more rapidly than tonic smooth muscles (Horiuti et al. 1989). This 
difference in cross-bridge cycling rates could be accounted for by a higher ADP 
affinity of myosin heads in tonic muscles (Khromov et al. 1995). Working against 
the activity of MLCK is myosin phosphatase which continuously 
dephosphorylates the activated MLC20. Therefore, In order to maintain 
contraction, the high level of cytosolic calcium needs to be sustained in order to 
preserve a high level of activated MLCK (MLCK > myosin phosphatase). As the 
internal calcium stores are used, it has been proposed that store-operated 
calcium channels (SOCCs) allow calcium influx (Putney 1993). Additionally, 
receptor-operated calcium channels (ROCCs), activated by the GPCR, also allow 
continued influx of calcium ions into the cell (Murray & Kotlikoff 1991). Calcium 
influx through SOCCs and ROCCs contribute to both the refilling of the internal 
calcium stores and maintaining smooth muscle contraction via a PKC dependent 
mechanism (Giembycz & Raeburn 1992). 
When stimulation is reduced or removed from the cell, the rate of calcium ions 
entering the cytosol via calcium channels will fall. Subsequently, levels of 
cytosolic calcium fall as ions are sequestered back into depleted internal calcium 
stores resulting in a decrease of calcium bound to calmodulin. This is turn leads 
to a reduced MLCK activity and myosin phosphatase activity predominates 
preventing further actin-myosin cross bridging. As this process continues the 
force generated by the cell reduces and the cell begins to relax back to a resting 
state. As mentioned above, relaxation can be caused by a cessation of 
stimulation but it can also be triggered by the presence of certain chemicals. One 
example of this would be caffeine. Caffeine has been found to relax 
noradrenaline-induced contraction of the aorta and the carbachol induced 
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contraction of the taenia coli (Ahn et al. 1988). This is in part due to caffeine’s 
inhibiting action of cyclic AMP breakdown. Additionally, caffeine may also inhibit 
Ca2+ influx by binding to Ca2+ channels (Martin et al. 1989) reducing the 
concentration of intracellular calcium. 
1.3 Animal models of smooth muscle 
As the long term aim of this thesis is to develop a tissue engineered model of 
smooth muscle to investigate airway disease and potentially replace currently 
used animal models, this section will focus on animal models to study specifically 
airway smooth muscle.  
There has been a wide variety of in vitro, in vivo and ex vivo studies to investigate 
the role of smooth muscle in asthma, however each model is not without its 
limitations. In vivo the majority of studies have been undertaken in rodents 
(Meurs et al. 2006; Lundblad et al. 2007; Kucharewicz et al. 2008), as well as dogs 
(Stephens et al. 1986), pigs (Turner et al. 2002), horses (Herszberg et al. 2006), 
sheep (Koumoundouros et al. 2006) and primates. Mice are favoured for in vivo 
studies due to their low cost, short breeding periods and importantly, the well 
characterised genome of the mouse gives the ability to knock out specific genes 
to study specific pathways in asthma. They are easily sensitised to a number of 
antigens including ovalbumin (OVA, the most common method of sensitisation) 
(Zosky et al. 2004), and other allergens such as house dust mite (HDM) (Fattouh 
et al. 2005). This induces an asthmatic state in the mice causing airway 
hyperresponsiveness (Zhang et al. 1997) or airway remodelling (Lloyd 2012) 
depending on the protocol used to sensitize the mice, key features being the 
mouse strain used (Shinagawa & Kojima 2003) as well as the route (Shore 2003) 
and duration (Lloyd 2012) of allergen exposure. Transgenic technology, coupled 
with the well characterised genome of the mouse makes mice ideal candidates 
for mechanistic studies where manipulation, antagonism, suppression or 
upregulation of a particular molecular pathway can be carried out to examine its 
role and importance in the development of symptoms of asthma (Elias et al. 
2003). Transgenic studies in mice have acknowledged the importance of the Th-2 
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phenotype in the progression of allergic disease and additionally, the importance 
of the cytokines IL-4 (Pauwels et al. 1997), IL-5 (Foster et al. 1996) and IL-13 (Fish 
et al. 2005) in allergic inflammation and the development of airway 
hyperresponsiveness. This has led to the development of several treatments 
targeting these cytokines. However, even though effective in mouse models, the 
same results were not seen in humans (Taube et al. 2004). 
Rats are commonly used in asthma studies due to their sensitivity to allergens 
such as OVA (Hylkema et al. 2002) and HDM (Liu et al. 2005) and their ability to 
replicate features of airway inflammation seen in humans such as early 
asthmatic responses (EAR) and late asthmatic responses (LAR) following allergen 
challenge (Eidelman et al. 1988). When exposed to broncho-constricting agents 
however, they produce relatively weak contractile responses (Kucharewicz et al. 
2008); therefore, although useful as a model of inflammation, rats do not 
replicate the levels of ASM contraction seen in humans.  
As with rats, guinea pigs also display EAR and LAR; in addition, their mast cells 
release histamine and leukotrienes upon allergen challenge. They are often used 
to screen drugs that act through pathways thought to be relevant to human 
asthma and have been used in the development of drugs such as β2 receptor-
agonists and corticosteroids (Selig & Chapman 1999). However the low number 
of inbred strains and lack of guinea-pig-specific reagents available currently limit 
mechanistic guinea pig studies. 
Although animal models can be used effectively to study airway inflammation 
and remodelling, the lung mechanics of mice are not highly relevant for 
modelling human lung function due to their difference in resting posture 
(Bettinelli et al. 2002), airway branching patterns (Schlesinger & McFadden 1981; 
Plopper et al. 1983) and low amounts of smooth muscle tissue in proportion to 
humans (Karol 1994). Despite this, mice have still been used for such studies and 
several methods exist for assessing lung function in mice. Unrestrained 
plethysmography (UP) is a non-invasive technique that measures the pressure 
changes in a box containing a free moving animal. The changes in pressure can 
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be used to directly measure airway resistance but these measurements can also 
be affected by the absolute lung volume and tidal volume of the animal, which 
when challenged by bronchoconstrictors are both changed. Therefore UP has 
very limited accuracy and obviously cannot be used to directly measure ASM 
contraction but is able to monitor changes in airway resistance without altering 
the behaviour of the animal (Hamelmann et al. 1997). On the other hand, 
breathing behaviour can be experimentally controlled by forced oscillation 
leading to much more accurate measurements of airway resistance. This 
accuracy comes at a cost however and requires that the animal is anesthetised, 
paralyzed and has a tracheostomy, completely removing the animal from a 
relaxed, natural state. Therefore any method of physical measurement of lung 
function in vivo suffers from a trade-off between invasiveness and accuracy 
(Bates & Irvin 2003). 
1.4 Ex vivo models 
In order to directly assess physical ASM function, using techniques such as 
myography (Liu et al. 2006), it is much easier to use ex vivo models. Several 
methods of analysing airway tissue ex vivo exist, with excised bronchial 
segments, isolated ASM strips or rings and thin cut lung slices (TCLS) all used to 
assess ASM contraction. Isolated ASM strips can be used to directly measure the 
contraction of the muscle through mounting the strips upon a force transducer in 
an organ bath and directly stimulating by electrical or chemical means. This has 
clear benefits as the degree of muscle shortening can be directly measured and 
comparisons between asthmatic and non-asthmatic ASM can be made. The 
contraction measured may not accurately predict contraction in vivo however 
due to the muscle being removed from the surrounding airway wall and other 
cell types that would regulate contraction. Whilst this is a useful tool for studying 
the contractile ability of both healthy and asthmatic ASM a major limitation is 
the limited availability of human tissue samples. In addition, challenging 
protocols to extract tissue require a high level of technical expertise. 
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1.4.1 Bronchial segments 
By using bronchial segments and ligating the side branches of the segments to 
prevent leaking, changes in airway pressure and volume can be directly 
measured (Gunst & Mitzner 1981). This relates to the contraction of ASM within 
the bronchial segment. Compared to in vivo models, airway segments allow for 
protocols which would not be possible in a live animal such as electrical 
stimulation of the tissue or the direct application of a pharmacological agent to 
the ASM (Mitchell & Sparrow 1994). Bronchial segments from pigs have been 
used to assess the effects of load (due to surrounding tissues) on airway 
narrowing in response to electrical field stimulation (EFS) and acetylcholine 
(Noble et al. 2002). Bronchial narrowing was measured using an endoscope and 
was found to be greater and faster in segments where the surrounding cartilage 
had been removed. Additionally, the effects of allergen sensitisation have been 
studied using bronchial segments from (ovalbumin sensitised and challenged) 
hyperresponsive pigs. Airway narrowing in these segments was found to be less 
than control segments, showing reduced contraction to acetylcholine (Turner et 
al. 2002). Another study using bronchial segments was able to explore the effects 
of cyclic strain applied to the airway prior to stimulation (Noble et al. 2004). It 
was found that following 10 minutes intraluminal pressure oscillation, there was 
a modest increase in the response to EFS compared to static controls. Within the 
same study, isolated ASM strips had a decreased response to EFS following 
similar cyclic strain protocols, indicating that the airway wall modifies ASM 
response to cyclic strain. A later study by the same group carried out similar 
experiments on bronchial segments from asthmatic and non-asthmatic donors. 
They recorded that there was no difference in sensitivity between the two donor 
groups although asthmatic donors had significantly increased levels of ASM 
tissue; therefore displayed greater maximal airway narrowing than non-
asthmatics (Noble et al. 2013).One large drawback of bronchial segments is that 
they only last for around one day in culture however and therefore are not 
suitable for long term studies.  
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1.4.2 Thin cut lung slices 
TCLS can last up to seven days in culture allowing for longer ex vivo studies when 
compared to bronchial segments. These are produced by filling ex vivo animal 
lungs with a low gelling temperature agarose gel to preserve alveolar structure 
and gives better tissue compliance (Siminski et al. 1992). The tissue is then cut 
into multiple slices (over 150µm in thickness) and incubated. An advantage that 
these slices have over airway segments when studying ASM contraction is the 
presence of the surrounding parenchyma which retains the mechanical structure 
found in vivo. As parenchymal load can oppose contraction; by removing this 
load, the contraction seen would be less representative of an in vivo airway. By 
partially digesting the mechanical environment of TCLS it has been found that 
the parenchymal load resisting contraction is mainly due to the presence of 
elastin whereas the level of airway stiffness is attributable to the level of collagen 
(Khan et al. 2010). 
 Dandurand et al. were the first to visualise contraction in lung slices using video 
microscopy and digital imaging (Dandurand et al. 1993) making it possible to also 
quantify airway contraction. This approach was then developed further by 
Martin et al. who assessed the effects of methacholine concentration on 
contraction (Martin et al. 1996). They found that the level of contraction in the 
lung slices was concentration dependent and additionally the presence of 
hydrocortisone increased the EC50 of the methacholine by a factor of six. 
Confocal microscopy allows for calcium imaging of smooth muscle cells within 
thin cut lung slices. Bergner and Sanderson imaged murine lung slices in the 
presence of acetylcholine. The magnitude of the airway contraction, the initial 
Ca2+ transient and the frequency of subsequent calcium waves were all found to 
be dependent on the concentration of acetylcholine (Bergner & Sanderson 
2002a). In a similar study, they looked at the effects of ATP analogues on airway 
contraction and calcium release. ATP (10µM) was found to induce Ca2+ 
oscillations for up to a minute whereas adenosine 5’-O-(3-thiotriphosphate) (0.5 
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µM) induced oscillations that lasted over 2 minutes (Bergner & Sanderson 
2002b).  
In addition to chemical agonist stimulation, lung slices have also been stimulated 
using EFS; airway contraction increased with higher frequencies with larger 
airways having stronger responses (Schlepütz et al. 2011). Guinea pig lung slices 
were found to be more appropriate for modelling human airway pharmacology 
than other rodent models with similar responses between several agonists 
except for serotonin which is a potent bronco-constrictor in guinea pigs but not 
in humans (Ressmeyer et al. 2006). Delmotte and Sanderson studied the effects 
of the two enantiomers of the β2 adrenergic agonist albuterol (commonly used as 
a bronchodilator to treat asthma) using murine lung slices, recording airway 
contraction and Ca2+ signalling (Delmotte & Sanderson 2008). They discovered 
that (R)-albuterol relaxed airways in a dose-dependent manner whereas (S)-
albuterol had no effect on the airways. A similar effect was seen in the calcium 
imaging experiments where (R)-albuterol decreased the frequency of 
methacholine induced Ca2+ oscillations, whereas (S)-albuterol had no effect. Lung 
slices have been used to test the efficacy of potential drug candidates. One 
example is a study by Fitzpatrick et al. who compared prostaglandin E2 (PGE2) 
with the commonly used β2-adrenoceptor agonist salbutamol where PGE2 was 
found to be more potent than salbutamol in opposing contraction initiated by all 
stimuli tested (Fitzpatrick et al. 2013). Kudo et al. reported using lung slices to 
study the effects of IL-17A on methacholine stimulated contraction. At multiple 
concentrations of methacholine studied, IL-17A significantly enhanced the levels 
of airway contraction recorded; removal of the epithelium enhanced the 
contractile forces further (Kudo et al. 2012). Other areas where TCLS have been 
used is in the study of the effects of tobacco smoke (Churg et al. 2009; Streck et 
al. 2010; Lin et al. 2012) and vehicle emissions (Bion et al. 2002; Fall et al. 2008; 
Morin et al. 2008) on the airways. One key drawback of TCLS is that as they are 
essentially a 2D section of the lung where the ASM is exposed and not protected 
by an epithelial layer as it would be in the 3D airway; this may lead to stronger 
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ASM contraction as any contractile agonist would hit the ASM directly instead of 
first passing through the epithelium. 
1.5 In vitro cell culture 
In vitro cell culture is not necessarily limited by sample availability and can be 
used to assess ASM cells over a longer period of time to look closely at the 
biological pathways involved in ASM contraction. ASM can be obtained from 
trachea or bronchi tissue samples via enzymatic digestion or explant culture. Due 
to the stiff surfaces used to culture cells in vitro, assessment of ASM contraction 
is not possible; however Ca2+ imaging of cells can be used to monitor the Ca2+ 
signalling pathway involved in contraction. Also, immunostaining of ASM cells as 
well as 2D protein gel assays can be used to determine the levels of smooth 
muscle phenotype markers such as contractile proteins, specific receptors, ion 
channels and cell junctions. Clear disadvantages of in vitro culture are the lack of 
a 3D structure which affects cell morphology and behaviour as well as the 
progressive loss of the contractile phenotype over time (Hirst 1996; Wright et al. 
2013; Roscioni et al. 2011). A current method of measuring the contraction of 
ASM in vitro requires seeding the cells within a collagen hydrogel. Upon addition 
of a contractile stimulus, the gels contract and the change in gel area can be used 
to estimate the extent of gel contraction. This method has had some successful 
results such as showing that asthmatic ASM shows a stronger contraction when 
exposed to histamine than ASM from non-asthmatics (Matsumoto et al. 2007). 
This contraction cannot be wholly attributed to the contraction of the ASM 
however as the ASM will naturally remodel the structure of the collagen gel, 
decreasing the gel size. Due to this, prolonged culture or repeat tests on these 
collagen gels are not possible. 
1.6 Tissue engineered models of smooth muscle 
Tissue engineering is a multidisciplinary field bringing together materials 
scientists, biologists, chemists, engineers and clinicians (amongst others) aiming 
to develop strategies for the creation or replacement of living tissues. The 
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approaches taken to achieve this goal include; using isolated cells (such as stem 
cells), using biochemical and physicochemical factors (such as growth factors) to 
encourage specific tissue-growth and combining isolated cells with synthetic 
materials that attempt to recreate the extracellular matrix found in vivo in order 
to produce a 3D living tissue. Although arguably still in its infancy, this field of 
study which has grown rapidly over the last 2 decades due to the potential for 
tissue engineering to deliver innovative products and therapies to meet unmet 
clinical needs. One of which is the currently limited supply of human donor 
organs. Success stories such as the production and implantation of a tissue 
engineered trachea (Macchiarini et al. 2008) have only led to increased interest 
and investment into the field. 
In addition to producing tissues for clinical purposes, tissue engineering holds the 
potential to further develop our understanding of cellular mechanisms and drug 
interactions via the development of more accurate/ representative pre-clinical 
models. This can be achieved by culturing primary cells or cell lines on 3D 
matrices which resemble the natural environment of living tissue. This could be 
used to potentially merge aspects of all the previously described ASM culture 
techniques, making a more accurate and flexible tool for investigating ASM in 
vitro. Unsurprisingly, several tissue engineered airway models have been 
developed in recent years. In most cases the models include ASM cells and other 
airway cells being seeded onto a 3D scaffold, the main variable between the 
models being the scaffold used. Scaffolds can range in complexity from simple 
collagen gels (Choe et al. 2006), similar to those previously discussed, through to 
de-cellularised airway tissue (Macchiarini et al. 2008). Although de-cellularised 
tissue completely replicates the natural ECM, the demand for tissue will always 
exceed availability. Also, due to donor variability it is impossible to fully 
characterise the composition of each donated tissue. Therefore, matrices made 
from ECM derived proteins and synthetic polymers offer an alternative. 
Collagen gels have been used as a 3D scaffold in several airway models. 
Gerthoffer et al. seeded ASM cells into collagen gels in wells containing a central 
polydimethylsiloxane (PDMS) post (Gerthoffer et al. 2007). When set and 
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removed from around the PDMS post, the gel then possessed a ring like 
structure representative of an airway. The ASM rings were exposed to 
constricting agents and the response measured using myography (the study of 
muscle contraction, a myograph measures the contractile properties of muscles 
through direct mechanical coupling to a force transducer). Collagen hydrogels 
have also been used in developing more complex airway models. Multi-cell 
layered collagen tubes composing of epithelial cells, fibroblasts and ASM have 
been constructed by Miller et al. (Miller et al. 2010). These tubes were cultured 
in a bioreactor for up to 60 days where they were mechanically stimulated in 
order to simulate breathing. Contraction of the tubes was measured but this was 
only in respect to remodelling of the gels, not contraction of the ASM in response 
to a stimulus. Cells seeded in collagen gels set around micro-scale cantilevers 
known as microfabricated tissue gauges can be used to measure and manipulate 
ASM contraction (Legant et al. 2009). By knowing the stiffness of the cantilevers, 
displacement of them can relate to the force generated due to the contraction of 
the gel. Also, stiffer cantilevers would resist against contraction, creating a more 
in vivo environment for the ASM within the collagen. Using these 
microfabricated tissue gauges, ASM response to histamine, KCl and acetylcholine 
have all been recorded (West et al. 2013). Unfortunately, long term studies are 
not possible with these tissues as they lose structural integrity as the cells 
remodel the gel (50% of tissues fail after 7 days). 
Synthetic materials are an alternative to natural ECM proteins and can be 
advantageous in that their physical properties and surface chemistry can be 
modified for biological purposes. Muscular thin film technology (Alford et al. 
2010) features an elastic film of PDMS used to culture a sheet of cells. The films 
possess geometric cues to aid cell organisation and can be used to measure the 
contractile properties of the tissues on them by measuring the degree of film 
contraction using imaging techniques. This technique has been demonstrated 
with vascular smooth muscle cells where endothelin-1 was used to trigger 
contraction (Alford et al. 2011). This approach has since been adapted for 
‘muscle on a chip’ experiments (Grosberg et al. 2012) and repeated using airway 
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smooth muscle cells (Nesmith et al. 2014). Film cultures however are essentially 
2D cultures and therefore do not replicate the ECM found in vivo. 
Electrospinning is a method of producing fibres in the nanofibre to microfibre 
range whereby a plethora of different polymers, both natural and synthetic, can 
be used (electrospinning theory will be discussed in further detail in chapters 2 
and 4). Electrospinning has previously been used to generate a range of scaffolds 
for the culture of smooth muscle including tubular structures simulating blood 
vessels for the culture of vascular smooth muscle (Wang et al. 2014; Elsayed et 
al. 2015)and nanofibre scaffolds for assessing smooth muscle growth and ECM 
production in vitro (Zhong et al. 2015).  
1.7 Thesis Aims 
The overall aim of this thesis is to develop a tissue engineered model of smooth 
muscle contraction that can be used to directly measure contractile force in 
response to different agonists. The model will be created using primary cells 
(with the future potential to use cell lines or stem cell derived SM cells) cultured 
upon aligned electrospun fibrous scaffold that will facilitate the proliferation of a 
uniaxially aligned confluent population of cells. The design of the model will 
allow it to be attached to force transducers, in a similar manner to ex vivo 
smooth muscle strips, allowing direct force measurement during contraction. 
The developed model could be used in drug screening test or to investigate 
mechanisms in smooth muscle contraction and/ or diseases that affect smooth 
muscle function such as asthma. This will reduce the need for ex vivo tissues and 
provide a reproducible model that can be used in both mechanistic and 
pharmacologic tests. 
In order to reach this aim, the following milestones will have to be met: 
 A method of isolating of primary smooth muscle cells should be established. 
 A method of measuring smooth muscle contraction directly using force 
measurement apparatus should be established. 
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 The key parameters in the electrospinning process should be identified and 
investigated in order to produce uniform, aligned scaffolds. 
 A range of flexible scaffolds that can support SM contraction should be 
produced. 
 Primary SM cells should be cultured upon the scaffolds; cell phenotype and 
proliferation should be monitored during culture. 
 The attachment of cell seeded scaffolds to the force monitoring apparatus in 
order to directly measure agonist induced SM contraction should be carried 
out.
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2. General Materials and Methods 
2.1 Electrospinning 
Electrospinning is a process of drawing out polymer fibres from a polymer 
solution or melt through a capillary/needle using a high voltage. A typical 
electrospinning setup consists of a syringe containing the polymer solution, a 
needle, a syringe pump, a high voltage power supply and a collector. The 
capillary is charged and a grounded collector plate is placed facing opposite the 
capillary. Once the electrostatic forces overcome the surface tension of the 
polymer solution, the polymer is ejected from the capillary in a jet and it is 
collected as fibres on the grounded collector. Aligned fibres can be collected 
using a rotating mandrel collector. A diagram of the typical electrospinning setup 
used in this work is displayed in Figure 2.1.  
Solutions of the desired polymer were stirred using a magnetic stirrer overnight 
at room temperature. The solutions were added to a 10 ml (PET) or 5 ml (gelatin 
and GelMa) polypropylene syringe (BD Falcon™, Oxford, UK) and placed in a 
syringe pump (Harvard Apparatus Ltd., Kent, UK). A needle was then attached to 
the syringe (18G blunt tip unless otherwise stated) and using crocodile clips, the 
needle was attached to a high voltage power supply and the collector 
plate/mandrel was grounded. The syringe pump was allowed to run until the 
solution first passed through the needle tip before applying an electric potential 
to the needle. Pump rates, spinning times and voltage applied were dependant 
on the solution concentration and polymer and are detailed in the relevant 
results chapters. Fibres were collected on either a stainless steel plate or a 
rotating mandrel. Mandrel speeds were dependant on desired fibre orientation 
ranging from 60 to 2000 rpm. A needle to collector distance of 15 cm was used in 
all electrospinning processes. All electrospinning was carried out at ambient 
temperature and humidity in a ventilated fume cabinet. 
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Figure 2.1: Diagram of a typical electrospinning setup with the capability to 
generate aligned fibrous scaffolds. The setup as shown was housed in an 
externally vented fume hood. 
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2.2 Scanning Electron Microscopy 
Scanning electron microscopy (SEM) is a form of microscopy that involves the 
use of a focussed beam of electrons ejected from a heated filament (usually 
tungsten). The electrons act as a source of illumination which gives a much 
higher resolution than light microscopy (which is limited by the wavelength of 
visible light). The electron beam scans the surface of the sample and secondary 
electrons are released by the sample. Secondary electrons are detected and used 
to generate an image of the sample, giving structural and topographical 
information about the sample (Reimer 1998). 
Samples of electrospun scaffolds were cut out using an 8.0 mm diameter biopsy 
pen and mounted on SEM holders using graphite adhesive SEM pads (Agar 
Scientific, Essex, UK). Samples were gold coated for 5 minutes (Balzers Union SCD 
030, Balzers Union Ltd., Liechtenstein). Samples were then imaged at 20-30 kV 
using a scanning electron microscope (JEOL JMS-6060 LV, JEOL Ltd., Welwyn 
Garden City, Hertfordshire, UK) at different magnifications. 
2.3 Uniaxial Tensile Testing 
Uniaxial tensile tests were performed on 3 replicate samples of the aligned PET 
scaffolds and cross-linked gelatin scaffolds (n=3). Samples of PET scaffolds were 
cut out (30mm in length and 3 mm in width) using a ‘dog-bone’ shape stencil and 
blade so that the fibres ran parallel to the direction of the applied  load. Samples 
of cross-linked gelatin scaffolds held in acetate frames (available scaffold size 32 
x 12.5 mm; fibres aligned parallel to length) were prepared by cutting the 
scaffold away from the frame along the length of the sample and cutting the 
frame on each side.  Samples were tested on a 5969 Universal testing system 
(Instron, High Wycombe, UK) with a 50N load cell operating with an extension 
rate of 5 mm min-1. A Video Gauge (Imetrum Ltd., Bristol, UK) was used to 
measure the strain. The Young’s moduli of the samples were calculated from the 
resultant stress/strain curves. 
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2.4 Mammalian Cell Culture 
2.4.1 Primary Human Airway Smooth Muscle (HASM) Cells 
Primary HASM cells from non-asthmatic individuals were isolated from bronchial 
biopsies at the Glenfield General Hospital (Leicester, UK) as described previously 
(Kaur et al. 2006). The research was approved by the Leicestershire Ethics 
Committee, and patients gave their written, informed consent. Primary HASM 
cells (frozen) were received from colleagues at Glenfield General Hospital 
between passage 2 and 6. Cells were defrosted and cultured (up to passage 8) in 
DMEM (Gibco, Fisher Scientific, Loughborough, UK) supplemented with 10% (v/v) 
FBS (Sigma Aldrich, Dorset, UK), 1% (v/v) antibiotic antimycotic solution (10000 
units ml-1 penicillin G, 100 mg ml-1 streptomycin sulphate and 25 µg ml-1 
amphotericin B) (Fisher Scientific), and 1x non-essential amino acids (Sigma 
Aldrich). Cells were cultured in 75 cm2 tissue culture flasks at 37°C, 5% CO2 in air. 
2.4.2 Isolation of Primary Rat Aortic Smooth Muscle (RASM) Cells 
Male Wistar rats (200-225g) were killed by stunning and exsanguination, using an 
approved Schedule 1 method of euthanasia. All procedures were approved by 
the animal welfare and ethical review body of the University of Nottingham. Rats 
were sacrificed for a separate study; the unwanted aorta was harvested for this 
study. The rat aorta was dissected from the aortic arch to the abdominal aorta 
and placed in a zero Ca2+ dissection buffer solution (5.40 mM KCl, 137.0 mM 
NaCl, 0.50 mM NaHPO4, 0.44 mM NaH2PO4, 10.0 mM glucose, 10.0 mM HEPES, 
1.0 mM MgCl2) on ice. The aorta was washed in ice-cold zero Ca
2+ dissection 
buffer and excess connective tissue removed using forceps. The aorta was placed 
in a low Ca2+ buffer (5.40 mM KCl, 137.0 mM NaCl, 0.50 mM NaHPO4, 0.44 mM 
NaH2PO4, 10.0 mM glucose, 10.0 mM HEPES, 1.0 mM MgCl2, 0.10 mM CaCl2) and 
incubated at 37°C for 5 minutes. The aorta was cut into small sections and placed 
in 2 ml papain solution (≥15 units ml-1 papain from papaya latex, 5.83 mM 1,4-
dithioerythritol, 0.90 mg ml-1 BSA, 5.40 mM KCl, 137.0 mM NaCl, 0.50 mM 
NaHPO4, 0.44 mM NaH2PO4, 10.0 mM glucose, 10.0 mM HEPES, 1.0 mM MgCl2, 
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0.10 mM CaCl2; Sigma Aldrich) before incubation at 37°C for 45 minutes. Aortic 
tissue was extracted from the papain solution and washed in BSA (Sigma Aldrich) 
solution (low Ca2+ solution plus 0.90 mg ml-1 BSA) 3 times before transferring into 
3 ml RASM media (high glucose DMEM supplemented with 10% (v/v) FBS and 1% 
(v/v) antibiotic/antimycotic solution (10000 units ml-1 penicillin G, 100 mg ml-1 
streptomycin sulphate and 25 µg ml-1 amphotericin B). The tissue was firmly 
agitated by pipetting for 30 seconds to release cells from the digested tissue 
before the cell suspension was transferred into two collagen coated T-25 flasks 
(flasks were incubated in 0.03 mg ml-1 type I bovine collagen (PureCol®, 
Advanced Biomatrix, San Diego, CA) in PBS (Fisher Scientific) solution at 37°C for 
60 minutes) containing 5 ml RASM media. Flasks were incubated (at 37°C, 5% 
CO2 in air) for 48 hours before the media was changed to remove decellularised 
tissue and unattached cells. 
2.4.3 Culture of RASM cells 
RASM cells at P0 obtained from enzymatic digestion of rat aorta (section 2.4.2) 
were cultured in RASM media at 37°C, 5% CO2 in air. Cells were cultured for 5 
days following isolation before first passage. Subsequent passages were carried 
out every 7 days; cells were split using a 1 in 6 dilution and cultured up to 
passage 3 in collagen coated flasks. Cells seeded into collagen gels and onto 
scaffolds were used at passage 2-3. 
2.4.4 Passaging cells 
SM cells that had reached approximately 90% confluency were deemed ready for 
passage; C2C12s (discussed in chapter 3) were passaged between 70 – 80% 
confluency. Culture media was aspirated from flasks and cells washed thoroughly 
with PBS solution. Trypsin-EDTA (0.05%) solution (Fisher Scientific) was added in 
sufficient volume to cover the surface of the culture flask and the flask incubated 
(at 37°C, 5% CO2 in air) for 5 minutes to allow for cell detachment. Detachment 
of cells was assessed visually under a light microscope. RASM cell detachment 
also required the use of a cell scraper to detach all cells. The trypsin was 
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deactivated by the addition of serum containing culture medium (volume was 
equivalent to 2 times the volume of trypsin added) and the cell suspension 
transferred to a centrifuge tube. Cells were collected by centrifugation (200XG) 
and supernatant removed. The cell pellet was re-suspended in a known quantity 
of culture medium and counted. Cells were then re-plated into T-flasks or used 
for experiments. 
2.4.5 Counting Cells 
Cells in a suspension of known volume were counted using a Neubauer 
haemocytometer. Cell suspension (10 µl) was added to 90 µl of trypan blue 
solution (Sigma Aldrich) and mixed thoroughly by pipetting. The resultant cell 
suspension (10 µl) was added to each chamber of the haemocytometer. The 
number of viable cells in each corner 1 mm2 square (of both chambers) was 
counted under a light microscope (viable cells do not take on the trypan blue dye 
due to possessing intact plasma membranes).The total number of viable cells 
was divided by 8 to calculate the average number of viable cells per corner 
square; this was then multiplied by 10 to account for the dilution factor in trypan 
blue. This number was multiplied further by 1x104 to calculate the number of 
cells per ml of the original cell suspension. 
2.4.6 Freezing and Resuscitation of Cells 
Excess C2C12 cells were frozen down following cell passage and counting. Cells 
were suspended in C2C12 growth medium (90% v/v) and dimethyl sulfoxide (10% 
v/v) at a density of 2x106 cells ml-1. Each 1ml of cell suspension was transferred 
to a 1.8 ml cryovial (Fisher Scientific) and cooled at a rate of approximately -1°C 
minute-1 (using a Mr Frosty (Fisher Scientific)) to -80°C overnight. The cryovials 
were then transferred to storage under liquid nitrogen. HASM cells were 
received cryopreserved and were stored under liquid nitrogen until required.  
Cells were resuscitated from cryopreservation by rapidly warming to 37°C in a 
water bath and plated into a T-75 flask containing 10 ml of C2C12 growth media/ 
HASM culture media.
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2.5 Cell Viability Assays 
The active chemical of both the alamarBlue® and PrestoBlue® assays is the blue, 
weakly fluorescent dye resazurin (7-Hydroxy-3H-phenoxazin-3-one 10-oxide). 
Upon entering metabolically active cells, the dye is reduced in the mitochondria 
to resorufin which is highly fluorescent. Measuring the fluorescence of a sample 
of dye solution that has been incubated with cells is therefore a good indicator of 
metabolic activity and therefore viability (O’Brien et al. 2000). The protocols for 
each assay are described in detail in the chapters 3 and 5 respectively.  
2.6 Immunocytochemistry 
Immunocytochemistry (ICC) provides a method of visualising specific proteins 
within cells by using antibodies that bind specifically to epitopes on the protein 
of interest (Bancroft & Gamble 2001). In order to carry out ICC, samples firstly 
need to be fixed and permeablised. Fixation denatures proteins within the cell by 
either coagulation or by forming crosslinks between proteins in the cells, binding 
soluble proteins to the cytoskeleton. This prevents the decay of the tissue and 
preserves the cells within.  This is commonly done by incubating the sample in an 
aldehyde solution (such as formaldehyde or glutaraldehyde). Formaldehyde 
binds to the residues of basic amino acids such as lysine, glutaraldehyde has a 
similar method of fixation however as it is a larger molecule, can form cross-links 
between more distant molecules. Another fixation method is to dehydrate the 
sample using alcohols such as methanol and ethanol. This causes soluble 
proteins within the cell to precipitate. One advantage of fixing with alcohols is 
that they can permeablise the cells during fixation. Prolonged chemical fixation 
can lead to excessive crosslinking and the masking of target proteins.  Where 
permeablisation is necessary, this can be achieved using detergents such as 
saponin, Triton X-100 and Tween-20. Following sample fixation and 
permeablisation, samples require blocking. Blocking involves incubation of the 
samples in a serum solution (usually the same species as in which the secondary 
antibody is raised) which binds to non-specific sites within the cells. This 
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prevents the secondary antibody (bound to the fluorophore) from binding to 
sites other than the intended antigen; preventing background fluorescence or a 
false positive. Following blocking, the samples can be incubated with the 
necessary antibodies. Primary antibodies (usually monoclonal antibodies) are 
added to bind to the protein of interest. Although some antibodies are also 
tagged with a fluorophore (direct immunofluorescence), most are not and so a 
secondary antibody is required; this two antibody approach is known as indirect 
immunofluorescence and is the method used in this body of work. Secondary 
antibodies are conjugated to a fluorophore (usually fluorescein isothiocyanate 
(FITC) or tetramethylrhodamine isothiocyanate (TRITC)) and are targeted 
towards IgG in the species in which the primary antibody was raised. This results 
in the secondary antibody binding to the primary antibody, allowing it to be 
visualised under light of a specific wavelength. Samples stained using ICC are 
imaged using fluorescence microscopy. The individual steps of indirect 
immunofluorescence are illustrated in Figure 2.2. 
All samples were washed with PBS prior to fixation with 3.8% (w/v) 
paraformaldehyde (10 minutes at room temperature). Samples were 
permeablised using a 0.5% (v/v) Triton X-100 in PBS  (5 minutes, 4°C) and then 
blocked sequentially with a 3% (v/v) BSA, 1% glycine (w/v) solution (1 hour, room 
temperature) followed by a 10% (v/v) goat serum solution in PBS (1 hour, room 
temperature). Samples were incubated with primary antibodies (1 in 200 dilution 
in 10% (v/v) goat serum in PBS) at 4°C overnight. Fluorescently tagged secondary 
antibodies (1 in 800 dilution in PBS) were then used to visualise the desired 
proteins. All antibodies used in this thesis are listed in Table 1; all listed 
antibodies were used at a dilution of 1:200. Nuclei were stained with Hoechst 
dye (Fisher) using a 1 in 833 dilution in PBS (10 minutes) or DAPI (Fisher) (1 in 
10000 dilution, 10 minutes) and actin was stained (1:100 dilution, 10 minutes) 
using Alexa Fluor 488 conjugated phalloidin (Life Technologies, Paisley, UK). 
Samples were imaged using a Leica TCS SP2 laser scanning confocal inverted 
microscope (Leica Microsystems Ltd, Milton Keynes, UK) or a Leica DM2500 M 
fluorescent microscope.  
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Figure 2.2: Steps involved in indirect immunofluorescence. Primary antibody binds 
specifically to antigen of interest (A). Secondary antibody binds to primary 
antibody (B).  Fluorophore is excited by  photon of specific wavelength (C). 
Fluorophore emits lower energy photon (D). 
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2.6.1 Analysis of ICC images 
Fluorescently stained samples were visualised using Leica Application Suite, 
images were then analysed using ImageJ. Nuclei alignment was calculated using 
particle analysis on binary images of Hoechst stained cell nuclei. Surfacecoverage 
was determined by calculating the fraction of confocal z-stack images that were 
not stained for SM22α. SM marker positivity was calculated by counting the 
number of nuclei co-expressing the marker of interest and subtracting from the 
total nuclei present. Cell density was determined by dividing the number of 
nuclei visible per micrograph by micrograph area. 
2.7 Statistical Analysis 
All statistical tests were carried out using the GraphPad prism 6 software 
package (GraphPad Software Inc. San Diego, CA). Each statistical test carried out 
is stated in the relevant chapters and figure legends. Statistically significant 
results are represented with asterisk(s) (*, **, ***, ****) and represent P values 
≤0.05, 0.01, 0.001 and 0.0001 respectively 
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3. Developing a hydrogel based model of smooth 
muscle contraction 
3.1 Introduction 
Organ bath studies using isolated tissue preparations are well-established 
procedures within the field of pharmacology and have been carried out for over 
a century (Waugh Young 1914). Traditionally used to investigate the 
physiological and pharmacological response of contractile tissues such as smooth 
and skeletal muscle, organ baths allow the force or displacement generated by 
ex vivo tissue preparations in response to stimulation to be measured. A typical 
organ bath setup consists of a vessel containing an oxygenated physiological 
buffer solution maintained at 37 °C with a fixed anchor point at the bottom and a 
force transducer above. By attaching a tissue preparation to these two points 
(usually via a cotton thread or nylon suture), any contraction of the tissue can be 
detected by the force transducer. An example of this is the study by Urquilla who 
investigated the dose dependent effects of the pyrimidine nucleotide uridine 5’-
triphosphate (UTP) on the contraction of SM within human and canine cerebral 
arteries (Urquilla 1978). In the study it was found that UTP stimulated dose-
related contractions within the range of 1.7 µM to 170 µM in canine arteries. 
Later organ bath studies testing UTP on bovine cerebral artery strips found that 
UTP can also stimulate vascular SM relaxation via an endothelium mediated 
mechanism in addition to contraction (Miyagi et al. 1996). 
The main drawback of using organ bath studies to assess the pharmacological 
effects of new drug candidates in humans is that in order to carry out the 
studies, freshly isolated human tissue is required. This can require tissue from 
both healthy and diseased donors which creates problems such as limited tissue 
availability, donor site morbidity and, (depending on the tissue required) the 
necessity for skilled individuals to carry out complex biopsies (Clark et al. 1977). 
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With increasing evidence that animal models do not accurately predict clinical 
outcomes in humans (Shin et al. 2009) an attractive alternative to using human 
tissue would be to use tissue engineered constructs; tissues created from 
isolated human cells seeded within or upon a biomimetic and biocompatible 
scaffold. This would allow for multiple cell-scaffold constructs to be produced 
from a single donor; additionally, if human derived stem cells were to be used as 
the cell source, this would reduce the need for donor tissue altogether. In order 
to pass as a suitable replacement however, these tissue engineered alternatives 
need to provide functional outputs that correlate with those obtained from ex 
vivo tissue and ultimately with the tissue in vivo. In the case of tissue engineered 
muscle constructs, both smooth and skeletal, the key functional output is 
contraction. In order to measure contraction, these cell-scaffolds constructs 
therefore also need to be mechanically robust to survive contraction assays 
similar in nature to organ bath experiments. 
Hydrogels made from naturally occurring ECM proteins such as collagen (Antoine 
et al. 2014) have received a lot of attention in the field of engineering muscle 
tissues in vitro, with collagen hydrogels used in cartilage (Bosnakovski et al. 
2005), nerve (Martens et al. 2014), skin (Lee et al. 2009), skeletal (Vandenburgh 
et al. 2008), cardiac (Duan et al. 2011), and smooth muscle (Berglund et al. 2003) 
engineering. Collagen is the most abundant protein found within the human 
body with type I collagen being a key component of the ECM in connective 
tissues (Di Lullo et al. 2002).The structure of collagen comprises of a tight triple 
helix of two identical chains and a third chain with a differing composition of 
amino acids. Glycine is the most abundant amino acid within collagen appearing 
at every third residue in the peptide chain. This allows the tight triple helix to 
exist as glycine is the smallest amino acid offering the least steric hindrance. 
Proline and hydroxyproline are the next most common residues in collagen with 
glycine-proline-hydroxyproline being the most common motif in the amino acid 
sequence (Ramshaw et al. 1998). Collagen hydrogels are therefore a favourable 
cell matrix scaffold for use in tissue engineering applications (DeLustro et al. 
1986). In addition, the hydrogels can be set within specific shaped moulds (Yost 
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et al. 2005) or possess micro patterned surfaces (Chiu et al. 2012); and the low 
stiffness of collagen hydrogels (Achilli & Mantovani 2010) can allow cells to 
contract and remodel them (Legant et al. 2009).  
The disadvantages of collagen gel studies are that bulk gels do not give any 
topographical or directed mechanical cues to cells seeded within them leading to 
randomly displaced and oriented cell populations (Ceresa et al. 2009). This does 
not represent the anisotropic nature of many of the tissues that these gels 
attempt to recreate. This can be overcome by culturing the gels between two 
fixed points such as posts (Oishi et al. 2000), cantilevers (Boudou et al. 2012), or 
mesh frames (Smith et al. 2012). Cellular attachment to the fibrillar matrix leads 
to the formation of uniaxial tension between the two points; this creates a 
mechanical cue which cells then align upon. Additionally, due to their low 
mechanical properties, collagen gels are very fragile meaning that attaching 
them to force measuring equipment such as organ baths usually results in 
failure. Allowing the cells to remodel the gels prior to force measurement studies 
however, does increase the stiffness (Raub et al. 2010) and compliancy to an 
extent but they remain more fragile than ex vivo tissues. 
By seeding SM cells within collagen gels in well plates it is possible to visually 
assess the contraction of the gels due to both remodelling (Kuzuya et al. 2004) 
and agonist induced contraction (Rosenfeldt et al. 2003) It is also possible to 
assess the effects of antagonists on SM contraction (Sakota et al. 2014). By using 
this experimental design, Matsumoto and co-workers were able to assess the 
contractile properties of airway SM cells from donors both with and without 
asthma. In the study they found that asthmatic airway SM seeded gels 
contracted more in response to histamine than those seeded with non-asthmatic 
airway SM cells (Matsumoto et al. 2007). Contraction was measured in all of 
these studies by measuring the reduction in collagen gel size, an indirect way of 
measuring force which will not take into account the increasing stiffness of the 
gels as they contract. As the gels contract due to cellular attachment without 
agonist stimulation, the cell density of the gels can be a limiting factor in these 
experiments. Additionally, due to the circular shape of the gels, contraction is 
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radial which leads to an uneven distribution of cells within the gel. Although 
useful at observing the effects of pharmacological agents on SM cells, more 
accurate data on SM contraction would be obtained if uniaxial contractile force 
could be directly measured in gels containing an aligned population of cells. 
Studies that set out to directly measure the mechanical forces generated by cells 
within a collagen hydrogel matrix require the experimental apparatus with the 
capability to do so. However it is only within recent years that commercially 
available bioreactors have entered the market with the ability to measure force 
and/ or apply a mechanical load to cultures; examples include the Ebers TC-3F 
(www.ebersmedical.com) and the TA Electroforce bioreactor 
(http://www.tainstruments.com). Therefore, many early studies investigating 
mechanical forces generated in tissue engineered constructs required the in 
house development of bespoke apparatus. One design that was developed by 
Eastwood and co-workers (Eastwood et al. 1994; Eastwood et al. 1996) was the 
culture force monitor (CFM), which contains a force transducer that can measure 
uniaxial force generated within contracting collagen gels. The first studies using 
the CFM investigated the attachment forces generated by fibroblasts at different 
densities and from different tissue types finding different contraction profiles 
generated by different cell populations. The majority of later studies using the 
CFM have focussed on analysing contraction produced by tissue engineered 
skeletal muscle constructs however one study by Cheema et al investigated the 
contraction of separate collagen gels seeded with rabbit bladder SM cells as well 
as those seeded with human dermal fibroblasts and mouse myofibroblasts 
(C2C12). In this study, the rabbit SM constructs were found to produce greater 
contraction than both the fibroblast and C2C12 constructs over a 24 hour period 
(Cheema et al. 2003). It is worth noting however, that this study was looking at 
the initial contractile forces associated with cellular attachment to the collagen 
matrix; the SM cells in this study were not chemically stimulated to contract. 
Over time, the size of the collagen constructs tested on the CFM has been scaled 
down. Earlier experiments attached 5 ml constructs to the CFM (Cheema et al. 
2003; Brady et al. 2008; Mudera et al. 2010), with 3 ml constructs later used by 
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Sharples et al on an amended CFM (referred to as CFM mk2) (Sharples et al. 
2012). Currently, 2 ml collagen constructs are regularly tested using CFM 
(unpublished data). In addition to the CFM, other bespoke devices such as the 
Mechanical Cell Stimulator (MCS) have been developed with similar objectives 
(Powell et al. 2002). Images of both the CFM and MCS are shown in Figure 3.1 A 
and B respectively. The MCS is designed to house commercially available 6 well 
plates containing collagen based skeletal muscle constructs which can be 
mechanically stimulated using a stepper motor. The MCS, likewise to the CFM, 
also contains two load cells that can monitor the tension within two of the 
constructs within the well plate. Both the MCS and CFM have been used to 
measure the contractile forces of skeletal muscle cells cultured within collagen 
constructs (Sharples et al. 2012; Powell et al. 2002). It is worth noting however, 
that in both studies the contraction measured was not active contraction of the 
muscle cells but the contraction of the engineered constructs caused my cellular 
remodelling of the collagen hydrogels. 
An alternative approach to building force monitoring apparatus is to design the 
engineered tissue in a way that allows it to be directly attached to a force 
transducer with very little manual manipulation required. Dennis and Kosnik 
cultured myooids from rat myogenic precursor cells around synthetic tendons 
pinned into a sylgard coated petri dish (Dennis & Kosnik 2000). Over time, the 
cells formed a muscle like structure between the two synthetic tendons. By 
attaching the minuten pin holding one of the tendons in place to a force 
transducer and gently removing it from the sylgard base; they managed to 
directly attach the tissue engineered myooid to the transducer without handling 
the construct itself. The other tendon remained pinned to the dish to act as an 
anchor point. This allowed them to electrically stimulate the constructs and 
directly measure active force generation. This experimental design was used and 
adapted by Baar and co-workers to measure the contractile force of cultured 
skeletal muscle constructs from both primary rat cells (Huang et al. 2005) and 
C2C12s (Khodabukus & Baar 2009) seeded within fibrin based gels. This approach 
to measuring the contraction of skeletal muscle constructs in fibrin gels has  
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recently been applied to co-cultures of myoblasts and motor neurons (Martin et 
al. 2015). 
This chapter explores the ability of primary SM cells to contract collagen based 
hydrogels due to both initial cellular attachment and agonist stimulated 
contraction of the SM cells. It will investigate methods to culture the gels in a 
way that can induce an aligned cell population within the gel and importantly, to 
develop methods to measure SM contraction; both indirectly through imaging of 
the gels, and directly by live measurement of the force generated during agonist 
induced contraction. 
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3.2 Chapter Aims 
The work carried out within this chapter aims to achieve the following: 
Develop a method for measuring the forces generated during the agonist 
induced contraction of smooth muscle cells seeded within a 3D matrix. This will 
be achieved by:- 
 Using image analysis techniques, measure the level of contraction of SM 
seeded collagen gels in response to a chemical agonist. 
 
 Replicate an established C2C12 collagen gel based skeletal muscle model 
and use it to assess the suitability of the CFM for measuring SM 
contraction. 
 
 Adapt the C2C12 model design for the culture of SM constructs. 
 
 Measure the contractile force of these SM constructs using live force 
monitoring apparatus such as the CFM. 
 
 Test the sensitivity of the constructs to agonist concentration and 
investigate how this affects contractile force. 
 
 Assess the effects of antagonists of SM contraction in SM constructs.
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3.3 Materials and methods 
3.3.1 HASM collagen gel contraction assay 
Primary human airway SM cells from 3 separate donors (passage 2-4) were 
seeded into a collagen solution at a final density of 4x105 cells ml-1. Collagen 
solution (2 mg ml-1) was made up (per ml of collagen solution) by adding 598 µl 
PureCol® type I bovine collagen solution (conc. 3 mg ml-1) in 0.01 M HCl 
(Advanced Biomatrix, San Diego, CA) to 74 µl 10X DMEM (Sigma) and mixed 
thoroughly. The mixture was neutralised with (≈ 40 µl) 4M NaOH (made from 
NaOH pellets, Sigma) until a colour change (yellow to pink) was seen. SM cell 
suspension in (288 µl) serum free DMEM (Gibco, Life Technologies) was added. 
The collagen solution was then pipetted into a 24 well plate (Nunc, Thermo 
Scientific) (500μl per well) and incubated for 60 minutes (37°C, 5% CO2 in air) to 
allow the gels to set. Gels were carefully detached from the sides of wells using a 
sterile needle before the well plate was imaged using a flatbed scanner (Epson 
UK, Hertfordshire, UK). Serum free DMEM (1ml) ± agonist (histamine 100μM 
(Sigma), bradykinin 100nM (Sigma)) was added to each well and the gel 
constructs incubated. Plates were imaged at selected time points to assess gel 
contraction. Images were analysed using ImageJ. N=3 gels per condition, 3 
separate experiments using cells from 3 different donors. 
3.3.2 RASM collagen gel contraction assay 
Primary rat aortic SM cells (RASM cells) obtained from 3 separate rats were 
trypsinised and counted at passage 3. The cells were seeded into a collagen 
solution at 3 densities; 2x105, 5x105 and 1x106 cells ml-1. Collagen solution (2 mg 
ml-1) was made up (per ml of collagen solution) by adding 598 µl PureCol® type I 
bovine collagen solution (conc. 3 mg ml-1) in 0.01 M HCl (Advanced Biomatrix) to 
74 µl 10X DMEM (Sigma) and mixed thoroughly. The mixture was neutralised 
with ≈ 40 µl 4M NaOH (made from NaOH pellets, Sigma) until a colour change 
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(yellow to pink) was seen. The different cell suspensions in (288 µl) serum free 
DMEM (Gibco, Life Technologies) were then added to the collagen solution and 
mixed thoroughly. The collagen solutions were pipetted into a 24 well plate 
(Nunc, Thermo Scientific) (500μl per well) and incubated for 60 minutes (37°C, 
5% CO2 in air) to polymerise. Gels were carefully detached from the sides of wells 
using a sterile needle before the well plate was imaged using a flatbed scanner 
(Epson UK,). 1ml RASM culture media was added to each well and the plate 
incubated (37°C, 5% CO2 in air) overnight to allow the cells to remodel the gel via 
cellular attachment. The plate was then imaged before the media was aspirated 
and the gels washed with PBS (Fisher Scientific) 3 times. Serum free DMEM (1ml) 
± UTP (Fisher) at multiple concentrations (1 µM, 10 µM, 100 µM and 1mM) was 
added to each well and the gels incubated. The plate was imaged after 30 min to 
assess gel contraction. Images were analysed using ImageJ. N=3 gels per 
condition, 3 separate experiments using cells from 3 different donors. 
3.3.3 C2C12 cell culture 
C2C12 murine skeletal myoblasts(Yaffe & Saxel 1977) (HPA Culture Collections) 
were cultured in T75 and T175 flasks in C2C12 growth media (GM) consisting of 
DMEM (Gibco, Life Technologies) supplemented with 20% (v/v) FBS (Pan Biotech, 
Aidenbach, Germany)  and 1% (v/v) 100X penicillin-streptomycin solution (10,000 
U ml-1) (Invitrogen, Paisley, UK). Cells were incubated at 37°C, 5% CO2 in air until 
80-90% confluent before passaging. Cells were used between passages 5 and 10. 
3.3.4 Collagen construct apparatus preparation 
Three rectangles (15.0 x 6.0 x 1.5 mm) cut from 10 count (10 holes inch-1) 
polyethylene mesh (Darice Inc., Strongsville, OH, USA) were bound together 
using 0.3 mm stainless steel orthodontic wire to create ‘floatation bars’. 
Orthodontic wire (0.7 mm) was folded unto a U-shape hook and driven into each 
floatation bar to create ‘A-frames’ that are used to attach the floatation bars to 
glass chambers with specific dimensions (45 x 20 x 7 mm). Once assembled  
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A B 
C 
Figure 3.2: Collagen construct setup. Floatation bar manufactured from 
polyethylene mesh (A) and A-frame inserted into the centre of the floatation 
bar (B). Final setup containing two floatation bars in A-frames at each end of a 
rectangular glass bath(C). 
10 mm 
Floatation Bar Floatation Bar plus A-frame 
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(Figure 3.2), the chambers with floatation bars and A-frames were sterilised 
using 70% IMS and UV radiation for 30 minutes before use. 
3.3.5 Manufacture of C2C12 Collagen Constructs 
The protocol for the manufacture of C2C12 collagen constructs was adapted 
from those detailed elsewhere (Sharples et al. 2012), (Smith et al. 2012). C2C12 
murine skeletal myoblasts at 80-90% confluency between passage 8 and 10 were 
trypsinised and counted. PureCol® type I bovine collagen solution (1196 µl; conc. 
3 mg ml-1) in 0.01 M HCl (Advanced Biomatrix) was added to 148 µl 10X DMEM 
(Sigma) and mixed thoroughly. The mixture was neutralised with ≈ 80 µl 4M 
NaOH (made from NaOH pellets, Sigma) until a colour change (yellow to pink) 
was seen. C2C12 cells (8x106) suspended in 576 µl of C2C12 GM were added to 
the collagen mixture and mixed thoroughly. The cell/ collagen solution was then 
pipetted into a sterile glass chamber fitted with floatation bars and A-frames and 
incubated (37°C, 5% CO2 in air) for 60 minutes to allow the gels to set. The gels 
were detached from the sides of the glass bath using a sterile needle and 4ml 
C2C12 GM was added to the chamber. Constructs were either immediately 
attached to the CFM (n= 5 constructs) or cultured to allow formation of 
myotubes. A flow chart of the individual steps taken to produce the collagen 
construct is shown in Figure 3.3. Constructs used to culture myotubes were 
incubated at 37°C 5% CO2 in air for 4 days, during this time the media was 
refreshed twice every 24 hours. The media was then changed to C2C12 
differentiation media (DM) (consisting of DMEM (Gibco, Life Technologies) 
supplemented with 2% (v/v) horse serum (Pan Biotech, Aidenbach, Germany)  
and 1% (v/v) 100X penicillin-streptomycin solution (10,000 U ml-1) (Invitrogen) 
for a further 10 days. The media was changed once every 24 hours during this 
time. Throughout culture constructs were imaged using a flatbed scanner 
(Epson); n= 5 constructs.  
3.3.6 Manufacture of RASM collagen constructs 
The protocol for the manufacture of RASM collagen constructs was adapted from 
the C2C12 collagen construct protocol. Primary RASM cells at passage 3 were  
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Figure 3.3: Manufacture of collagen constructs. Flow chart dictating the steps required to 
produce collagen constructs. 
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trypsinised and counted. PureCol® type I bovine collagen solution (1196 µl; conc. 
3 mg ml-1) in 0.01 M HCl (Advanced Biomatrix) was added to 148 µl 10X DMEM 
(Sigma) and mixed thoroughly. The mixture was neutralised with ≈ 80 µl 4M 
NaOH (made from NaOH pellets, Sigma) until a colour change (yellow to pink) 
was seen. RASM cells (1x106) suspended in 576 µl of RASM media were added to 
the collagen mixture and mixed thoroughly. The cell/ collagen solution was then 
pipetted into a sterile glass chamber fitted with floatation bars and A-frames and 
incubated (37°C, 5% CO2 in air) for 60 minutes for the gels to set. The gels were 
detached from the sides of the glass bath using a sterile needle and 3ml RASM 
media added. Gels were imaged using a flatbed scanner (Epson) and incubated 
(37°C, 5% CO2 in air) for 3 days. During this period gels were imaged every 24 
hours. Media was changed every 24 hours.  After 3 days the constructs were 
used for contractile assays. 
3.3.7 Immunostaining of cell seeded collagen constructs 
Collagen constructs were detached from the glass chamber via removal of the A-
frames. Media was removed from the glass chambers and the constructs washed 
with TBS three times before fixation using an ice cold methanol/acetone solution 
for 15 minutes. Constructs were then washed with TBS three times before the 
floatation bars were removed. Samples were then immunostained following the 
protocol described earlier (section 2.6) 
3.3.8 Measuring construct contraction using the culture force 
monitor 
Whilst attached to the glass chamber, via the A-frames, stainless steel loops 
made from 0.7 mm orthodontic wire were pressed into each of the floatation 
bars until secure before removal of the A-frames. All media was aspirated from 
the glass chamber and the construct was transferred to a PTFE chamber 
containing 5 ml of serum free DMEM (Gibco) (5 ml of C2C12 GM used for C2C12 
constructs). The PTFE chamber was placed in the CFM housing incubator (37°C , 
5% CO2 in air) and the stainless steel hoops were placed over the two attachment  
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hooks of the CFM. This enabled a sensitive force transducer (Measurements 
Group, Basingstoke, UK) to measure the real-time cell contraction of the collagen 
gel. The analogue output signal was amplified, digitized and processed through a 
model P3 strain indicator and recorder (Vishay, Basingstoke, UK). 
Positionaladjustment of the transducer and fixed hook allows careful positioning 
of the constructs in the CFM system. Constructs were positioned so that they 
were straight, free floating and without slack. A diagrammatic explanation of 
setting up the CFM is given in Figure 3.4. The CFM reading was adjusted to zero 
and recording started. C2C12 constructs were incubated whilst attached to the 
CFM for 24 hours. RASM constructs were attached to the CFM until a constant 
force reading was attained. Following this constructs were stimulated with the 
addition of 1 ml of 600 µM UTP in serum free DMEM to the PTFE chamber. N= 2 
RASM constructs tested. 
3.3.9 Visual assessment of RASM collagen construct contraction 
RASM collagen constructs were removed from incubation 3 days after 
manufacture. Media was aspirated from the glass chambers and constructs 
washed twice with serum free DMEM. 2 ml serum free DMEM was then added to 
each chamber. One A-frame was removed from each construct leaving one 
floatation bar attached to the glass chamber and the other free floating. Half of 
the gels tested had the free floatation bar carefully removed from the gel. Glass 
chambers were placed on a flatbed scanner (Epson) and imaged. UTP (1 ml; 300 
µM) was added to each chamber (1 ml serum free DMEM for controls) and 
chambers imaged every minute for 30 minutes. Images were analysed using 
ImageJ. N= 5 constructs per condition (attached/ detached). 
3.3.10 Measuring RASM collagen construct contraction using muscle 
physiology apparatus 
RASM collagen constructs were removed from incubation 3 days after 
manufacture. Media was aspirated from the glass chambers and constructs  
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Transducer 
Collagen gel 
Floatation bar 
A B 
C D 
Figure 3.4: Attaching collagen constructs to the CFM. A glass bath containing a set 
collagen gel construct (A) is removed of media and A-frames are replaced with wire 
hoops (B). Construct is placed into a larger PTFE bath (C) and hoops are hooked 
around the force transducer (D, left) and fixed anchor (right). 
A-frame 
Media Glass chamber 
45mm 
7mm 
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washed twice with serum free DMEM. 2 ml serum free DMEM was then added to 
each chamber. One A-frame was removed from its floatation bar and a minuten 
pin adhered to a glass bead was threaded through the underside of the construct 
in a central position approx. 4 mm away from the floatation bar (Figure 3.5). The 
pin was then attached to a model 403A force transducer (Aurora 
Scientific,Dublin, Ireland) using canning wax. The force transducer was 
connected to a Powerlab 4/25T unit with associated software (AD Instruments, 
Oxford, UK). Force was measured at a frequency of 1 kHz. Once stable, the 
baseline force of the resting constructs was measured for 3 minutes before the 
addition of 500 µL of 500 µM UTP in serum free DMEM (500 µL serum free 
DMEM in control experiments). Contraction was then measured for 60 minutes. 
N= 4 individual RASM constructs measured following treatment with 100 µM 
UTP. 
3.3.11 Evaluating the effects of agonist concentration on RASM 
collagen construct contraction 
RASM collagen constructs were removed from incubation 3 days after 
manufacture and attached to a model 403A force transducer (Aurora Scientific) 
as described in section 3.3.10. Once stable, the baseline force of the resting 
constructs was measured for 2 minutes before the addition of 500 µl of 50 nM 
UTP in serum free DMEM once peak force had been attained at this 
concentration, 500 µl of the media was removed from the glass chamber. After 
60 seconds, the UTP concentration was increased by a factor of 10 via the 
addition of 500 µl of a 500 nM solution. The process of increasing the UTP 
concentration by a factor of 10 for each measurement following the attainment 
of peak force was repeated until the final concentration added to the bath was 5 
mM UTP. N=6 RASM constructs tested. 
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A 
B C 
Figure 3.5: Attaching smooth muscle constructs to muscle physiology apparatus. 
Diagrams describing the protocol steps involved when attaching a RASM collagen 
construct to the force transducer (A). Photographs showing a side on and aerial 
view of the final setup (B and C respectively) 
1 2 
3 4 
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3.3.12 Evaluating the effects of antagonists on RASM collagen 
construct contraction 
RASM collagen constructs were removed from incubation 3 days after 
manufacture and attached to a model 403A force transducer (Aurora Scientific) 
as described in section 3.3.10. Once stable, the baseline force of the resting 
constructs was measured for 3 minutes before the addition of 500 µl of 500 µM 
nifedipine (500 µl serum free DMEM in control experiments). After 5 minutes 
treatment with nifedipine, 200 µl of 1.25 mM UTP was added to the glass 
chambers and force recorded for 30 minutes. N= 3 constructs per condition 
(control/ nifedipine). 
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3.4  Results 
3.4.1 HASM seeded collagen gel contraction in response to 
chemical stimuli 
In vivo SM tissue contracts in response to a range of physiochemical stimuli. In 
order to determine whether collagen based constructs could be used to measure 
the force of SM contraction in response to such stimuli, an established well plate 
assay (Matsumoto et al. 2007) was used.  HASM cells seeded into 500 µl collagen 
hydrogels in a 24 well plate were stimulated with histamine, bradykinin or serum 
free media (control) and imaged over 150 minutes (Figure 3.6 A). All gels, 
including the controls, contracted over the time period for all donors. Final gel 
size (as a percentage of original size) reached for each condition was 69.21 ± 
18.23%, 49.84 ± 12.26% and 41.92 ± 10.52% (mean ± standard deviation) for the 
control, histamine and bradykinin gels respectively. The bradykinin stimulated 
gels contracted significantly more than control gels (Figure 3.6 B) from t=60 to 
t=150 minutes (P<0.05 Tukey’s Two-Way ANOVA with Multiple Comparisons). 
There was no significant difference seen between histamine stimulated gels and 
control gels. 
3.4.2 Isolation and characterisation of primary RASM cells 
Due to the limited availability of primary human tissue, especially from within 
the peripheral airways, an alternate source of SM cells was required for 
optimisation of the contraction model. As an alternative source of SM tissue, 
aortic tissue was dissected from male Wistar rats and enzymatically digested. 
The dissociated aortic SM cells were seeded onto collagen coated tissue culture 
flasks and expanded up to passage 3. Upon digestion of the aortic tissue, an 
average of 2.74 x 106 ± 9.78 x 105 cells (n=6, mean ± standard deviation) were 
isolated, 66.34% of which were viable (determined using trypan blue dye  
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Figure 3.6: Contraction of ASM cells in collagen gels. Primary human ASM cells from 3 
separate donors were seeded into 500µl collagen gels in a 24 well plate. Gels were treated 
with a solution of bradykinin, histamine or serum-free DMEM for 150 minutes . The gels 
were imaged at designated time intervals (A) and gel size measured, graph shows mean 
contraction (n=3), error bars display standard error of the mean (B). Gels stimulated with 
bradykinin contracted significantly more than control gels from T=60 minutes onward 
(*P<0.05. Tukey’s Two-Way ANOVA with Multiple Comparisons). Indicating that the 
addition of bradykinin increased the level of contraction when compared to the 
unstimulated control. 
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exclusion). At passage 1 an average of 3.43 x 106 ± 1.88 x 106 cells (n=6, mean ± 
standard deviation) were isolated, 78.36% of which were viable.Isolated RASM 
cells seeded onto glass coverslips were fixed and immunostained for smooth 
muscle markers (n= 5 donors, 3 images per donor Figure 3.7). The RASM cells 
stained for smooth muscle specific markers SM22α and calponin (Figure 3.7A, B 
respectively) with high expression of both markers seen (94.60 ± 2.75% and 
82.52 ± 5.32% respectively; mean ± standard deviation, n=5 donors, 3 images per 
donor). Staining was also seen for the focal adhesion protein vinculin (Figure 
3.7D) with clear focal adhesion points visualised at the cell extremities. High 
expression of the gap junction protein connexin was seen in the samples with a 
granular appearance concentrated around the nucleus (Figure 3.7C). The 
majority of RASM cells within the samples stained negative for the intermediate 
filament protein desmin (Figure 3.7C). 
3.4.3 Contraction of RASM seeded collagen gels 
As seen with primary HASM cells, SM cells seeded within collagen hydrogels 
were able to contract the gel without the addition of an agonist due to the 
attachment of the cells to the collagen fibrils within the gel structure. With the 
addition of an agonist to the culture media, the level of contraction seen is 
significantly greater. In order to determine the difference between cell 
attachment mediated gel contraction and agonist induced cell/ gel contraction, 
RASM cells were seeded into collagen gels at three different densities and 
stimulated with a range of agonist (UTP) concentrations (n=3). After cell seeding, 
gels were incubated overnight (17 hours) for the gel to set and gel remodelling to 
occur (Figure 3.8 A). Gels seeded at a density of 2 x 105 cells ml-1 contracted due 
to remodelling significantly less (62.48% original size) than gels seeded at a 
density of 5 x 105 and 1 x 106 cells ml-1 (32.91% and 23.19% of original size 
respectively (P<0.01 and P<0.001 respectively. Tukey’s two-way ANOVA with 
multiple comparisons) Figure 3.8 D). Remodelled gels were stimulated by 
addition of a UTP solution for 30 minutes 
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Figure 3.7: Characterisation of primary rat aortic smooth muscle cells. Primary rat 
SM cells from 4 separate donors were seeded onto glass coverslips and cultured 
for 10 days. Cells were fixed and immunostained for smooth muscle markers 
SM22α (green, A) and calponin (green, B), intermediate filament protein desmin 
(red, C) as well as gap junction protein connexin (green) (C) and focal adhesion 
protein vinculin (red, B and D). Scale bars = 100µm. All samples were additionally 
stained with the nuclear stain Hoechst 33342 (blue). All donors displayed high 
positivity for all markers. 
B 
A 
C 
SM22α - green 
Calponin -green and 
vinculin - red 
Connexin - green 
 Page 
57 
 
  
 
Figure 3.8: Effects of UTP concentration and cell density on gel contraction. Scanned images 
of RASM collagen gels at T=0 minutes (A) and T=30 minutes (B) after stimulation.  Graph of 
percent gel contraction against UTP concentration at various cell densities, error bars 
represent standard deviation (C, n=3). Graph of initial remodelling of the gels after 17 hours in 
culture, error bars represent standard deviation (D, n=3). Gels seeded with 2x10
5
 cells ml
-1
 
contracted significantly less than those seeded with 5x10
5 
and 1x10
6
 cells (P<0.01 and P<0.001 
respectively. Tukey’s One-Way ANOVA with Multiple Comparisons.). Cell densities are 
expressed in cells ml
-1
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(Figure 3.8 B). The greatest observable change in gel size when compared to 
controls was seen in 2 x 105 cells ml-1 gels treated with 1 mM UTP (44.43 ±  18.8% 
vs 62.48 ± 8.12% , mean ± standard deviation) however as seen in Figure 3.6 C, 
the variability in results at this density was higher than in other gels.  At a density 
of 5 x 105 cells ml-1 the greatest gel contraction was seen when stimulated with 
100 µM UTP (23.06 ± 8.53% of original size) when compared to the control 
(32.91 ± 3.96%). Although UTP stimulated contraction was measured in 1 x 106 
cells ml-1 gels, it was not possible to observe a difference between UTP 
concentrations. This is possibly because the gels cannot contract further beyond 
a maximum cell density where there is less collagen matrix to contract. The 
optimal conditions for measuring maximum agonist stimulated contraction in 
collagen gels therefore was observed when using gels seeded at a density of 5 x 
105 cells ml-1 stimulated by 100 µM UTP. 
3.4.4 Measurement of force generated during contraction of an 
established C2C12 model using the culture force monitor 
The forces generated by initial cell attachment by  various cell types including SM 
cells (rabbit bladder) and C2C12s (Cheema et al. 2003) within collagen gels have 
been measured using a CFM, a bespoke piece of equipment consisting of a force 
transducer parallel to a fixed anchor point, designed for measuring uniaxial 
contraction in hydrogel cultures (Brady et al. 2008)(Eastwood et al. 1994). In 
order to replicate similar experiments and validate the CFM for use in measuring 
SM contraction, C2C12 collagen constructs were manufactured. Constructs were 
rectangular in shape and were made from 2 ml of C2C12 cells (4 x 106 cells ml-1 a 
density published previously (Sharples et al. 2012)) suspended in a  collagen 
solution (Figure 3.9A). When maintained in culture, cellular attachment caused 
remodelling of the constructs leading to a reduction in gel width (Figure 3.9B). 
The majority of gel contraction was seen in the first 36 hours of culture where 
the average gel width reduced down to 50.55 ± 5.50% (mean  ± standard  
 Page 
59 
 
  
 
 
Figure 3.9: Remodelling effects of C2C12’s within a collagen gel under uniaxial tension. 
Photographs of a C2C12 seeded 2ml collagen gel at day 0 (A) and day 4 (B). A graph 
showing the reduction of gel width over time (C), error bars show standard deviation 
(n=4). Image of C2C12 seeded gel immunostained for desmin (red) and the nuclear stain 
DAPI (blue) after 14 days in culture, scale bar = 100µm(D). Distribution curve showing 
nuclear alignment within the collagen gels after 14 days (n=5, 3 images per n taken) (E). 
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deviation, n=4) of the width at day 0. After 4 days of culture, no more 
remodelling was seen with the gel width reaching 43.07 ± 3.22% of the original 
width (Figure 3.9C). When allowed to differentiate over 14 days, the C2C12s 
fused into myotubes (Figure 3.9D) which align along the lines of tension that 
form within the gel, perpendicular to the two floatation bars. The alignment of 
cells within the constructs was determined by measuring the angles of individual 
nuclei. 21.67% of nuclei (nuclei analysed from 3 constructs, 5 images analysed 
per construct) were within 10° of the mean nuclear angle. 
Initial remodelling forces were measured by attaching newly formed constructs 
(allowed to gel for 60 minutes) to the CFM and measuring the force for at a 
frequency of 0.167 Hz (1 reading per minute) for a 24 hour period (Figure 3.10A). 
The majority of the recorded gel contraction occurred within the first 80 minutes 
after attachment to the CFM (Figure 3.10B). After this time, the force reading 
plateaued. The average peak force reading for C2C12 constructs was 502 ± 129 
µN (mean ± standard deviation, n=5). The highest rate of contraction (10.2 ± 4.3 
µN min-1, mean ± standard deviation, n=5) was seen in the first 10 minutes with 
the rate of contraction gradually declining to 0.8 ± 1.1 µN min-1 after 60 minutes 
(Figure 3.10C).  
C2C12 constructs that were attached to the CFM for 24 hours were fixed and 
immunostained for desmin and counterstained with DAPI (Figure 3.11A) The 
C2C12 cells within the constructs were highly aligned with 31.78% of cell nuclei 
within ± 10° of the mean nuclear angle (Figure 3.11B). This indicates that uniaxial 
tension is formed within the constructs whilst attached to the CFM system. 
3.4.5 Measurement of RASM contraction using the CFM system 
As seen with the remodelling of C2C12 constructs, the CFM can be used to 
measure collagen construct contraction in a uniaxial manner. Therefore, RASM 
constructs were manufactured following the same design of the 2 ml C2C12 
constructs in order to measure the force generated during agonist induced 
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Figure 3.10: C2C12 gels initial cell attachment forces. CFM traces of 5 separate C2C12 gels over a 
24 hour period (A), the majority of the force measured was generated within the first two hours 
after placing on the CFM (B).  Average rates of contraction over the first 80 minutes after 
attachment to CFM (C). Error bars represent standard deviation. 
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Figure 3.11:  Cell alignment on the CFM. Image of C2C12 seeded gel 
immunostained for desmin (red) and the nuclear stain DAPI (blue) after 24 
hours on CFM, scale bar = 100µm (A). Distribution curve shows nuclear 
alignment within the collagen gels after 24 hours on the CFM (B) 
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contraction of RASM cells. Using the results obtained whilst studying RASM 
collagen gel contraction in 500 µl round gels, the cell density used for the RASM 
collagen constructs was 5 x 105 cells ml-1. The constructs were cultured for 3 
daysto allow the initial cell attachment and gel remodelling to take place. 
Additionally, this allows the cells to form an aligned population as they align 
parallel to the tension that is generated within the gels. This will ultimately result 
in a more accurate force measurement during contraction. When cultured over 3 
days, the RASM collagen constructs remodelled due to cellular attachment 
(Figure 3.12A-E). At 72 hours after construct formation, the mean gel width had 
reduced to 33.8 ± 6.6% of the original gel size (mean ± standard deviation, n=3 
donors, 6 gels per donor). Cellular morphology was observed over the first 3 days 
following polymerisation. Immediately after polymerisation the majority of cells 
had a round morphology with no visible protrusions (Figure 3.12F); at 24 hours 
after manufacture, cell morphology was much more spindle like with some 
alignment seen (Figure 3.12G). Following 72 hours after manufacture, cells 
remained spindle shaped and elongated; additionally, the cell density appeared 
greater due to gel contraction and the cell population appeared to be highly 
aligned (Figure 3.12H). 
Immunostaining of RASM constructs allowed for more accurate measurements 
of cellular alignment and density within the constructs. Cell alignment and 
density was not homogenous throughout the construct and varied between 
different areas. Cells were much more aligned (38.18% of nuclei within 10° of the 
line parallel to the length of the gel)  along the edges of the constructs than in 
the centre of the gels (14.57%) or close to the floatation bars (7.35%, Figure 
3.13B; n= 3 gels, 6 images per region per gel). The majority of cells within the 
floatation bar regions of the constructs are almost perpendicular to the 
orientation of cells along the edges with 7.56% and 8.77% of cells in this area 
orientated in the -75° to -85° and 75° to 85° ranges. The edges of the constructs 
were also the most densely populated areas (281.7 cells mm-2) with the 
floatation bars (175.3 cells mm-2) and the centre (61.78 cells mm-2) being  
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Figure 3.12: Remodelling effects of RASM cells on collagen gels. Images of 2 ml 
collagen constructs at T= 12hours (A), 24 hours (B), 48 hours (C) and 72 hours (D) 
after initial seeding. Average reduction in gel width was measured over time (E, n= 
3 donors, 6 gels per donor. Error bars show standard deviation). Micrographs of 
constructs taken on a light microscope at T= 1 hour (F), 24 hours (G) and 72 hours 
(H) after initial seeding. Scale bar = 100 µm, red arrows indicate the orientation of 
the gels, perpendicular to the floatation bars. 
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Figure 3.13: Cellular alignment and distribution of cells within RASM constructs. 
Photograph of a RASM collagen construct with the analysed regions highlighted (A). 
Graphs of nuclear angle distribution (B) and cell density (C) within specific areas of 
the constructs 
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significantly less densely populated (Figure 3.13C; n= 3 gels, 6 images per region 
per gel). RASM cells within the constructs stained positive for smooth muscle 
markers SM22α and calponin as well as focal adhesion protein vinculin and gap 
junction protein connexion. Constructs did not stain for intermediate filament 
protein desmin. No difference in expression could be seen for any marker in 
different areas of the gel (Figure 3.14). By culturing RASM constructs for 3 days 
prior to attachment to the CFM, cells were given sufficient time to attach to 
collagen fibrils within the gels. This remodels the gels causing uniaxial tension to 
form along which the RASM cells align themselves. It is important that this occurs 
before measuring agonist stimulated contraction for two main reasons: firstly, 
gel contraction due to cellular attachment would mask agonist stimulated 
contraction if both were to be measured simultaneously; secondly, an aligned 
population of cells will contract in the same direction, which better represents in 
vivo smooth muscle and also will generate a larger force in the direction of the 
force transducer. When attached to the CFM, RASM constructs were left to 
equilibrate within the system for at least 30 minutes or until the force reading 
was stable for 1 minute. The constructs were then stimulated to contract using 
100 µM UTP solution in serum free DMEM. No contractile force was measured 
when gels were stimulated once (Figure 3.15A) or twice (Figure 3.15B) with UTP. 
An increase in force was seen immediately after addition of the UTP solution 
however this was due to the change in volume within the chamber, an effect 
seen in control experiments. 
In order to investigate why no RASM contraction could be detected on the CFM, 
the contractile ability of free floating constructs were tested. In the experiment, 
one set of constructs had one A-frame removed whereas the other set had were 
completely detached from A-frame and floatation bar at one end (Figure 3.16A 
and B respectively). Both were stimulated with 100 µM UTP and serum free 
DMEM was used as a control. The gels were imaged at set time intervals and 
change in gel length was measured (Figure 3.16E), n=5 for attached stimulated 
constructs. Error bars display standard error of the mean). Constructs that were  
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Figure 3.14: Characterisation of RASM cells within collagen constructs. 
Fluorescence microscope images of RASM cells stained for smooth muscle 
markers SM22α and calponin as well as connexin (all green) and vinculin (red). All 
samples were counterstained with nuclear stain DAPI (blue). Images were taken 
from 3 different regions within the construct. Scale bar = 100 µm. 
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Figure 3.16: Effect of floatation bars on RASM construct contraction. 
Images of RASM constructs with one A-frame removed (A), and 
completely detached from one floatation bar (B). Images of the same gels 
30 minutes after stimulation with 100 µM UTP (C,D). Graph showing 
reduction in length over time of stimulated and unstimulated constructs 
(E). 
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completely detached reduced in size (Figure 3.16D) by 15.31 ± 5.97% (mean ± 
standard deviation). Constructs that were still attached to floatation bars showed 
no visible reduction in gel size (Figure 3.16 C). Unstimulated constructs showed 
nosigns of contraction. Therefore, the load applied by the mass of the floatation 
bars was too great for the constructs to pull. The rate of contraction within the 
free floating stimulated gels was greatest within the first 10 minutes with the 
greatest percent decrease seen between 8 and 10 minutes (0.73% min-1) after 
stimulation. Between 10 and 30 minutes post stimulation, the rate of contraction 
was stable at 0.42% min-1. A time lapse video of RASM construct contraction is 
shown in supplementary video 1. Constructs were able to contract with the 
floatation bars attached when seeded with 4 x 106  RASM cells (2 x 106 cells ml-1) 
although the reduction in construct size was still much less than detached gels 
seeded at 5 x 105 RASM cells ml-1. A video of this can be seen in supplementary 
video 2. It was necessary therefore, to develop a novel method of measuring the 
contractile forces generated by collagen constructs without the use of the 
floatation bars. 
3.4.6 Development of a novel method to measure contractile force 
in free floating collagen constructs. 
RASM collagen constructs contract in response to stimulation by an agonist (in 
this case, UTP). However, whilst the constructs are attached to the floatation 
bars used to manufacture the gels, this contraction is greatly restricted. When 
measuring contraction on the CFM, the floatation bars are used to attach the 
fragile collagen constructs to the force transducer. In order to accurately 
measure the contractile force therefore, a new method for measuring uniaxial 
contractile force in collagen hydrogels would have to be developed. In typical ex 
vivo organ bath studies the methodology used involves directly attaching the 
tissue to a force transducer using cotton thread or a pin. This experimental 
design was used as a template to overcome the problems encountered 
previously, removing the necessity of the floatation bars. By attaching the 
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constructs to a more sensitive force transducer (used to measure isometric 
contraction) using the method outlined in section 3.3.10, this was achieved. The 
additional load applied to the gel previously when using the floatation bars (2.59 
± 0.19mN plus 3.30 ± 0.69mN applied by mass of floatation bar plus hoops; mean 
± standard deviation, n=6 for floatation bars, n=4 for hoops) was massively 
reduced by using a minuten pin adhered to a fine glass bead (0.070 ± 0.006 mN, 
n=6) to attach the construct to the transducer. RASM constructs were cultured 
for 3 days prior to attachment to the transducer. Once attached, the force was 
allowed to stabilise before recording started. The stable force reading was 
measured for 3 minutes before the constructs were stimulated with 100 µM UTP 
in serum free DMEM, controls were stimulated with serum free DMEM. An 
increase in force was detected within seconds of adding the agonist solution and 
continued to rise for up to 30 minutes before beginning to plateau (Figure 
3.17A). The maximal force and therefore rate of force generation varied greatly 
between individual constructs (Figure 3.17B). The maximal force generated by 
the RASM constructs ranged from 196.33 µN to 542.36 µN with the average max 
force being 394.30 ± 147.76 µN (mean ± standard deviation). If the data is 
expressed as the percentage of the maximal contractile force measured 
however, the contraction profiles of the different gels appear to be highly similar 
(Figure 3.17C) and are logarithmic in shape. The majority of contraction occurs 
within the first 5 minutes following stimulation with 46.00 ± 7.77% of the 
maximal force measured occurring within this time; 76.20 ± 6.41% measured 10 
minutes following stimulation and 94.66 ± 3.44% after 20 minutes stimulation. 
The constructs all responded to the addition of 100 µM UTP; in order to 
investigate the sensitivity of the constructs and the contraction assay, a dose 
response experiment was carried out whereby the dose of UTP was increased by 
an order of magnitude once the force had plateaued at the current 
concentration. The lowest concentration tested was 10 nM increasing up to 1 
mM (Figure 3.18A). At doses of 10 nM UTP, there was no significant difference 
detected in the force readings when compared to the resting construct. A small 
change in force was detected at 100 nM although this was not large enough to  
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Figure 3.17: Measuring contractile force of RASM constructs attached to an 
isometric force transducer. Representative force trace of a RASM construct 
stimulated with 100 µM UTP over 60 minutes (A). Graph of force over time for 
four different RASM constructs (B). The same constructs are shown on a graph of 
% maximum force over time (C). 
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Figure 3.18: Effects of UTP concentration on the magnitude of force generated. 
A representative force trace of a RASM construct stimulated consecutively with 
increasing doses (A). A graph of % maximum contraction against UTP 
concentration (B), error bars represent standard deviation (n= 6; p<0.0001, One 
Way ANOVA with Tukey’s multiple comparisons test) 
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be statistically significant. When stimulated with 1 µM UTP, a large significant 
increase in force (p < 0.0001) was measured with 29.66 ± 7.1% (mean ± standard 
deviation, n=3 donors, 2 constructs per donor) of the maximal force observed at 
this concentration (Figure 3.18B). The force increased to 68.44 ± 15.94% of 
maximum force at 10 µM UTP and 97.68 ± 3.56% at 100 µM, both of these 
concentrations produced a significantly greater (p<0.0001) contraction than the 
previous. There was no statistically significant difference between the contractile 
forces recorded when constructs were stimulated with 100 µM and 1mM UTP 
indicating that the maximal dose is in the region of 100 µM. Using statistical 
analysis software (GraphPad Prism), the EC50 of UTP in stimulating the RASM 
constructs was calculated to be 3.19 µM. 
Due to the methods employed in the dose-response experiments it was not 
possible to tell whether the increases observed in force between UTP 
concentrations were due to the concentration rise or the addition of more UTP 
to the glass chamber. Therefore a repeat dose experiment was carried out to 
determine if the contractile force changed when constructs were stimulated 
repeatedly with the same dose. Constructs were stimulated with 10 µM UTP and 
the force allowed to plateau, the constructs were then stimulated with the same 
dose and allowed to plateau 3 more times. Finally, the constructs were 
stimulated with 100 µM UTP and left for the force to plateau a final time (Figure 
3.19). Following the initial stimulation with 10 µM UTP, the construct contracted 
as seen previously resulting in an increase in force. Once the force had 
plateaued, the repeat stimulations did not cause any increase in contraction and 
after two doses of 10 µM UTP, the force actually started to decline. When 
stimulated with the final 100 µM dose, the force measured rose to a level much 
higher than any previously registered force. 
The previous experiments show that the RASM collagen constructs can be used 
to assess SM contraction in response to chemical agonists at different 
concentrations. The final experiment of this chapter sought to investigate 
whether the RASM constructs could be effective in testing the effects on  
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Figure 3.19: Effects of repeat dosing on RASM constructs. A representative force 
transducer trace of a RASM construct stimulated repeatedly with a 10 µM dose of 
UTP before a final 100 µM dose. 
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Figure 3.20: Effects of the calcium channel inhibitor nifedipine on the 
contractile response of RASM constructs. A graph of force over time for RASM 
constructs stimulated with UTP following pre-incubation with nifedipine or 
serum free DMEM (control). Blue line indicates addition of 100 µM nifedipine 
solution. Red line indicates stimulation with 100 µM UTP. Error bars represent 
standard deviation. 
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chemicals that act as contractile antagonists. RASM constructs were attached to 
the force transducer and pre-incubated with nifedipine, a calcium channel 
inhibitor, for 5 minutes before being stimulated with 100 µM UTP (Figure 3.20). 
Although contractile force was measured upon UTP stimulation in all constructs, 
those that were pre-incubated with nifedipine prior to UTP stimulation produced 
significantly less contractile force than those that were pre-incubated in serum 
free DMEM (n=3; p< 0.0001, paired t-test). 
 
 
 
 Page 
78 
 
  
 
3.5 Discussion 
SM contraction in vivo contributes to shortening of the muscle tissue and 
narrowing of hollow organs such as blood vessels and airways. In diseases such 
as asthma (Heard & Hossain 1973; Hossain 1973) and atherosclerosis 
(Pasterkamp et al. 1996; Pasterkamp et al. 1997), where remodelling of the 
tissue is a key feature, narrowing of the organs due to SM contraction can be 
excessive leading to temporary obstruction of the vessel/ airway. In order to fully 
investigate the biological processes that influence SM contraction and to develop 
therapeutic agents that can regulate it in diseases such as those mentioned 
above, effective models of SM contraction need to be developed. As discussed 
earlier, ex vivo tissue preparations from both humans (Lee et al. 1999) and 
animals (Prendergast et al. 2006) can be stimulated using organ baths. However 
human tissue is limited in availability and due to fundamental differences 
between humans and animals (Ginis et al. 2004; Castellano et al. 2015), animal 
tissue may not fully recreate human responses. Although tissue engineering 
strategies to recreate smooth muscle contraction have been developed 
(Matsumoto et al. 2007; Sakota et al. 2014; Ilagan et al. 2010; Margulis et al. 
2009), very few have been designed to be used in force measurement studies 
(Gilmont et al. 2013; Oishi et al. 2000; Oishi et al. 2002). Here, new methods 
were developed to measure the contractile force of aligned SM cells seeded 
within collagen gels in real time. Agonist induced contraction was concentration 
dependant and could be negated by the presence of antagonists. 
3.5.1 Measuring SM contraction via image analysis of collagen gels 
Visual assessment of both primary human airway and primary rat aortic SM 
contraction within collagen gels in response to chemical agonists was carried out. 
Initial experiments using primary human cells found that gels exposed to 
bradykinin and histamine both reduced in size at a faster rate than unstimulated 
gels. These results are similar to those obtained by Matsumoto et al. who 
stimulated gels seeded with airway SM cells from donors both with and without 
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asthma with 100 µM histamine (Matsumoto et al. 2007). Both sets of gels were 
found to contract much more than the unstimulated controls with asthmatic SM 
gels contracting significantly more. Sakota and co-workers also stimulated 
human airway SM seeded gels with 100 µM histamine, finding that the gels 
contracted to around 50% of their original size 60 minutes after stimulation 
(Sakota et al. 2014). In our study, the gels continued to contract over the full 
course of the experiment (150 min), much longer than the time to reach 
maximum gel contraction found by both Matsumoto (15.7 min) and Sakota 
(approx. 50 mins). This is most probably due to differences in the methodology 
of each study. In this case, the gels were stimulated 1 hour after plating which 
did not allow time for the gels to attach or remodel the collagen prior to 
stimulation. Sakota incubated the gels for 3 days prior to stimulation but allowed 
the gels to remain attached to the well plate until stimulation whereas 
Matsumoto incubated detached gels for 24 hours prior to stimulation. Due to 
this, in our experiments it is highly probable that the contraction measured 
within these gels is due to a mixture of cellular attachment to the matrix, 
unloading of the gels from the well plates and agonist induced contraction. 
In order to remove the noise created by initial cell attachment mediated 
contraction from the experiment; the subsequent contraction assay (using RASM 
cells, discussed in section 3.5.2) allowed the detached gels to incubate overnight 
for 17 hours before stimulation. In this case, although using a different SM 
source and agonist, the time to maximum contraction was much closer to that 
observed in other studies (25 min). Therefore, in order to accurately depict SM 
contraction in response to an agonist, it is important to allow the gels to contract 
prior to stimulation. Cell density had a direct effect on the level of the initial gel 
contraction, an observation found in collagen constructs containing fibroblasts 
(Redden & Doolin 2003) and mesenchymal stem cells (Nirmalanandhan et al. 
2006). At a density of 1 x 106 cells ml-1 the initial gel contraction was too great to 
observe any further contraction when stimulated. Therefore, 5x105 cells ml-1 was 
chosen for further experiments. During this assay it was found that stimulation 
with 100 µM UTP resulted in the maximal gel contraction at a density of 5x105 
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cells ml-1, a similar finding to that found by Urquilla, who recorded maximum 
contraction of canine cerebral artery segments at a concentration of 170 µM UTP 
(Urquilla 1978). 
3.5.2 Isolation of vascular smooth muscle cells from rat aorta 
Primary human airway SM cells were initially used in the collagen contraction 
experiments described within this chapter. Due to the limited availability of 
primary human tissue it was decided that another cell source should be used in 
the initial optimisation and development of the contraction assays. Within the 
Queen’s Medical Centre, University of Nottingham, male Wistar rats are 
sacrificed for various studies on a regular basis. As these animals are readily 
available and that using tissues from them would be in line with 3Rs principles 
(replacement, reduction and refinement), primary RASM cells were used as a 
readily available alternative to human cells. Isolated RASM cells were 
immunostained for smooth muscle markers SM22α and calponin at passage 3.  
Smooth muscle phenotype was confirmed via a high level of expression of both 
SM22α and calponin. SM22α is a Ca2+ sensitive 22kDa protein which binds to F-
actin (Kobayashi et al. 1994) originally isolated from chicken gizzard (J. P. Lees-
Miller et al. 1987). It is thought to be specific to SM cells (Solway et al. 1995; J P 
Lees-Miller et al. 1987) although its exact role within SM remains unknown. 
Recent studies propose that SM22α has an important role in the regulation of 
basal tone within SM cells as upregulation of SM22α within tonic SM resulted in 
relaxation of the cells. Conversely, temporary silencing of SM22 caused 
contraction within both phasic and tonic SMs (Rattan & Ali 2015). Calponin is a 
34 kDa protein that binds to F-actin, tropomyosin and calmodulin (Takahashi et 
al. 1986) that is found within smooth muscle cells (North et al. 1994). It is 
thought to regulate SM contraction by inhibiting actin-activated myosin 
MgATPase activity (Winder & Walsh 1990) which is reversed via calponin 
phosphorylation (Pohl et al. 1997); therefore contributing to cross-bridge cycling 
in SM contraction. The high expression levels of these two markers therefore 
indicate that the majority of the isolated cells are smooth muscle cells. The low 
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standard deviation in the expression of these markers indicates that smooth 
muscle content showed little variation between isolations, regardless of the large 
differences in initial cell number. Although the intermediate filament protein 
desmin is frequently observed within SM cells (in addition to cardiac and skeletal 
cells), it was not expressed in the isolated RASM cultures. This result correlates 
with results obtained by Gabbiani et al. who found that whereas smooth muscle 
from other areas of the body contain large amounts of desmin; intermediate 
filaments in vascular smooth muscle contain very little (if any) desmin with 
vimentin being the key protein expressed (Gabbiani et al. 1981). 
3.5.3 C2C12 collagen constructs as a model system to test the force 
measuring ability of the CFM 
C2C12 collagen constructs were successfully manufactured following protocols 
similar to those previously published (Smith et al. 2012; Sharples et al. 2012). 
Constructs narrowed over time due to cellular attachment to the collagen matrix. 
This was to a similar degree as seen in those manufactured by Sharples et al. and 
within the constructs cells aligned along the lines of tension previously predicted 
by finite element analysis experiments (Eastwood et al. 1998). When placed on 
the CFM the force generated by this initial cellular attachment and subsequent 
gel remodelling could be measured. Force traces were similar in shape, peak 
force and time to reach peak force to those produced by C2C12 collagen 
constructs manufactured by Sharples et al. This is in contrast to the traces 
generated by C2C12 collagen constructs published by Cheema et al. where an 8 
hour lag phase was recorded prior to any major contraction (Cheema et al. 
2003). This is most probably due to differences in the manufacture of the 
constructs; primarily, those produced by Cheema and co-workers were 5 ml in 
volume and seeded with 5 x 106 cells. The resultant cell density used by Cheema 
(1 x 106 cells ml-1) is much lower than those used here and by Sharples (4 x 106) 
and cell density has been shown to have a clear effect on both the rate and 
amount of gel contraction (Awad et al. 2000).  
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The majority of the force generated by the constructs occurred within the first 
two hours before shortly plateauing; however when assessing the constructs 
visually, they continue to remodel for several days. Upon immunostaining the 
constructs following 24 hours on the CFM, it is clear that the cells are aligning as 
they would in static isometric culture. This indicates that there is uniaxial tension 
forming within the constructs. Therefore, it is plausible to suggest that as the 
constructs contract and displace the force transducer beam; the counter force 
produced by the beam reaches a point where it is in equilibrium with the force of 
contraction. It is this that leads to the plateau seen after approximately 2 hours; 
this theory could be tested by using beams with varying spring constant. 
According to Hooke’s law, those with lower spring constants would produce less 
force at the same level of displacement.   
As the CFM was able to reliably measure the remodelling force of C2C12 
constructs up to an average peak force of ≈500 µN, it was decided that the CFM 
would be suitable apparatus to initially measure the agonist induced contraction 
of RASM collagen gels. 
3.5.4 Manufacture of RASM collagen constructs and contractile 
force measurement 
RASM collagen constructs were manufactured to the same specifications as the 
C2C12 constructs, differing only in cell density and culture time. RASM constructs 
remodelled and narrowed over time, due to cellular attachment and alignment, 
in a similar fashion to their C2C12 counterparts. Alignment however was not 
found to be uniform throughout the construct, nor was the density of the cells. 
Cells appeared highly aligned and densely packed at the edges of the constructs 
but cells located near the floatation bars aligned perpendicular to those on the 
edge. This is due to uneven distribution of the tension through the gels, an 
observation found by Eastwood et al. when studying fibroblast seeded collagen 
constructs (Eastwood et al. 1998). They found that the in area directly around 
the floatation bars (referred to as the ‘delta zone’), the gel was supported by the 
stiffness of the bars resulting in a lack of tension and consequently, a lack of 
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alignment. In contrast to the RASM constructs however these gels were 
stimulated with cyclic uniaxial loading for 16 hours, which resulted in more 
alignment within the centre of the gels than seen in this study. Expression of SM 
markers did not appear to show any change in phenotype than when cultured 
upon glass however cell morphology was more spindle-like in nature and 
expressed less obvious stress fibres due to the 3D collagen matrix  (Hakkinen et 
al. 2011). 
When stimulated to contract upon the CFM, RASM constructs registered no 
increase in force. SM constructs have been found previously to generate 
measurable force on the CFM; this was however caused by remodelling of the gel 
and not by agonist stimulation (Cheema et al. 2003). This was found to be 
because the load applied by the mass of the floatation bars and connecting 
hoops was too great (2.59 ± 0.19mN plus 3.30 ± 0.69mN applied by mass of 
floatation bar plus hoops; mean ± standard deviation, n=6 for floatation bars, 
n=4 for hoops)  for the contractile force generated by the cellular contraction to 
overcome. This was exemplified by the difference noted in contraction between 
free floating RASM constructs and those still attached to the floatation bars. 
Additionally, the load applied by the floatation bars is greater than forces 
recorded in earlier studies of SM gel contraction (Oishi et al. 2000; Gilmont et al. 
2013).  
In order to measure contractile forces generated by RASM constructs, a simpler 
experimental setup was used. This setup was similar in concept to both the CFM 
and traditional organ baths in that it possessed both a fixed point and a force 
transducer. In this case however, the gels were attached to the transducer via a 
minuten pin (unlike CFM) and no perfusion system was connected to the 
chamber (unlike organ bath). The pins used to attach constructs to the force 
transducer applied a much lower initial load (0.070 ± 0.006 mN, n=6) than 
floatation bars. RASM constructs stimulated with UTP contracted whilst attached 
to the force transducer setup and force was successfully measured. Although the 
shape of the force over time curve was very similar between individual 
constructs, the maximal force generated by constructs varied greatly. This is 
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most likely due to the experimental setup as the pin has to be passed through 
the construct manually. As the constructs contract and reduce in size, any item 
held within the construct (such as a pin) would be displaced in the direction of 
contraction. Therefore if the pin is placed closer to the end of the construct, it 
will be displaced more than a pin positioned a few mm further towards the 
centre of the construct. This is obviously a major limitation of the experimental 
setup which would require modifying in order to increase the accuracy of the 
assay. The mean maximal force generated by the constructs was similar to that 
obtained from tissue engineered internal anal sphincter constructs stimulated 
with KCl (Gilmont et al. 2013). It was approximately half the level of force 
achieved by guinea pig stomach smooth muscle cells seeded within collagen gel 
fibres stimulated with phenylephrine (approx. 1mN), although it is worth noting 
that the initial seeding density was 3 times higher than in the RASM constructs 
investigated here (Oishi et al. 2000). 
RASM constructs contracted in a dose responsive manner in the range of 0.1 µM 
to 1mM, a range previously recorded by Miyagi et al. who measured the 
contractile force of bovine middle cerebral artery strips in response to UTP. The 
dose response curve produced by RASM construct contraction is very similar to 
curves of inositol (poly)phosphate accumulation in response to UTP stimulation 
of rat aortic SM cells (Harper et al. 1998; Kumari et al. 2003). RASM constructs 
were found to not increase in force when repeatedly stimulated with the same 
dose, indicating that contraction was concentration dependant. 
Nifedipine is an L-type Ca2+ channel blocker that prevents the influx of 
extracellular calcium into the cell (Hayashi et al. 2010) that is used in the long 
term treatment of hypertension (Snider et al. 2008). 100 µM nifedipine has been 
found to inhibit Ca2+-sensitive K+ channels (Thomas-Young et al. 1993) and 10 
μM nifedipine reduced calcium ion influx in vascular smooth muscle cells by 44% 
(Cirillo et al. 1993). Pre-treatment of RASM constructs with 100 µM nifedipine 
caused a significant reduction in the contractile force produced by the constructs 
in response to UTP stimulation but did not fully inhibit contraction. This was 
expected as the initial stage of SM contraction is not dependant on extracellular 
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calcium and is caused by release of Ca2+ ions from the sarcoplasmic reticulum. 
The influx of extracellular calcium is important for sustained contraction. 
Although much lower in force, sustained contraction was seen in nifedipine 
treated RASM constructs and was most probably due to the activity of T-type 
Ca2+ channels which are also present in SM cells (Hayashi et al. 2003; Hayashi et 
al. 2010) and are much more resistant to dihydopyridine calcium channel 
blockers (such as nifedipine) than L-type Ca2+ channels (Perez-reyes et al. 2009). 
These results strongly suggest the presence of L-type Ca2+ channels, a marker of 
differentiated vascular SM cells (Gollasch et al. 1998) and also display the ability 
of the RASM constructs and contraction assay to assess the effects of antagonists 
(as well as agonists) on SM contraction. 
3.5.5 Chapter Summary 
Within this chapter of work, RASM cells were successfully isolated and 
characterised in vitro. When seeded into collagen hydrogels they were found to 
contract them in response to chemical stimuli in a similar manner to primary 
human airway SM cells. RASM cells expressed high levels of SM markers SM22α 
and calponin and stained negative for desmin, all of which are expected from 
contractile vascular SM cells. Using the design of an established C2C12 model, 
RASM/ collagen gel constructs were established and stimulated to contract 
whilst free floating and attached to force measurement apparatus. Furthermore, 
RASM construct contraction was successfully measured using a force transducer. 
However this was not possible using the CFM due to the added mass of the 
floatation bars. This was overcome by directly attaching the constructs to a 
sensitive force transducer via a minuten pin. In the contraction studies, RASM 
construct contraction was found to be agonist concentration dependant and 
additionally, contraction could be inhibited by L-type Ca2+ channel inhibition. 
Limitations of the RASM constructs developed and used within the chapter 
include the heterogeneity of cell alignment and density between different 
regions of the construct. This may affect the accuracy of uniaxial SM contraction 
measurement as a minority of the population (predominantly located close to 
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the floatation bars will contract perpendicular to the direction of force 
measurement. Finally, the attachment of the constructs to the force transducer 
currently introduces too much variability into the force measurement results; 
illustrated by the range of maximum force generated by individual constructs. 
Following these studies, the next step was to develop a novel scaffold that could 
support the growth of a population of smooth muscle cells and improve the 
levels of alignment seen when compared to the collagen hydrogels which lacked 
uniformity. Therefore, scaffolds with topographical features that could guide this 
alignment would be highly beneficial. Electrospinning provides a method to 
generate fibrous scaffold mats, including those with aligned fibres. By 
manipulating the electrospinning parameters, it may be possible to produce 
scaffolds that can support the growth of aligned smooth muscle cells 
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4. Electrospinning aligned PET scaffolds for the in 
vitro 3D culture of Smooth Muscle cells 
4.1 Introduction 
As discovered in the previous chapter, collagen hydrogels can be used as a matrix 
to culture smooth muscle (SM) cells that can contract the gels in response to a 
stimulus. Additionally, when the gels are cultured under tension, the cells 
embedded within them align in response to the mechanical cues. However, this 
alignment is not uniform throughout the gel and additionally, the mechanical 
properties of the collagen gels (for example, elasticity) are much weaker than the 
ECM found in vivo. Therefore, an alternative scaffold matrix was sought that 
could not only provide topographical cues to the SM population resulting in a 
highly aligned population of cells but also possess mechanical properties that 
more closely represent in vivo environments. The field of tissue engineering has 
investigated and developed multiple ways of producing scaffolds or surfaces that 
can provide cells with topographical cues. In addition, a number of 
biocompatible polymers can be used to produce synthetic scaffolds, each with 
differing mechanical properties. Examples of methods that can be used to design 
scaffolds with topographic features include 3D printing(Serra et al. 2013), 
photolithography(Vasiev et al. 2013) and stereolithography (Gauvin et al. 2012). 
The focus of this chapter of work however will be upon the process of 
electrospinning, a technique used to draw fibres (usually in the micro or nano 
scale) from a polymer solution or melt using a high voltage electrical supply. 
These fibres can be collected as non-woven mats for various applications such as 
filtration membranes (Guo et al. 2011), textiles (Deitzel et al. 2001), drug delivery 
vessels (Zeng et al. 2003), wound dressings (Jia et al. 2007) and scaffolds for 
tissue engineering (Pham et al. 2006). 
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Electrospinning was first reported in 1934 by Formhals who submitted the patent 
titled ‘Process and apparatus for preparing artificial threads’ (Formhals 1934) 
Although the process of drawing fibres from a solution using an electrical charge 
had been known for many years before, prior to Formhals’ work it was not 
possible to successfully collect the spun fibres. This was corrected by spinning 
acetate fibres onto a moving collector device. Formhals went on to refine his 
electrospinning method in subsequent patents (Formhals 1939) but it was to be 
another two decades before any further developments in electrospinning would 
be made. Whilst carrying out studies on the formation of electrically driven jets, 
Taylor examined the shape of the droplet at the tip of a needle when exposed to 
an electric field (Taylor 1969). He found that in this state the droplet forms a 
cone from which jets are ejected from the vertex. This droplet shape 
subsequently became known as the ‘Taylor cone’. Later studies on the 
electrospinning of fibres began to focus on the morphology of the fibres 
themselves (Baumgarten 1971) and how the process parameters affected the 
resultant fibres (Larrondo & Manley 1981a; Hayati et al. 1987). Studies by 
Reneker and Chun investigating electrospun polyethylene terephthalate (PET) 
fibres expanded on the previous work by Taylor, describing the electrospinning 
jet as 4 regions: the base, the jet, the splay and the collection (Reneker & Chun 
1996). The base is the droplet at the needle tip and its shape is dependent on 
both the voltage of the electric field and the surface tension of the solution. If 
the electrical field is strong enough to overcome the surface tension a jet is 
ejected from the tip of the cone. Electrostatic forces accelerate the jet as it 
travels towards the collector causing it to stretch; this coupled with the 
evaporation of volatile solvents causes the jet to narrow and decrease in 
velocity. Reneker and Chun hypothesised that charge repulsion within the jet 
caused it to split (or splay) into multiple equal fibres before being deposited on 
the collector. This was however later disproved by Shin et al. who studied the jet 
using high speed photography finding that the ‘splaying’ fibres was actually a 
single rapidly whipping jet (Shin et al. 2001). An illustrated diagram of the 
electrospinning process is shown in Figure 4.1. 
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Figure 4.1: Diagram displaying the key aspects of the electrospinning 
process. 
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Many factors have been found to affect the morphology of the resultant fibres 
produced by electrospinning. Properties of the polymer solution, variation in the 
electrospinning apparatus and external parameters have all been found to play a 
role in the fate of electrospun fibres. It is worth noting that some parameters 
have a greater effect on fibre morphology than others and also that some 
parameters (such as solution viscosity and polymer concentration) are 
intrinsically linked. Polymer concentration and solution viscosity have been 
found to have a direct effect on fibre diameter when electrospinning a wide 
range of polymers such as poly(lactic co-glycolic aclid) (PLGA) (H. S. Kim et al. 
2005), PET (Kim et al. 2004), poly(vinyl alcohol) (PVA) (Koski et al. 2004; Zhang et 
al. 2005), poly(L-lactic acid) (PLLA) (Jun et al. 2003), polystyrene 
(Jarusuwannapoom et al. 2005) and poly(ethylene oxide) (PEO) (Son et al. 2004). 
When low polymer concentration solutions are electrospun, the resultant fibres 
contain non-uniform spherical defects (an effect referred to as beading) caused 
by the jet breaking down into droplets (Kumbar et al. 2007); a similar result is 
seen when electrospraying (Bock et al. 2011). At low concentrations the 
collected fibres may still be wet with solvent resulting in merging of fibres 
forming ‘junctions’(Deitzel et al. 2001). As the concentration and viscosity 
increase however, the level of beading and junctions observed reduces and the 
diameter of the fibres increases (Ki et al. 2005; McKee et al. 2004). However, if 
the solution is too concentrated, the droplet can dry out at the needle, blocking 
the flow of solution on preventing any further electrospinning (Zong et al. 2002; 
Duan et al. 2004). The solution conductivity and surface tension have also been 
found to affect the electrospinning process; for example, beading can be reduced 
in electrospun fibres by adding salts to increase solution conductivity (Mit-
uppatham et al. 2004; Kim et al. 2005) and surfactants to decrease the surface 
tension (Yao et al. 2003; Lin et al. 2004). Cationic surfactants such as 
cetyltrimethylammonium bromide (CTAB) (Yang et al. 2009) or 
tetraethylammonium chloride (TEAC) (Chaurey et al. 2012) can be added to 
solutions to alter both the conductivity and surface tension of solutions. It is 
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worth noting that it is also possible to electrospin a polymer from a melt 
(Larrondo & Manley 1981a; Larrondo & Manley 1981b; Larrondo & Manley 
1981c), removing the effects of solvent properties from the electrospinning 
process. One advantage that melt electrospinning possesses over solution 
electrospinning is that much greater control over fibre deposition can be 
achieved (Dalton et al. 2008) allowing for the production of intricate lattices 
(Hutmacher & Dalton 2011) or even precise writing (Brown et al. 2011). 
In addition to the solution concentration, the parameters that are easiest to 
control are those that are part of the electrospinning setup. These include the 
flow rate, needle size (and design), applied voltage and the distance between the 
needle and collector. The rate at which the polymer solution is ejected from the 
needle has been found to affect the diameter of electrospun fibres. Lowering the 
flow rate can produce fibres with smaller diameters (Zong et al. 2002). 
Conversely, increasing the flow rate can lead to wet fibres being deposited on 
the collector (Yuan et al. 2004). The needle diameter effects the velocity of the 
solution at a set flow rate, additionally, the shape size and stability of the Taylor 
cone is linked to needle diameter (Scheideler & Chen 2014). In addition to this, 
by changing the design of the needle to a co-axial two-capillary design, it is 
possible to produce hollow fibres (Li & Xia 2004; Yu et al. 2014) or two separate 
polymers together in a core-shell fibre design (Zhuo et al. 2011; Kriel et al. 2012). 
This approach can also be used to encapsulate active molecules within the fibres 
(Yu et al. 2011). The electric potential applied across the electrospinning setup 
needs to be strong enough to overcome the surface tension of the solution and 
form a Taylor cone. Several studies have investigated the effects of voltage on 
the electrospinning process however there does not appear to be a clear 
correlation between voltage and fibre diameter. Studies electrospinning PDLA  
(Zong et al. 2002)and PVA (Zhang et al. 2005) reported an increase in fibre 
diameter with increasing voltage whereas those electrospinning polysulfone 
(Yuan et al. 2004) and protein polymers (Buchko et al. 1999) have reported the 
opposite. One effect of applied voltage that is widely reported however, is that 
too high a voltage will result in beading (Zong et al. 2002; Zhang et al. 2005; Yuan 
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et al. 2004) due to the Taylor cone receding into the needle tip (Deitzel et al. 
2001). The final controlled parameter is the distance placed between the needle 
tip and the collector. Fibres that are spun too close to the collector will still be 
wet upon collection resulting in non-uniform fibres or junctions between fibres. 
Studies by Baker and co-workers suggest that there is a linear trend between the 
distance and the fibre diameter with diameter reducing as distance increases 
(Baker et al. 2006). At increased distances beading has been observed (Lee et al. 
2004), most probably due to increased jet instability and whipping. 
Environmental parameters such as temperature and humidity are also known to 
have effects on the electrospinning process. An increase in temperature can lead 
to decreased fibre diameter due to reduced solution viscosity (Mit-uppatham et 
al. 2004) and increased humidity can lead to the development of pores on the 
surface of fibres (Casper et al. 2004) and a reduction in fibre uniformity 
(Pelipenko et al. 2013).  
In order to produce aligned fibrous scaffolds through electrospinning, the design 
of the collector needs to be taken into consideration. Electrospinning onto a flat 
collector plate (in the majority of cases) will result in a randomly oriented 
scaffold. Therefore, other collector designs have been used in the pursuit of 
aligned fibres. By electrospinning directly onto a rotating drum or mandrel, it is 
possible to generate aligned fibre scaffolds; however, the degree of alignment 
achieved is dependent on the velocity of the drum itself (Bashur et al. 2006; 
Hadjizadeh et al. 2011a). An alternative method to generate aligned fibres is to 
use two parallel electrodes to collect fibres. This can be achieved either by using 
dielectric materials (Yan et al. 2009) or separating two conductive strips by an 
insulative material such as glass (Li et al. 2003). Chaurey et al compared these 
two methods of aligning electrospun fibres using solutions of PLGA. They found 
that greater alignment was achieved when using parallel electrodes and that in 
both methods, fibre alignment increased with fibre diameter (Chaurey et al. 
2012).  
Both fibre diameter and alignment, in addition to the mechanical properties of 
the scaffold, have been found to affect the behaviour of cells cultured upon 
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them. Therefore, when designing electrospun scaffolds for tissue engineering 
applications, it important to attempt to recreate the extracellular environment 
found in vivo. For example, chondrocytes cultured upon electrospun PLLA were 
found to have higher rates of proliferation and increased glycosaminoglycan 
production on nanofibres than on microfibres (Li et al. 2006). This effect was also 
seen in fibroblasts cultured upon Bombix mori silk fibroin scaffolds with fibres 
ranging from 250 to 1200 nm. Fibres 250 to 300nm in diameter supported cell 
proliferation significantly more than those in the 1 µm range (Hodgkinson et al. 
2014). In addition, the number of cell-fibre interactions reduced as fibre 
diameter increased.  On the other hand, NIH 3T3 fibroblast proliferation was not 
significantly altered by the diameter of PLGA scaffolds (Bashur et al. 2006). 
Schwann cells also have been found to proliferate and adhere faster upon 
nanofibres than microfibres although cell migration and motility was greater on 
microfibres (Gnavi et al. 2014). A study by Rueder et al cultured human umbilical 
vein endothelial cells (HUVECs) and SM cells on electrospun 
copolyetheresterurethane (PDC) fibres ranging from 2 µm to 500 nm in diameter. 
HUVEC viability and proliferation was higher on microfibre scaffolds whereas 
nanofibre scaffolds supported SMC viability (Rueder et al. 2013), indicating that 
cell response to fibre diameter is dependent on the cell type. 
Fibre alignment has been reported to have a clear effect on cell morphology and 
behaviour. For example, human ACL fibroblasts appear spindle-shaped and 
orientate in the fibre direction of aligned polyurethane fibres. They were also 
found to synthesize significantly more collagen when cultured upon aligned than 
randomly orientated fibres (Lee et al. 2005). Aligned PLGA fibres have been 
reported to enhance the proliferation of rat periodontal ligament cells when 
compared to randomly aligned and 2D PLGA controls (Shang et al. 2010). 
Furthermore, aligned fibrous scaffolds have also been found to promote 
Schwann cell maturation (Chew et al. 2008) and modulate axon organisation 
(Gnavi et al. 2015). Similar to the study by Rueder et al who found differential 
behaviours between cell types on different diameter fibres, a corneal 
engineering study by Yan et al found that aligned fibres were favoured by 
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keratocytes whereas corneal epithelial cells interacted better with random fibres 
(Yan et al. 2012). 
SMCs have been cultured on electrospun scaffolds made from several materials 
including PCL (Zhu et al. 2010), PLLA (Ahvaz et al. 2012), P(LLA-CL) (Xu et al. 2004) 
and a PCL-gelatin copolymer (Kuppan et al. 2015). SMCs cultured upon aligned 
fibres are reported to possess a spindle like morphology and higher expression of 
cytoskeletal markers indicative of a contractile phenotype (Zhu et al. 2010; Xu et 
al. 2004). In this chapter of work, solutions of PET were electrospun to generate 
various aligned scaffolds designed for the culture of primary HASM cells with the 
aim of producing a confluent, aligned population of contractile smooth muscle 
cells. PET was chosen as the initial polymer to study due to its biocompatibility 
and chemical stability during electrospinning; it is non-biodegradable (with 
potential for long culture periods) and also cost effective. The mechanical 
properties of PET also allow for the manual handling of fibrous scaffolds in cell 
culture. PET is a member of the polyester family and has the repeating polymer 
unit displayed in Figure 4.2. Some investigations into the effects of 
electrospinning parameters on PET fibres have already been undertaken 
(Hadjizadeh et al. 2011a; Veleirinho et al. 2007; Kim et al. 2004) however due to 
the complex nature of electrospinning, many of the parameters differ between 
studies. 
 
Figure 4.2: Repeating monomer unit of polyethylene terephthalate (PET). 
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4.2 Chapter Aims 
The work carried out within this chapter aims to achieve the following: 
Develop a range of electrospun scaffolds that can facilitate the culture of a 
population of aligned and randomly oriented smooth muscle cells. This will be 
achieved by:- 
 Investigate the effects of electrospinning parameters on the morphology 
of electrospun PET fibres 
 
 Develop sets of electrospinning parameters that can produce fibres 
ranging from 100s of nanometres to several micrometres in diameter 
from solutions of PET. 
 
 To align the electrospun fibres by using a rapidly rotating mandrel to 
collect the fibres. 
 
 To characterise the physical and mechanical properties of both the 
random and aligned electrospun scaffolds. 
 
 Assess the effects of fibre diameter and fibre orientation on the resultant 
morphology and phenotype of cultured HASM cells 
 
 To attempt to stimulate contraction of SM cells cultured upon the PET 
scaffolds 
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4.3 Materials and Methods 
4.3.1 Production of electrospun PET scaffolds 
Solutions of polyethylene terephthalate (PET) at various concentrations were 
made from PET pellets (Sigma Aldrich, Dorset, UK) or bottles (Lucozade, GSK, UK) 
by dissolving the PET in a solvent mixture of dichloromethane (DCM, Fisher 
Scientific, Loughborough,UK) and trifluoroacetic acid (TFA, Fisher Scientific) at a 
ratio of 1:1. In some cases, solutions were also made with 1% w/v 
cetyltrimethylammonium bromide (CTAB, Sigma Aldrich) or 1% w/v Triton X-100 
(Sigma Aldrich) in order to increase solution conductivity and reduce surface 
tension. Solutions were stirred using a magnetic stirrer overnight at room 
temperature. The PET solutions were added to a 10ml syringe (BD Falcon™, 
Oxford, UK) and electrospun following the protocols described in Section 2.1. 
Flow rates ranged from 0.5 to 4.0 ml h-1, needle diameters used were either 18 
or 23 G and PET concentration ranged from 7 to 50% w/v. Voltage (14 kV), 
volume of solution spun (2.0 ml) and needle-collector distance (15 cm) all 
remained constant throughout this chapter. The collector mandrel speed ranged 
from static to 2000 rpm to produce scaffolds that were randomly oriented or 
aligned. Upon completion of electrospinning, scaffolds were cut from the 
mandrel using a scalpel blade and stored in aluminium foil. 
4.3.2  Analysis of electrospun PET scaffolds 
Scaffold fibre diameter and fibre alignment were determined by analysis of SEM 
micrographs using the image analysis software packages MeasureIT (Olympus 
Soft Imaging solutions GmbH, Münster, Germany) and ImageJ respectively. 
Alignment was calculated by expressing individual fibre angles as deviations from 
the sample mean fibre angle. SEM sample preparation and SEM protocols were 
as described in section 2.2. Scaffold pore size was also measured from SEM 
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images using the MeasureIT software (Olympus Soft Imaging Solutions, Münster, 
Germany).  
Scaffold porosity was calculated was estimated using the following formula 
(Hadač et al. 2007): 
Porosity (%) = 1-(ad/bd) x 100 
Where ad is the apparent density of the scaffold and bd is the density of pure 
amorphous PET (1.335 g/cm3). Samples of scaffold were cut out using an 8.0mm 
diameter biopsy pen, the mass of these samples measured using a top-pan 
balance (accurate to 0.1 mg) (Mettler Toledo, Leicester, UK) and the thickness 
measured using a digital thickness gauge (accurate to 10 µm) (Mitutoyo, 
Coventry, UK). These measurements were used to calculate the apparent density 
of the scaffold. 
The tensile properties of the scaffolds were determined through uniaxial tensile 
tests using a Universal testing system (Instron, High Wycombe, UK) and a Video 
Gauge (Imetrum Limited, Bristol, UK) as described in section 2.3. N=3 individual 
scaffolds per scaffold type, 3 measurements per scaffold 
4.3.3  Production of a biphasic electrospun PET scaffold 
Biphasic scaffolds were produced by firstly electrospinning a microfibre PET 
scaffold onto a rotating mandrel (60 rpm/ .022 ms-1). Microfibre scaffolds were 
produced by spinning 2 ml of a 30% w/v PET solution at 2 ml h-1 through an 18 G 
needle. The voltage and needle-collector distance were as previously stated. 
Once complete, a nanofibre scaffold was electrospun directly onto the existing 
microfibre scaffold. Nanofibre scaffolds were produced by spinning 1.5 ml of 8% 
w/v PET solution at 0.5 ml h-1 through a 23 G needle. Again the voltage and 
needle-collector distance remained unchanged. The biphasic scaffold was then 
cut from the mandrel using a scalpel and stored in aluminium foil. 
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4.3.4  Decellularisation of bronchial tissue 
Bronchial tissue segments from 3 individual donors were isolated from bronchial 
biopsies carried out at the Glenfield Hospital (Leicester, UK) as described 
previously (Kaur et al. 2006). The procedure was approved by the Leicestershire 
Ethics Committees and all donors gave their written informed consent. The 
tissue was frozen at -80 °C and sliced into thin sections using a scalpel blade. The 
decellularization procedure was modified from a previously published protocol 
(Schaner et al. 2004). Sections were washed with PBS before being incubated 
overnight in 0.5% w/v SDS solution in PBS at 37 °C overnight on a tube roller. 
Sections were washed 5 times in PBS (10 minutes per wash) before being fixed in 
3% v/v glutaraldehyde solution overnight at 4 °C. Sections were washed with PBS 
3 times (10 minutes per wash) before being dehydrated through a series of 
ethanol concentrations: 25%, 50%, 70%, 90%, 95% v/v EtOH in H2O (10 minutes 
each) before 3 100% EtOH solutions (5 minutes each). Sections were then dried 
at 37 °C overnight before being prepared for SEM imaging as described in section 
2.3. 
4.3.5 Human Airway Smooth Muscle culture on electrospun PET 
scaffolds 
Primary HASM cells from 3 individual donors (defrosted at passage 6 and 
cultured until passage 8) were cultured in HASM media as described in section 
2.4.1. Cells (1 x 105) were seeded onto individual aligned 10%, 20% and 35% PET 
scaffold samples and cultured in 2 ml HASM media over a 14 day period (at 37 
°C, 5% CO2 in air) to assess cell proliferation and viability. Where necessary, 
scaffolds (20% and 35%) were adhered to the bottom of well plates using 
aquarium sealant (Sinclair animal and household care Ltd., Gainsborough, UK) 
whereas 10% scaffolds were held in place with stainless steel rings. All scaffolds 
were sterilised by UV treatment for 20 minutes on either face and soaked in a 5% 
(v/v) antibiotic/antimycotic solution (10,000 units ml-1 penicillin G, 10 mg ml-1 
streptomycin sulfate and 25 μg ml-1 amphotericin B) overnight at 4°C. Scaffolds 
were then washed with PBS prior to cell seeding. HASM cells were also cultured 
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on tissue culture plastic and glass coverslips for immunocytochemistry (section 
2.6). 
4.3.6  AlamarBlue® cell viability assay 
HASM viability was measured post seeding on aligned scaffolds using the 
alamarBlue® assay at various time points across a 14 day period. Samples were 
washed with PBS prior to were incubation with 1ml alamarBlue® solution (10% 
(v/v) alamarBlue® in HASM culture media) for 90 minutes at 37 °C. The 
alamarBlue was then collected (100 µL aliquots) and replaced with ASM media. 
The fluorescence emissions of the collected samples were measured on a plate 
reader (excitation 560 nm/ emission 590 nm) (Tecan Infinite M200, Reading, UK). 
4.3.7 Scaffold contraction assays 
Samples of 10% w/v PET scaffolds were prepared as described above (section 
4.3.1) and cut into discs. Scaffolds were placed in 6 well culture plates and 
sterilised by UV exposure (20 minutes each side) followed by incubation in cell 
culture media (60 minutes, 37°C) prior to seeding of cells. Primary HASM cells (2 
x 105) were seeded onto individual PET disks, samples were then incubated for 
10 days (37°C, 5% CO2 in air) to allow cell proliferation.  
Following incubation, culture media was aspirated and 1 ml serum free DMEM 
added to each sample, plates were then imaged using a flatbed scanner. 1 ml 
serum free DMEM ± 200 μM histamine was then added to each sample. Well 
plates were then imaged at specific time intervals for 60 minutes. Scanned 
images were analysed using ImageJ; changes in scaffold surface area were used 
to determine the level of scaffold contraction. 
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4.4 Results 
In order to develop a model of SM tissue that is more representative than a 
hydrogel based SM model, a suitable scaffold that could: (1) support the 
attachment and proliferation of ASM cells, (2) direct the alignment of these cells, 
and (3) possess the correct mechanical properties to facilitate SM contraction; 
needed to be developed. The morphologies of electrospun fibres are affected by 
virtually all electrospinning process parameters (flow rate, needle-collector 
distance, temperature, humidity etc.). However, not all parameters affect the 
properties of the final scaffold to the same degree. Due to this, various 
combinations of differing parameters exist within the literature. The initial 
parameters chosen to electrospin PET were derived from previous work done 
within the Tissue Engineering research group at Nottingham and are presented 
in Table 1. The initial source of PET used was from PET pellets (supplied by 
Sigma). The resultant fibres obtained when using these parameters were 
analysed using SEM images. The fibres appeared fine and uniform in diameter 
however they contained many imperfections in the form of beads (Figure 4.3A). 
In order to remove this beading and create a range of scaffolds differing in fibre 
diameter as well as fibre orientation, several process parameters would have to 
be changed and this was investigated within this thesis. 
 
PET 
concentration 
Flow Rate Voltage 
Needle-collector 
distance 
Needle Solvent 
8% 0.5 ml h
-1
 14 kV 15 cm 18 G 1:1 DCM:TFA 
Table 4.1: Initial nanofibre electrospinning parameters 
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4.4.1 Effects of flow rate and PET solution concentration on fibre 
diameter and morphology 
Initial studies into the electrospinning parameters focussed on the PET 
concentration and the rate at which the solution was expelled from the syringe. 
A range of concentrations and flow rates were tested and the resultant fibres 
were imaged using SEM, these are summarised in Figure 4.3. When attempting 
to spin nanofibres, solutions of 7%, 8% and 10% w/v PET at a flow rate of 0.5 ml 
h-1 all produced highly beaded scaffolds (Figure 4.3 images A and C) although the 
amount of beading did appear to reduce slightly with increasing concentration. A 
12.5% (w/v) solution still resulted in beaded scaffolds whilst the fibres were 
becoming visibly thicker than those produced from lower concentrations of PET. 
When spinning microfibre scaffolds at concentrations ranging from 25% to 50% 
w/v PET, no beaded fibres were observed. An increase in flow rate when 
electrospinning 50% w/v PET solutions was necessary to produce fibres without 
blockage of the needle occurring. When increased further, flow rate had a 
marked effect on the morphology of the fibres produced. When spinning at low 
rates of 0.5 ml h-1, the electrospinning process failed due to the needle blocking. 
Doubling the flow rate to 1 ml h-1 prevented the solution from drying and 
blocking the needle but produced flat ribbon-like fibres that lacked uniformity in 
shape and diameter (Figure 4.3G). Electrospinning the same solution at 2ml h-1 
removed this issue and produced uniform microfibres. Further increasing the 
flow rate to 4ml h-1 did not make any visible difference to the individual fibres 
produced but the thickness of the scaffolds produced were uneven due to fibres 
depositing in localised areas on the collector plate rather than being evenly 
distributed as seen when electrospinning at the slower flow rates. 
4.4.2 Effects of the addition of cationic surfactants to PET solution 
to fibre morphology 
Addition of 1% w/v of the cationic surfactant cetyltrimethylammonium bromide 
(CTAB) to the nanofibre PET solutions (8% and 10% w/v) caused a visible 
reduction in the amount of beading in the resultant fibres. Figure 4.4 displays  
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Figure 4.3: Effects of flow rate and PET concentration on fibre morphology and 
diameter. Matrix describing the initial investigations into the effects of PET 
concentration and flow rate. In addition, SEM images showing representative images 
of some scaffolds are shown. Labelling refers to scaffold letters in the matrix. 
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Figure 4.4: Changing scaffold morphology by addition of surfactants. SEM images of 
nanofibre scaffolds spun from 10% (A,B), and 8% (C,D) w/v PET pellet solutions. 
Scaffolds B and C were spun with the addition of 1% CTAB to the PET solution 
mixture. 
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SEM images of nanofibre scaffolds electrospun with and without the addition of 
surfactant in the PET solution. Another cationic surfactant, tetraethylammonium 
chloride (TEAC) was also added to PET solutions to reduce beading however the 
resultant electrospun fibres were repelled from the collector plate making 
itimpossible to collect a scaffold. The non-ionic surfactant Triton X-100 produced 
similar results to CTAB in terms of fibre morphology but the scaffolds themselves 
were very thin and fragile, making them impractical for use in cell culture. 
4.4.3 Assessing the source of PET used for electrospinning 
Solutions of PET made from PET pellets consistently produced cloudy solutions 
which contained an insoluble precipitate. This made it difficult to ascertain the 
actual concentration of the PET solutions as the precipitate was not electrospun. 
In contrast, solutions made from PET originating from plastic bottles produced 
clear solutions with no precipitate. To investigate this, the 1HNMR spectra of 
both PET sources were obtained (Figure 4.5). The spectra of the PET from both 
sources were very similar however the spectra obtained from PET pellets 
contained several small peaks indicative of impurities that were not present in 
the spectra of PET from bottles. 
The difference between using PET pellets and bottles for producing fibrous 
scaffolds was investigated by electrospinning scaffolds from equivalent 
concentrations of PET from both sources. The two groups of scaffolds greatly 
differed in fibre size and morphology (Figure 4.6). A 10% w/v solution of PET 
from bottles produced bead free nanofibres (Figure 4.6A) whereas the same 
concentration of PET pellets resulted in beaded nanofibres, even with the 
addition of cationic surfactants (1% w/v CTAB) (Figure 4.6C). A 35% w/v solution 
of PET from bottles produced thick uniform microfibres (Figure 4.6B) whereas 
the same concentration solution from PET pellets produced much thinner and 
less uniform fibres. Due to the improved morphology of both the nanofibre and 
microfibre scaffolds when using PET sourced from PET bottles, pellets were no 
longer used as the source of PET for any further experiments. 
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Figure 4.5: 1HNMR spectra of PET pellets (A) and bottles (B). Possible impurities 
within the PET pellet spectrum are highlighted with a blue rectangle. 
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Figure 4.6: PET pellets vs. PET bottles. Representative SEM images of scaffolds 
spun from PET pellets (A,C) and PET bottles (B,D). Microfibre scaffolds (A,B) spun 
from 35% wt/vol  PET solutions and nanofibre scaffolds (C,D) spun from 10% 
wt/vol  PET solutions . 1% wt/vol CTAB was also added to the PET solution for 
scaffold C. 
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4.4.4 The effect of needle size on the production of nanofibres 
In order to determine the thinnest obtainable PET nanofibres, the concentration 
of PET used was reduced from 10% to 8% w/v. Nanofibres electrospun from 8% 
w/v PET solutions at a flow rate of 0.5 ml h-1 contained a small amount of beads 
when spun using a blunt tip 18 G needle. When using a narrower 23 G needle 
instead, the beading was removed, generating uniform bead free nanofibres. 
Figure 4.7 shows the effect of the needle used on the morphology of the 
resultant fibres. 
4.4.5 Properties and parameters of optimised PET nanofibre and 
microfibre scaffolds 
The final electrospinning parameters chosen to manufacture uniform, bead free 
nanofibre and microfibre scaffolds are listed in Table 2. Parameters were 
reached following the investigative steps previously discussed (sections 4.4.1 – 
4.4.4). In both cases the voltage, solvent ratio and needle tip – collector distance 
were the same (14 kV, 1:1 DCM:TFA and 15 cm respectively). Microfibres were 
electrospun using 2 ml of a 30% w/v solution of PET sourced from plastic bottles 
at a flow rate of 2 ml h-1 with a blunt tip 18G needle. Nanofibres were 
electrospun using 1.5 ml of an 8% w/v solution of PET from plastic bottles at a 
flow rate of 0.5 ml h-1 with a 23 G needle.  
By changing these parameters the scaffolds differed greatly in fibre diameter and 
thickness. The average fibre diameter in the microfibre scaffolds was 2.50 ± 0.02 
µm (mean ± SEM) whereas the average fibre diameter in the nanofibre scaffolds 
was 255 ± 3.00 nm (mean ± SEM), approximately an order of magnitude smaller 
than the microfibre scaffolds (average fibre diameter was calculated by 
measuring the diameter of 20 fibres on 8 SEM images from 3 separate scaffolds 
(480 total measurements per scaffold type)). The distribution of fibre diameter in 
the two scaffold types ranged from 160 to 490 nm and 1.22 to 3.88 µm for the 
nanofibre and microfibre scaffolds respectively (Figure 4.8). The fibre diameters  
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Figure 4.7: Effect of needle size on nanofibre scaffold morphology. 
Representative SEM images of scaffolds spun through different sized needles. 
Scaffold A was spun using an 18 G needle. Scaffold B was spun using a 23 G 
needle. Reduced beading was seen with the 23 G needle. Both scaffolds were 
spun from an 8% PET (bottle) solution at a flow rate of 0.5 ml h
-1
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Table 4.2: Final Electrospinning parameters for production of nanofibre and 
microfibre PET scaffolds 
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Figure 4.8: Comparison of fibre diameters between nanofibre and 
microfibre scaffolds. Histograms displaying the distribution of fibre 
diameters in the nanofibre (A) and microfibre (B) scaffolds. Fibre diameters 
were analysed by measuring the diameter of 20 fibres on 8 SEM images from 
3 separate scaffolds (480 total measurements per scaffold type) 
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Figure 4.9: Properties of nanofibre and microfibre scaffolds. Pore size 
distribution of nanofibre (mean fibre diameter = 225 nm) (A) and microfibre 
(mean fibre diameter = 2.50 µm) (B) scaffolds, average scaffold thickness (C) and 
average porosity (D) of all scaffolds in addition to commercially available trans-
well inserts. Error bars display the standard deviation. One way ANOVA with 
Tukey’s multiple comparisons test was carried out between all scaffolds thickness 
and porosity. All scaffolds were significantly more porous than the trans-well 
inserts (****P<0.0001). N= 3 scaffolds, 3 measurements per scaffold. 
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of both scaffolds follow a normal distribution, as do the pore sizes in each 
scaffold (Figure 4.9 A and B). Scaffold thickness ranged from 10 to 50 µm in the 
nanofibre scaffolds and 50 to 150 µm in the microfibre scaffolds; average 
thickness of the nanofibre and microfibre scaffolds were 24 ± 2.5 µm and 107 ± 
5.1 µm (mean ± SEM; n=6 scaffolds, 3 measurements per scaffold) respectively. 
There was a clear statistical difference seen between the two scaffolds 
(P<0.0001, one way ANOVA with Tukey’s multiple comparisons test). The, 
calculated porosities of the two scaffolds were quite similar with the nanofibre 
scaffold porosity measuring 84.33 ± 6.21% and the microfibre scaffold 89.06 ± 
1.12% (mean ± standard deviation; n=3 scaffolds 3 measurements per scaffold). 
Although the two scaffolds had a very similar porosity, the average pore size in 
each scaffold was very different. The microfibre scaffolds had an average pore 
size of 10.45 ± 0.13 µm (mean ± SEM) whereas the nanofibre scaffolds had an 
average pore size of 1.43 ± 0.02 µm (mean ± SEM) (average pore size was 
calculated by measuring the width of 20 pores on 8 SEM images from 3 separate 
scaffolds (480 total measurements per scaffold type)). 
4.4.6 Creating a biphasic scaffold from nanofibre and microfibre 
scaffolds 
By electrospinning nanofibres directly onto pre-spun microfibres it was possible 
to create a scaffold consisting of two distinct, separate phases; a ‘biphasic’ or 
hybrid scaffold. The biphasic scaffold possessed a microfibre layer and a 
nanofibre layer with little or no merging between the layers. This was created 
with the intention of providing an environment where two different cell 
populations could be cultured separately, but within close proximity, on the 
same scaffold. SEM images of the biphasic scaffold are displayed in Figure 4.10 
where the clear distinction between the nanofibre and microfibre layers can be 
made. The average fibre diameters of each ‘phase’ of the scaffold were 280 ± 20 
nm and 2.30 ± 0.06 µm for the nanofibre and microfibre layers respectively 
which are very similar to those seen from the individually spun scaffolds. 
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C D 
Figure 4.10: Biphasic electrospun scaffolds. A cross sectional view of a biphasic scaffold 
with the nanofibre scaffold on top of the microfibres (A). The two scaffold layers 
simultaneously from above (B) and the individual micro and nanofibre layers (C and D 
respectively). 
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The average thickness of the biphasic scaffold was 120 µm, slightly thinner than 
the sum of the individual microfibre and nanofibre scaffolds (Figure 4.9 C). All 
electrospun scaffolds were thicker than a commercial trans-well insert (10 µm) 
with a clear statistical difference (P<0.0001, one way ANOVA with Tukey’s 
multiple comparisons test) seen between the trans-well inserts and both the 
microfibre and hybrid scaffolds. In addition, the average calculated porosity of 
the trans-well inserts (14.74%; Figure 4.9 D) was statistically much lower than all 
the electrospun scaffolds (P<0.0001, one way ANOVA with Tukey’s multiple 
comparisons test). 
When compared to decellularised bronchiole tissue from human donors (Figure 
4.11B and D), the average fibre diameter of the nanofibre phase (350 ± 218 nm; 
mean ± SD; n= 3 scaffolds, 20 measurements per scaffold) was thicker than the 
average fibre diameter measured from the acellular reticular basement 
membrane which was 153 ± 30.6 nm (mean ± SD, n= 50 measurements) . 
Similarities in morphology can be seen between the cross sections of biphasic 
scaffolds and the decellularised tissue (Figure 4.11C and D), both possess a thin 
nanofibrous membrane with a thicker and much more porous layer of fibres or 
matrix proteins underneath. 
4.4.7 Developing a rotating mandrel for the electrospinning of 
aligned fibres 
To produce aligned fibres, a rotating mandrel approach was chosen as this 
method has the potential to produce much larger scaffolds (depending on the 
drum size) when compared to other methods such as parallel electrodes (Yan et 
al. 2009). This was necessary for cutting scaffolds for future cell culture and 
scaffold contraction studies. A mandrel was therefore designed and 
manufactured in-house by members of the medical engineering unit at the 
University of Nottingham; this allowed the mandrel to fit all required design 
specifications. Photographs of the mandrel are shown in Figure 4.12 as well as a 
diagram of the mandrel within an electrospinning setup.  The developed mandrel  
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Figure 4.11: Biphasic scaffold vs decellularised tissue. SEM images of nanofibre (A) and 
biphasic (C) PET scaffolds. These are compared with decellularised basement membrane 
(B), and a bronchiole cross section (D). 
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Figure 4.12: A diagram of the electrospinning equipment. A syringe containing the 
polymer solution (with needle attached) is placed on a syringe pump facing the 
mandrel. An electric potential is established between the needle and mandrel causing 
fibres to be ejected from the needle tip and deposited on the rotating mandrel.  
Additionally, photographs of the mandrel from the front and side. 
Syringe Pump Syringe 
Mandrel 
Motor 
15cm 
 Page 
117 
 
  
 
possesses a stainless steel drum with a width of 10.7cm and a circumference of 
22.2 cm meaning that scaffolds produced were rectangular sheets (with 
diameters length; 22.2cm, width; 10.7cm) where fibres aligned parallel to the 
length. An additional feature built into the mandrel design included ridges at the 
sides of the drum and a single ridge running the width of the drum which allow 
for scaffolds to be cleanly cut away from the mandrel with a scalpel blade. 
Importantly, the mandrel was able to rotate smoothly at very high speeds (over 
2500 rpm) and also features an electrical banana socket allowing for the drum to 
be earthed attracting the negatively charged electrospun fibres to the drum 
surface. 
4.4.8 Effects of mandrel speed on fibre alignment 
In order to achieve aligned fibres, the collector drum has to be rotating at a 
sufficient speed. In order to find what mandrel speeds were necessary to align 
PET fibres, scaffolds were electrospun onto the mandrel rotating at various 
speeds. Figure 4.13 shows SEM images of PET scaffolds collected whilst the 
mandrel was rotating at 50, 300 and 2000 rpm respectively. Given the diameter 
of the mandrel was 22.2cm, this correlates to speeds of 0.19, 1.11 and 7.40 m/s 
respectively. No fibre alignment was seen at 50 rpm with the scaffold resembling 
those that were electrospun onto a static collector plate. At 300 rpm the fibres 
displayed some degree of alignment but several fibres appear to be straying 
from the direction of the majority. When spun onto the mandrel spinning at 
2000 rpm, the scaffold was more highly aligned with very few stray fibres. 
4.4.9  Changing aligned fibre size with concentration 
A collection of aligned fibre scaffolds varying in fibre diameter was desired in 
order to assess how the fibre size and resultant scaffold topography affects the 
growth of smooth muscle cells cultured upon them. To produce aligned 
nanofibre PET scaffolds, 7.5%, 8%, and 10% w/v PET solutions were electrospun 
onto the mandrel rotating at a rate of 2000 rpm. The resulting scaffolds varied in  
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Figure 4.13: Effects of mandrel speed on fibre alignment. 
Representative SEM images of scaffolds spun on a mandrel rotating at 
50rpm (A), 300rpm (B), and 2000rpm (C) 
50 rpm 
300 rpm 
2000 rpm 
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Figure 4.14: Developing a range of aligned electrospun scaffolds. Top (A to C) 7.5, 
8 and 10% w/v PET respectively. Bottom (D-F) 20, 30 and 35% w/v PET 
respectively. All scaffolds were spun on to a mandrel rotating at 2000rpm. 
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fibre alignment and morphology. Fibres spun from 7.5% w/v PET had highly 
aligned fibres but also possessed several beads throughout. Fibres spun from 8% 
w/v PET were highly aligned and bead-free. However, the majority of the fibres 
themselves were not straight and had a wave-like morphology. Highly aligned, 
straight, bead-free nanofibres were successfully electrospun when using a 10% 
w/v solution of PET. Representative SEM images of scaffolds produced from 
7.5%, 8% and 10% w/v PET are shown in Figure 4.14 A-C respectively. When 
producing aligned microfibre scaffolds, a range of PET concentrations were 
tested. These were 20%, 25%, 30% and 35% w/v PET. The resultant fibres were 
all highly aligned and had mean fibre diameters of 1.12, 1.45, 2.20 and 3.53 µm 
respectively (n=480 for 20% and 35% scaffolds, n=80 for 25% and 30% scaffolds). 
The 20% and 35% w/v PET scaffolds were chosen to be taken forward for cell 
culture as these gave the greatest range in fibre diameter. Representative images 
of the 20%, 30% and 35% w/v PET scaffolds are shown in Figure 4.14 D-E 
respectively. 
4.4.10 Analysis of optimised aligned PET scaffolds 
The chosen parameters for electrospinning aligned nanofibre (10% w/v) and 
microfibre (20% and 35% w/v) scaffolds are shown in Table 4.3. The table also 
displays the average fibre diameter and fibre alignment data for the scaffolds. 
The distribution of fibre diameter in all the scaffolds follows a Gaussian 
distribution as shown in Figure 4.15 A-C. Fibre diameter does not appear to 
affect the degree of alignment seen in the scaffolds as seen in Figure 4.15 D 
where all 3 scaffold types display a very similar distribution of fibre angles. In all 
scaffolds, over 50% of fibres are within a ±5° deviation from the mean fibre angle 
(over 78% within ±10°). When compared to the level of alignment seen in 
random nanofibre scaffolds (4.79% within ±5°) to the level of alignment in 
aligned nanofibre (10%) scaffolds (55.21% within ±5°) a clear difference can be 
seen (Figure 4.15 E). These measurements were taken from scaffolds 
electrospun on 3 different occasions (3 scaffolds per PET concentration). As the  
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Table 4.3: Chosen Electrospinning parameters for production of a range of aligned 
PET scaffolds. 
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Figure 4.15: Properties of aligned PET 
scaffolds. Fibre diameter distribution of 
10% (A), 20% (B) and 35% (C) w/v PET 
aligned scaffolds. Distribution curves 
showing deviation from mean fibre angle in 
10% 20% and 35% w/v PET aligned scaffolds 
(D), over 50% of fibres were within 5° of the 
mean angles in all scaffolds. In addition, a 
comparison of the alignment between a 
random and aligned nanofibre scaffold (E) is 
shown.  
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electrospinning process can be influenced by external factors such as 
temperature and humidity, it is important to note any variability seen between 
scaffold batches. For scaffolds spun from 10% w/v PET the mean fibre diameter 
ranged from 198.7nm to 231.2nm between batches, a difference of 32.4nm 
(14.75% of the overall mean). For 20% PET scaffolds the mean fibre diameter 
ranged from 1.087µm to 1.159µm between batches, a difference of 71.3nm 
(6.38% of the overall mean). The 35% PET scaffolds had the largest batch to 
batch variance with the batch mean fibre diameters ranging from 2.974µm to 
3.872µm, a difference of 897.8nm (25.46% of the overall mean) between them. 
The ideal scaffold for producing a functional model of SM will be robust enough 
to allow manual handling during preparation and cell culture but also possess 
elastic properties that will allow the attached SM cells to contract it in response 
to a stimulus. In order to obtain the mechanical properties of the aligned 
scaffolds, uniaxial tensile tests were performed on samples of the 10%, 20% and 
35% PET aligned scaffolds. Representative stress/strain curves for each scaffold 
are shown in Figure 4.16 A. The stress strain curves increase in gradient as the 
thickness of the scaffold fibres increase; this is represented in Figure 4.16 B 
where the Young’s moduli for all 3 scaffolds are shown. Young’s modulus ranged 
from 211.2 ± 18.63 MPa for 10% PET scaffolds to 340 ± 18.36 MPa for 35% PET 
scaffolds (mean ± SEM, n=3 individual scaffolds per scaffold type, 3 
measurements per scaffold). 
4.4.11 Culture of primary HASM cells on aligned electrospun PET 
scaffolds 
In order to determine whether scaffold fibre diameter had an effect on the 
ability of SM cells to proliferate and align along them, primary HASM cells were 
cultured on 10%, 20% and 35% w/v electrospun PET scaffolds for up to 14 days. 
During this time, cell viability/ cell number was monitored using the AlamarBlue® 
assay and samples were fixed for immunostaining. 
Scaffolds seeded with HASM cells were fixed at days 3, 7 and 14 and stained for 
the SM marker SM22α (Figure 4.17). HASM cells were also cultured on glass  
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Figure 4.16: Tensile properties of aligned PET scaffolds. Representative 
stress/ strain curves for the 10%, 20% and 35% w/v aligned PET scaffolds 
(A). The Young’s modulus of each scaffold is displayed also (B). Error bars 
display standard deviation. One way ANOVA with Tukey’s multiple 
comparisons test was carried out between the Young’s modulus of the 
different scaffolds. There was a significant difference between 10% and 
35% PET (**P < 0.01) 
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Figure 4.17:  Airway SM cells cultured on aligned PET scaffolds. Immunofluorescence 
images of airway SM cells seeded onto 10% (A,E,I), 20% (B,F,J) and 35% (w/v) PET 
scaffolds in addition to glass coverslips (D,H,L). Samples were fixed and stained for 
SM22α and nuclear stain Hoechst at days 3, 7 and 14. Scale bar = 50 µm  
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coverslips as a 2D control. Several morphological differences can be seen 
between HASM cultured on glass and PET scaffolds. Firstly, the nuclei of cells 
cultured on glass appear to be more rounded than those cultured on the 
scaffolds. Also, although all cells appear spindle like, those cultured on 
electrospun fibres appear to travel along the direction of individual fibres, 
especially on the 20% and 35% PET scaffolds where fibre diameter is in the 
micron range. This has a great impact in the overall alignment of the cell 
population. Cell alignment on each PET scaffold and glass coverslips at days 3, 7 
and 14 is displayed in Figure 4.18 A-C. The greatest degree of alignment was 
seen on 35% PET scaffolds at day 3 with 60.41% of nuclei within 10° of the mean 
nuclear angle. This reduced to 52.67% at day 7 and 46.93% by day 14. The 10% 
and 20% PET scaffolds both displayed the greatest alignment of cells at day 7 
with 48.78% and 44.57% of nuclei within 10° of the mean nuclear angle 
respectively. The alignment of cells on glass coverslips was lower than each of 
the scaffolds on each day (13.95%, 31.70% and 22.49% at days 3, 7 and 10% 
respectively). Alignment of cells located within HASM bundles (as determined 
from histology sections donated by colleagues at Glenfield Hospital, Leicester) 
was found to be slightly higher than that achieved on the scaffolds with 64.89% 
of nuclei within 10° of the mean nuclear angle. 
The metabolic activity of the HASM cells cultured on PET scaffolds (and tissue 
culture plastic controls) was monitored using the alamarBlue® assay (Figure 4.19 
B). This was used to estimate the number of cells, and hence the level of cell 
proliferation, on the scaffolds over the culture period. All scaffolds and controls 
showed a steady increase in fluorescence over the first 10 days of culture with a 
sharp increase between days 10 and 14. No observable difference was seen 
between HASM cells seeded on tissue culture plastic and PET scaffolds. 
HASMcells cultured upon 10% PET scaffolds produced a fluorescence reading 
that was consistently lower than other samples. The surface coverage (by cells) 
of each scaffold at days 3, 7 and 14 is shown in Figure 4.19A. The amount of 
scaffold covered by HASM cells increases over time in correlating with the trend 
seen in the alamarBlue® results. There appears to be a drop in coverage between  
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Figure 4.18: Alignment of airway SM cells on aligned PET scaffolds. Distribution curves of 
nuclei alignment of HASM cells cultured on electrospun PET scaffolds (image E) and glass 
cover slips at day 3 (A), 7 (B) and 14 (C). Distribution curve of nuclear alignment in 
histological sections of HASM tissue (D) (image F). 
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day 3 and 7 on 35% PET scaffolds but by 14 days in culture, virtually the entire 
scaffold is covered. As are the 10% and 20% scaffolds, indicating a confluent 
layer of cells after 14 days in culture. 
4.4.12 Contraction of HASM cells on electrospun PET scaffolds 
Samples of 10% w/v aligned PET scaffold seeded with primary HASM cells were 
cultured for 10 days prior to attempting agonist stimulated contraction. The 
scaffolds were then stimulated with bradykinin and histamine and the scaffolds 
imaged over time (Figure 4.20). Upon initial stimulation, the image analysis 
suggested that the scaffolds reduced in size over the first 5 minutes. However, 
this was due to scaffolds floating after the initial addition of agonist (fluid 
movement). Over time the scaffolds settled back to the bottom of the well 
plates, and the scaffold size returns to its original size as seen in Figure 4.20 B. 
No difference in scaffold size was observed between stimulated samples and 
controls indicating that the HASM cells were unable to contract the PET 
scaffolds. Therefore a more elastic scaffold had to be developed. 
 Page 
129 
 
  
Figure 4.19: Proliferation of airway SM cells on aligned PET scaffolds. Graph displaying 
percent surface coverage of airway SM seeded scaffolds over time (A). Error bars represent 
standard deviation; one way ANOVA with Tukey’s multiple comparisons test was carried 
out between scaffolds at each time point (*** P<0.001, * P<0.05), n=5. Graph displaying 
alamarBlue® data of airway SM cells cultured on all scaffolds over a 14 day period (B), n=3. 
Graph of fluorescence readings taken from alamarBlue® cell viability assay over 14 days for 
all scaffolds and tissue culture plastic (TCP) controls, error bars represent SEM, n=3. 
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Figure 4.20: Attempted contraction of HASM cells on electrospun 10% 
(w/v) PET scaffolds. Scanned images of cell seeded scaffolds at various 
times after stimulation with bradykinin, histamine or serum free media 
(control) (A). A graph of visible scaffold contraction over time was plotted 
from image analysis of the scanned images (B); error bars represent 
standard deviation (n=2). 
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4.5 Discussion 
Electrospinning provides a method that allows researchers to produce fibrous 
mats with potential to be used as scaffolds for the culture of cells. By altering the 
process parameters of the electrospinning process it is possible to fine tune the 
properties of the resultant scaffold (fibre diameter and orientation, mechanical 
properties). As cells are known to respond to the surface topography of 
materials, in addition to the mechanical properties, the customisable nature of 
electrospinning is of great use when designing scaffolds to suit a specific cell 
type. In vivo SM cells form an aligned population that surrounds hollow vessels 
such as blood vessels and airways with individual cells having an elongated, 
spindle-like morphology. This morphology can be recreated in vitro by culturing 
SM cells upon anisotropic scaffolds such as aligned fibrous electrospun mats. 
Here, the effects of electrospinning parameters of on PET fibre morphology were 
investigated and a range of aligned fibrous scaffolds (differing in fibre diameter) 
were electrospun for the culture of HASM cells. Cell morphology and 
proliferation rate was assessed on the scaffolds and compared to 2D controls. 
4.5.1 Investigating the effects of electrospinning process 
parameters on PET fibre morphology 
Initial investigations into electrospinning parameters focussed on the PET 
solution concentration and the rate at which the solution was extruded from the 
needle. Concentrations of 12.5% w/v and lower all produced fibres with sub-
micron diameters however all of these scaffolds contained unwanted beads. 
Beading is well known to occur when spinning low concentration (or viscosity) 
polymer solutions (Ki et al. 2005; Hongliang Jiang et al. 2004; Huang et al. 2001). 
This was overcome by increasing the PET concentration which also led to 
increased fibre diameter; another widely recorded observation (Ki et al. 2005; 
Huang et al. 2001; Deitzel et al. 2001; Jarusuwannapoom et al. 2005). When 
concentration was increased to 50% w/v PET, the solution was not able to be 
electrospun due to the needle blocking, most likely due to the increased solution 
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viscosity, an observation also made by Garg et al. whilst electrospinning high 
concentration solutions of PEO (Garg & Bowlin 2011). By increasing the flow rate 
to 1ml h-1 this problem was overcome but the resultant fibres possessed a very 
thick, flat ribbon-like morphology. A possible reason for this could be that the 
ejected polymer dried before the whipping phase of the electrospinning process. 
Therefore the fibres were not stretched out as they would do to form rounded 
fibres. When the flow rate was increased to 2 and 4 ml h-1 the fibre morphology 
was that of uniform microfibres.  When compared to other studies 
electrospinning PET, different results have been seen at this range of 
concentrations. Ma et al produced fibres ranging from 200-600 nm when 
electrospinning 20% w/v PET (Ma et al. 2005). Veleirinho et al. produced fibres 
within a similar diameter range electrospinning solutions ranging from 10 to 30% 
PET (Veleirinho et al. 2007). These fibres are thinner than obtained here although 
the flow rate used by Veleirinho was much higher at 12 ml h-1. In this study 
beading was also observed when 10 and 20% PET solutions were spun. In 
contrast, a study by Hadjizadeh et al recorded successfully spinning a 7.7% w/v 
solution resulting in average fibres 400 nm in diameter (Hadjizadeh et al. 2011a) . 
Also worth noting in the study by Hadjizadeh is that solutions greater than 14% 
PET could not be electrospun, most probably due to needle blockage. These 
differences in fibre morphology when using similar parameters could be due to 
the molecular weight of the PET used as all studies use PET from different 
sources. Polymer molecular weight can have a significant effect on the viscosity 
and surface tension (and therefore fibre diameter) as shown previously by Kim et 
al (Kim et al. 2004). 
When attempting to spin PET fibres in the nanofibre range by lowering the PET 
concentration, high levels of beading were observed. In an attempt to reduce 
this beading, the cationic surfactant CTAB was added to the PET solutions to 
reduce the solution surface tension and increase solution conductivity. Addition 
of CTAB led to a visible reduction in the level of beading when spinning 
nanofibres, similar to results seen by Yang et al when spinning solutions of 
polycarbonate with CTAB (Yang et al. 2009). Different results were seen when 
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the source of PET was changed from PET pellets to PET bottles. Fibres spun from 
bottles were much thicker at equivalent concentrations and were able to be 
spun at concentrations as low as 8% w/v without any beading occurring. This 
difference between the two sources is theorised to be due to differences in the 
average molecular weight of the PET polymer chains in each source, as witnessed 
by Kim et al. (Kim et al. 2004), although this was not proven in the present study. 
Also worth noting is that PET pellets were not fully soluble in the solvent system, 
leaving behind a solid residue and a cloudy; due to the inclusion of glass as a 
stabiliser in the PET pellets.  This was not seen with PET obtained from bottles 
where clear solutions were produced. 
Average diameter of PET fibres ranged from 250 nm to 2.5 µm by altering the 
solution concentration and flow rate. This range is greater than those achieved in 
previously published research (Ma et al. 2005; Kim et al. 2004; Veleirinho et al. 
2007; Hadjizadeh et al. 2011a). Average pore size increased with average pore 
size although the porosity of scaffolds was unaffected by fibre diameter; two 
observations also recorded by Hadjizadeh and co-workers.  
By electrospinning nanofibres onto microfibres it was possible to create a 
scaffold with two distinct phases on either side. The reasons were doing this 
were two-fold. Firstly, nanofibre scaffolds are much thinner than microfibre 
scaffolds and as a result, much more fragile. Also all, electrospun PET scaffolds 
proved to be initially highly electrostatic. These two properties of nanofibre 
scaffolds make them very difficult to handle, especially when attempting to 
prepare them for cell culture. By spinning them onto a supporting structure of 
microfibres, the nanofibre scaffolds became much easier to handle with no effect 
to their fibre morphology. Secondly, by spinning two distinct scaffolds together 
in close proximity, this would be a good platform for the co-culture of two 
separate cell types that perform differently on different size/ oriented fibres. 
This approach would be useful if the SM model in development here was to be 
expanded to a blood vessel or bronchiole model by co-culture with endothelial or 
epithelial cells respectively. A similar approach has been made previously to 
produce bilayer and trilayer scaffolds for tissue culture (Bye et al. 2013) although  
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different polymers were used for each layer of the scaffold. Biphasic scaffolds 
were slightly thinner than the sum of individual microfibre and nanofibre 
scaffolds. As the microfibre scaffolds are spun first, these probably act as an 
insulative layer upon the collector which reduces the electrostatic attraction to 
the nanofibres. This results in a slightly thinner deposition of nanofibres than 
when the microfibre scaffold is not present. 
4.5.2 Producing aligned fibrous PET scaffolds 
In order to produce aligned fibre scaffolds, it was necessary to use a collector 
that facilitated this alignment. The design of a rotating mandrel was chosen not 
only due to its ability to align fibres when rotating at a sufficient speed; but also 
as the cylindrical shape of the drum can produce large, neat rectangular scaffold 
sheets that can easily be manipulated for cell culture post-spinning. As the speed 
of the drum increased so did the degree of fibre alignment seen in the scaffolds, 
a similar observation that has been made in previous studies (Hadjizadeh et al. 
2011a; Bashur et al. 2006). The fibres all seemed to align to a similar degree, 
regardless of the diameter of the fibres that were spun although 10% PET aligned 
fibres possessed a slightly thinner diameter than 8% randomly aligned fibres; 
indicating that the alignment process may cause further elongation of the fibres. 
The tensile properties of the aligned scaffolds were measured in order to assess 
the effect of fibre diameter on scaffold mechanical properties. The Young’s 
modulus of the scaffolds increased with fibre diameter indicating that thicker 
fibres were stiffer than their thinner counterparts. The Young’s modulus of the 
scaffolds ranged from approximately 210 to 340 MPa, a range that is significantly 
higher than those previously recorded (Veleirinho et al. 2007; Kim et al. 2004; 
Hadjizadeh et al. 2011a). It is unclear as to why the scaffolds electrospun here 
were significantly stiffer than those in other studies, differences in the modes of 
measuring the scaffold properties may play a part. Additionally, due to the 
nature of electrospinning (many electrospinning set-ups and protocols 
developed in-house), it is difficult to directly compare studies as multiple 
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parameters differ between them, making it difficult to explain differences in the 
scaffolds produced. 
4.5.3 Culture of HASM cells on aligned PET scaffolds 
HASM cells cultured upon the electrospun PET scaffolds adopted a spindle-like 
morphology and aligned along the direction of the fibres; a feature commonly 
seen in studies where SM cells are cultured upon aligned fibres (Zhu et al. 2010; 
Xu et al. 2004). Cells stained positive for the SM marker SM22α with no visible 
difference in expression seen between controls and scaffolds. Cells cultured on 
scaffolds attached along individual fibres when fibre diameter was in the micron 
range (20% and 30% PET scaffolds) but appeared to attach to many fibres when 
cultured on nanofibres. The cells achieved greatest alignment upon the largest 
fibre diameter scaffolds but seemed to have enhanced surface coverage on the 
smallest fibres. These results are similar to those found when macrophages were 
cultured upon quartz etched with grooves of varying diameters 
(photolithography); cells elongated faster on deep wide grooves  but spread 
more quickly over shallow grooves (Wójciak-Stothard et al. 1995). Cell alignment 
was higher than seen in controls on all days. Cell alignment seemed to reduce as 
the cells reached confluency upon the scaffold; this is in part down to the cells 
attaching to each other in addition to/ instead of the underlying fibres. Cell 
viability increased over 14 days for all scaffold cultures and controls. Cultures on 
10% PET scaffolds appeared to be slightly less viable than the rest; this was 
probably due to the aluminium rings used to hold the nanofibre scaffolds in place 
(sealant could not be used like on the thicker scaffolds as it was found to seep 
through the nanofibrous structure, destroying the topography). The aluminium 
rings reduced the available surface area of the scaffold providing less room for 
cell proliferation on the scaffold. 
As the HASM cells expressed markers of a contractile SM phenotype, the next set 
of experiments set out to assess the extent of HASM contraction achievable on 
the PET scaffolds. When stimulated with bradykinin or histamine no visible 
contraction was measured. Scaffolds did not change in size or shape indicating 
 Page 
136 
 
  
that either the cells were not contracting or that the scaffold fibres were too stiff 
for the SM cells to displace. Due to the presence of the same markers seen in the 
collagen gel model (which did contract), it was hypothesised that the scaffolds 
were restricting SM contraction. Given that the Young’s modulus of in vivo SM is 
much lower than the Young’s moduli of the PET scaffolds (200-300 MPa). For 
example, the Young’s moduli of human arteries and porcine bronchi range from 
0.1 to 1.0 MPa and 0.35 to 1.35 MPa respectively (Riley et al. 1992; Wang et al. 
2011). These values are 100 to 1000 times smaller than the values obtained for 
the PET scaffolds. As a result, a much more elastic material was required to 
provide suitable mechanical properties that would facilitate SM contraction. 
4.5.4 Chapter Summary 
Within this chapter of work, PET fibres were electrospun whilst varying the 
electrospinning parameters in order to produce an array of highly aligned and 
random, uniform fibrous scaffolds varying in fibre diameter. Solution 
concentration had a considerable effect on the resultant fibres. As the 
concentration increased, the flow rate used had to be increased also to 
accommodate the subsequent change in solution viscosity. Reducing the surface 
tension and increasing the conductivity of the PET solutions was achieved via the 
addition of a small amount (1% w/v) of anionic surfactant. This reduced the 
amount of beading observed when spinning low concentrations of PET to 
produce uniform nanofibres. Another method used to reduce beading was to use 
a narrower needle which increased solution velocity at the same flow rates. By 
changing the source of PET used, the fibre diameters that were spun were 
dramatically changed; this was highly likely due to differences in polymer chain 
length in each source. The porosity of electrospun scaffolds did not vary with 
increased diameter and all were much more porous than conventional trans-well 
membranes. Pore size increased with increasing fibre diameter. By 
electrospinning nanofibres directly onto microfibre scaffolds it was possible to 
create a two phase scaffold offering different matrices for the co-culture of 
different cell types. Aligned PET scaffolds were produced successfully with the 
aid of a rotating mandrel and were used for the culture of HASM cells. Cells 
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aligned along the direction of the fibres with greater alignment seen when cells 
were cultured on thicker fibres. Cells proliferated on the surface of the scaffolds 
and formed a highly aligned, confluent layer of HASM after 14 days in culture.  
The aligned PET scaffolds that have been electrospun in this chapter have been 
found to produce a highly aligned confluent population of SM cells. However, the 
high Young’s moduli of these scaffolds proved to be too stiff for the cells to 
contract. The following chapter therefore will explore the electrospinning of 
more elastic natural polymers. 
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5. Electrospun gelatin based scaffolds as a 
platform for the culture of contractile smooth 
muscle cells 
5.1 Introduction 
The mechanical properties of in vivo tissues are determined primarily through 
the composition of the extracellular matrix (ECM); with proteins such as collagen, 
elastin fibrinogen and laminin being key components. Natural polymers/ proteins 
such as these are much more elastic in nature than synthetic polymers (such as 
PET) and play a key role in the structure and mechanical properties of all tissues 
(Hinds et al. 2011). They would therefore be ideal candidates to produce 
electrospun scaffolds with the mechanical properties to facilitate SM 
contraction. 
With collagen being the primary ECM component in tissues, it is unsurprising 
that the majority of studies electrospinning natural polymers have focussed on 
electrospinning collagen (Huang et al. 2001; Matthews et al. 2002; Matthews et 
al. 2003; Sell et al. 2009). Several other natural polymers such as elastin (Li et al. 
2005) and fibrinogen (Wnek et al. 2003; M. C. McManus et al. 2007; M. 
McManus et al. 2007) have also been electrospun previously. Although these 
natural materials possess desirable mechanical properties and high 
biocompatibility when compared to synthetic polymers, they do have some 
disadvantages. For example, many natural polymers are highly soluble in water 
and therefore require chemical crosslinking prior to use as a scaffold for cell 
culture. They are also biodegradable which could be of concern in long term in 
vitro studies or if designing a commercial product where shelf life would have to 
be taken into consideration. Collagen has also been shown to trigger antigenic 
and immunogenic responses when used in vivo (Lynn et al. 2004). 
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Elastin plays a key role in elastic tissues including arteries, skin, tendon and 
ligaments (Sandberg et al. 1981) due to its high elasticity (Young’s modulus of 
elastic fibres typically range from 300 to 600 kPa but can be as low as 100 kPa for 
arterial elastin (Mithieux et al. 2005; Zou & Zhang 2009)) and as such would 
make an ideal candidate for SM scaffold production.  In studies by Nivison-Smith 
and Weiss, electrospun elastin scaffolds were produced by electrospinning 
recombinant human tropoelastin prior to chemical cross-linking (Nivison-Smith & 
Weiss 2012). These scaffolds, when aligned, had an average Young’s modulus 
(111 kPa) within the range of natural aorta elastin (Zou & Zhang 2009)  with 
fibres similar in diameter to elastin fibres found in vivo (Parker & Winlove 1988). 
Additionally, the scaffolds were able to support the growth of primary human 
vascular SM cells for up to 7 days. No studies investigating SM contraction were 
reported however. Commercially available tropoelastin is very expensive in the 
quantities necessary to produce electrospun scaffolds. By genetic modification of 
bacteria such as Escherichia coli however, it is possible to create a reliable source 
of human recombinant tropoelastin (Vrhovski et al. 1997; Muiznieks et al. 2003); 
this however, was not in the scope of this thesis. 
As seen in chapter 3, collagen hydrogels provided a matrix that SM cells could 
readily contract both due to remodelling and agonist stimulation. In chapter 4, 
electrospun scaffolds provided a much more uniform and aligned population 
than seen in the collagen hydrogels although the scaffolds proved too stiff to 
contract. It would be intuitive therefore to investigate the possibility of using 
electrospun collagen scaffolds for a contractile SM model. However, previous 
studies have found that when electrospinning collagen, the fluorinated alcohols 
used as electrospinning solvents such as 1, 1, 1, 3, 3, 3 hexafluoroisopropanol 
(HFIP) and 2, 2, 2 trifluoroethanol (TFE) cause denaturation of the collagen  (Yang 
et al. 2008; Liu et al. 2010), altering the tertiary protein structure. As a result of 
this there is very little difference between the resultant electrospun collagen 
fibres and electrospun gelatin fibres (Tsai et al. 2012). Gelatin is a product of 
collagen hydrolysis and therefore chemically very similar possessing the same 
amino acid sequences (Lou & Chirila 1999); as collagen is denatured during the 
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electrospinning process, one study suggested that the electrospinning of pure 
collagen is an expensive way to make gelatin (Zeugolis et al. 2008). A study 
comparing electrospun collagen and gelatin scaffolds found that at the same 
polymer concentration there was no significant difference in fibre diameter 
between the scaffolds however, when crosslinked using the same method, 
collagen scaffolds were found to be significantly stiffer than their cross-linked 
gelatin counterparts (average Young’s modulus of 94.29 and 71.88 MPa 
respectively) (Tsai et al. 2012). This was found to induce differential behaviour of 
MG-63 osteoblast-like cells cultured upon the different scaffolds. 
Due to the fact that electrospun collagen and gelatin are both structurally and 
chemically almost identical, it is clear that electrospinning gelatin would be a 
more cost effective way of electrospinning scaffolds that are chemically similar to 
the collagen gel matrices used in chapter 3. In addition, the apparent reduced 
stiffness (compared to PET scaffolds) of gelatin scaffolds will prove advantageous 
when producing a contractile model. As mentioned earlier collagen can have 
antigenic effects in vivo, this has not been observed with gelatin scaffolds (Zhang 
et al. 2006; Bigi et al. 2002). Like many other biological materials, gelatin is water 
soluble and therefore requires cross-linking prior to cell culture; cross-linking 
gelatin can provide stability against enzymatic degradation (Gorgieva & Kokol 
2011), lower water solubility and an increase mechanical properties (Zhang et al. 
2008). It is of increased importance in electrospun scaffolds where retention of 
the fibrous structure is necessary for topographical cell guidance. An alternative 
to cross-linking gelatin scaffolds is to co-electrospin gelatin with a synthetic 
polymer such as poly(lactic-co-glycolic acid) (PLGA), this also increases the 
mechanical properties of the scaffolds (Meng et al. 2010). 
Methods of cross-linking gelatin in the literature include physical, enzymatic 
(Yamamoto et al. 2013) and chemical crosslinking. Physical crosslinking methods 
include using UV radiation (Brinkman et al. 2003; Bhat & Karim 2009), plasma 
(Prasertsung et al. 2013) or dehydrothermal treatment (Ratanavaraporn et al. 
2010). These methods are advantageous in that they do not require any 
potentially cytotoxic chemicals; however the reaction kinetics are difficult to 
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control resulting in lower degrees of cross-linking and mechanically weaker 
constructs compared to chemically cross-linked scaffolds (Khor 1997).  
Chemical cross-linking methods can be described as either ‘zero-length’ or ‘non-
zero-length’ cross-linking. Non-zero-length cross-linking agents act as chemical 
bridges between amino acid residues in the gelatin structure. They covalently 
link free amine residues (lysine) in the gelatin structure to each other or to free 
carboxylic acid residues (aspartic and glutamic acid) also present. This can 
significantly alter both the biological and mechanical properties of gelatin 
constructs (Bigi et al. 2002). Typical non-zero-length cross-linking agents include 
aldehydes such as glutaraldehyde (Matsuda et al. 1999; Talebian et al. 2007), 
formaldehyde (Usta et al. 2003), and glyceraldehyde (Sisson et al. 2009). 
Glutaraldehyde is the most commonly used due to its high solubility and fast rate 
of reactions and increased cross-link stability compared with other aldehydes. 
The level of cross-linking and therefore the resultant mechanical properties of 
glutaraldehyde cross-linked scaffolds can also be altered by changing the 
concentration of glutaraldehyde used (Skotak et al. 2010). One concern when 
using aldehyde cross-linkers is that upon degradation, the toxic aldehydes are 
released from the scaffold and taken up by nearby cells. Glutaraldehyde 
crosslinked constructs have been found to cause inflammation and calcification 
in vivo in rabbits (Vyavahare et al. 1997; Speer et al. 1980). As a result, less toxic 
non-zero-length cross-linking agents such as genipin (Tsai et al. 2000) have also 
being used to produce less toxic gelatin based scaffolds (Panzavolta et al. 2011). 
Zero-length cross-linking agents are advantageous as they do not add any toxic 
reagents to the scaffold. They activate the carboxylic groups on aspartic and 
glutamic acid residues and facilitate their reaction with free amine groups 
(primarily on lysine residues). This forms an amide bond between the two amino 
acid residues with no bridging molecule required. Commonly used methods on 
zero-length crosslinking use a carbodiimide (Kuijpers et al. 2000) or an acyl azide 
(Jorge-Herrero et al. 1999). A commonly used carbodiimide used in cross-linking 
is 1-ethyl-3-(dimethyl aminopropyl) carbodiimide (EDC). EDC is usually used in 
combination with N-hydroxysuccinimide (NHS) to increase the efficiency of the 
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reaction and reduce the level of side reactions caused by hydrolysis of the EDC-
activated carboxylic acid groups (Kuijpers et al. 2000). These two chemicals in 
combination have been successfully used previously to cross-link electrospun 
scaffolds of pure gelatin (Tonsomboon & Oyen 2013; Zhang et al. 2008) and 
poly(glycerol sebacate): gelatin blends (Kharaziha et al. 2013). 
Another method of cross-linking gelatin based scaffolds is to chemically modify 
the gelatin to add a functional group that can be crosslinked under UV light in 
the presence of a photoinitiator. The most common way of achieving this to use 
gelatin methacrylate (GelMa), this is synthesised via a reaction between gelatin 
and methacrylic anhydride where free amines on lysine residues reacts with the 
methacrylic anhydride resulting in multiple methacrylamide groups bound to the 
gelatin structure (Van Den Bulcke et al. 2000).  These can then form chemical 
cross-links between gelatin molecules in the presence of free radicals from a 
photoinitiator. This is advantageous as it gives the ability to fine tune the 
mechanical properties of the materials by altering the degree of methacrylation 
that occurs and the concentration of GelMa used. Additionally, the level of cross-
linking can also be controlled via the concentration of photo-initiator used and 
the amount of UV exposure (Van Den Bulcke et al. 2000). Due to this high 
flexibility in the cross-linking of GelMa, coupled with the fact that once 
synthesised no chemicals are required to cross-link the GelMa other than the 
photoinitiator, GelMa has been seen to hold great potential in the field of tissue 
engineering. As a result, over the last few years its use has been published in 
hydrogel cultures (Nichol et al. 2010; Zhao et al. 2015), micropatterning (Ramón-
Azcón et al. 2012; Nikkhah et al. 2012), and 3D-printing (Ovsianikov et al. 2011; 
Bertassoni et al. 2014). It has also been used as a scaffold to support the culture 
of contractile skeletal muscle tissue (Hosseini et al. 2012), making it a potentially 
viable material for the production of a contractile SM model. However, in the 
current literature, there is no evidence of the application of electrospun GelMa; 
quite possibly due to difficulties in the cross-linking process which will require 
the scaffolds to be submerged in an aqueous solution. Due to the high solubility 
of the material in water, this is clearly problematic. 
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Due to the extremely high Young’s moduli of the PET scaffolds discussed in the 
previous chapter, it is highly unlikely that any SM cells cultured upon the 
scaffolds would be able to generate sufficient contractile forces to deform the 
scaffolds to any extent that could be measureable. As a result, new scaffold 
materials, with mechanical properties that better mimic those found in vivo, 
must be explored. This chapter explores alternative electrospun gelatin scaffolds 
which possess more elastic properties than PET scaffolds. The possibilities of 
producing and cross-linking electrospun GelMa scaffolds are explored and their 
mechanical properties compared to gelatin and PET scaffolds. Finally SM cells are 
cultured upon both gelatin based scaffolds and the contraction of the cell/ 
scaffold constructs measured. 
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5.2 Chapter Aims 
The work carried out within this chapter aims to achieve the following: 
Develop an aligned electrospun scaffold using gelatin based materials that can 
facilitate the contraction of smooth muscle cells cultured upon it, ultimately 
leading to the development of a model that can actively measure smooth muscle 
contraction. This will be achieved by:- 
 Create a range of cross-linked electrospun aligned gelatin scaffolds with 
similar fibre dimensions and orientation to the PET scaffolds previously 
produced and characterise their physical and mechanical properties. 
 
 Synthesise and electrospin GelMa to produce aligned scaffolds. 
 
 Develop a method to cross-link the electrospun GelMa scaffolds and 
characterise their physical and mechanical properties. 
 
 Characterise and assess alignment and proliferation of RASM cells 
cultured upon both gelatin and GelMa scaffolds 
 
 Test the ability of RASM cells to contract both gelatin and GelMa 
scaffolds. 
 
 Physically measure the contraction of SM cells cultured on electrospun 
scaffolds using the equipment and procedures developed in chapter 3. 
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5.3 Materials and methods 
5.3.1 Production of electrospun gelatin scaffolds 
Solutions of gelatin at various concentrations (6, 8 and 10% w/v) were made by 
dissolving gelatin powder (type A 300 bloom) (Sigma Aldrich, Dorset, UK) in 100% 
hexafluoroisopropanol (HFIP) (Sigma Aldrich). Solutions were stirred using a 
magnetic stirrer overnight at 37°C. The gelatin solutions were added to a 5ml 
syringe (BD Falcon™, Oxford, UK) and electrospun following the protocols 
described in Section 2.1. For each scaffold 4 ml of solution was electrospun at a 
flow rate of 1.2 ml h-1. The needle collector distance was 15 cm and the voltage 
across the apparatus was 15 kV. The collector mandrel was set to spin at a speed 
of 2000 rpm. Upon completion of electrospinning, scaffolds were cut from the 
mandrel using a scalpel blade and stored in aluminium foil. 
5.3.2 Crosslinking of electrospun gelatin scaffolds 
Prior to crosslinking the scaffolds, they were first secured in an acetate frame 
(5star™, Cambridge, UK) using aquarium sealant (Sinclair animal and household 
care Ltd., Gainsborough, UK) on either side of the scaffold. Acetate frame size 
was either 23 x 42 mm with an internal window of 13 x 32 mm or 25 x 25 mm 
with an internal window of 15 x 15 mm. Once the acetate frames were adhered, 
the individual scaffolds were cut out and left overnight to dry. Figure 5.1 
illustrates the preparation of the scaffolds within the acetate frames. In order to 
crosslink the scaffolds, a solution of 250 mM 1-Ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC) (Applichem, Darmstadt, Germany) and 100 mM N-
Hydroxysuccinimide (NHS)  (TCI Europe, Zwijndrecht, Belgium) was prepared in 
distilled water. Ethanol (Sigma Aldrich) was added to the solution until the total 
volume was 10 times the original volume; the resultant solution was then 
refrigerated to 4°C. The scaffolds were placed in the EDC, NHS solution for 24 
hours at 4°C. The scaffolds were removed from the crosslinking solution and 
washed in distilled water (x3) before being lyophilised overnight to leave the  
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Figure 5.1: Preparation of gelatin/ GelMa scaffolds prior to crosslinking. Electrospun 
scaffold sheet was pinned in place (A) before acetate frames were glued (B) and 
placed onto one side of the electrospun scaffold (C). Excess scaffold was cut away from 
the edges of the frames and frames were glued to the other side of the scaffold (D). 
Individual scaffolds were then cut out (E), pinned and left to dry (F). 
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dry, cross linked scaffolds. The mechanism of gelatin crosslinking using EDC and 
NHS is shown in Figure 5.2.  
5.3.3 Synthesis of gelatin methacrylate 
GelMa was synthesised following a previously published method (Nichol et al. 
2010). Gelatin powder (10 g; type A 300 bloom) was dissolved in 95 ml PBS at 
50°C and stirred for 1 hour. Methacrylic anhydride (8.0 ml) was added to the 
gelatin solution and stirred for a further 3 hours at 50°C. PBS (400 ml) was added 
to the mixture and stirred for a further 30 minutes. The solution was then 
transferred into three dialysis membranes (12-14 kDa cut-off). The membranes 
were placed in 3.0 L of distilled water and stirred at 50°C. The water was changed 
twice daily for 7 days before the membranes were removed and the solution 
inside transferred to plastic beakers and frozen overnight at -80°C. The frozen 
gelatin methacrylate (GelMa) solution was lyophilised and the GelMa stored at 
room temperature until ready for use. The mechanism of gelatin methacrylate 
synthesis is shown in Figure 5.3. 
5.3.4 Production of GelMa scaffolds 
Solutions of GelMa at 10% w/v mere made by dissolving freeze-dried GelMa in 
hexafluoroisopropanol (HFIP) (Sigma Aldrich). Solutions were stirred using a 
magnetic stirrer overnight at 37°C. The GelMa solutions were added to a 5ml 
syringe (BD Falcon™) and electrospun following the protocols described in 
Section 2.1. For each scaffold 4 ml of solution was electrospun at a flow rate of 
1.2 ml h-1. The needle collector distance was 15 cm and the voltage across the 
apparatus was 15 kV. The collector mandrel was set to spin at a speed of 2000 
rpm. Upon completion of electrospinning, scaffolds were cut from the mandrel 
using a scalpel blade and stored in aluminium foil at room temperature. 
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Figure 5.2: Mechanism of gelatin crosslinking with EDC and NHS. Mechanism 
adapted from (Kuijpers et al. 2000) 
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Figure 5.3: Mechanism of reaction between gelatin and methacrylic anhydride. 
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5.3.5 Crosslinking of GelMa scaffolds 
Prior to crosslinking the scaffolds, they were first secured to an acetate frame as 
described previously. The scaffolds were then submerged in a 1% w/v solution of 
2-Hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (photoinitiator) in a 
solvent mix of ethanol and water. Solvent ratios used ranged from 1:0 to 9:1 
ethanol: water. Scaffolds were then exposed to UV radiation (0.5 Wm2) for 10 
minutes. Scaffolds were washed in PBS three times. The proposed mechanism of 
the crosslinking process is displayed in Figure 5.4. Samples used for SEM imaging 
were washed in dH2O and freeze-dried prior to analysis. Samples used for cell 
culture were incubated in antibiotic/antimycotic solution (50000 units ml-1 
penicillin G, 500 mg ml-1 streptomycin sulphate and 125 µg ml-1 amphotericin B) 
(Fisher Scientific) in PBS at 4°C prior to use. 
5.3.6 NMR analysis 
Samples of gelatin and GelMa were dissolved in D2O in glass NMR tubes and the 
NMR spectrum of each sample was determined using a Bruker Avance 600MHz 
spectrometer (Bruker, Coventry, UK). Spectra were analysed using the 
MestReNova LITE software package (Mestrelab research, Hereford, UK). 
5.3.7 Tensile measurements of GelMa scaffolds 
Samples of electrospun GelMa scaffolds were crosslinked in acetate frames (25 x 
25 mm with an internal window of 15 x 15 mm) as described above. Crosslinked 
scaffolds were cut away from the edges of the scaffold along the two sides 
parallel to the fibre direction using a scalpel. Scaffolds were then placed in a 
TA.HDPlus Texture Analyser (Stable Micro Systems Ltd, Surrey, UK) with a 5 kg 
load cell. Samples were held in place using the tensile grips attachment with the 
fibre direction parallel to the testing direction. Once secure, the acetate frames 
were cut on the two sides parallel to the fibre direction removing the mechanical 
support offered by the acetate. Samples were tested at an extension rate of 6  
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Figure 5.4: Mechanism of photo-initiated crosslinking of GelMa.  Decomposition of 
the photoinitiator (A) is followed by reaction of the ketyl radical with the β-carbon 
atom of the methacrylate enone. (B). Two  GelMa radicals  react to form crosslinked 
GelMa (C) 
A 
B 
C 
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mm min -1. The Young’s moduli of the samples were calculated from the 
resultant stress/strain curves generated from the tests. 
5.3.8 PrestoBlue® cell viability assay 
RASM cell viability was measured post seeding on aligned scaffolds using the 
PrestoBlue® assay at various time points across a 10 day period. Samples were 
washed with PBS prior to incubation with 1ml PrestoBlue® solution (10% (v/v) 
PrestoBlue® in HASM culture media) for 10 minutes at 37 °C. The PrestoBlue was 
then collected (100 µL aliquots) and replaced with RASM media. The 
fluorescence emissions of the collected samples were measured in duplicate on a 
plate reader (excitation 560 nm/ emission 590 nm) (Tecan Infinite M200, 
Reading, UK) A blank sample reading was subtracted from the fluorescence 
readings for each sample and duplicate readings were averaged. The resultant 
readings were then expressed as a fraction of the fluorescence reading at day 0. 
5.3.9 Scaffold contraction assays 
Samples of crosslinked 10% w/v gelatin or GelMa scaffolds were prepared as 
described above. All scaffolds were placed in 6 well culture plates and sterilised 
by UV exposure (20 minutes) followed by incubation in cell culture media (60 
minutes, 37°C) prior to seeding of cells. Gelatin/ GelMa scaffolds were seeded 
with RASM cells at a density of 2x 105 cells cm-2. All samples were then incubated 
for 10 days (37°C, 5% CO2 in air) to allow cell proliferation.  
Following incubation, culture media was aspirated and 1 ml serum free DMEM 
added to each sample, gelatin/ GelMa scaffolds were cut out from their acetate 
frames and well plates were imaged using a flatbed scanner. Serum free DMEM 
(1 ml)  ± agonist (200 μM UTP) was then added to each sample. Well plates were 
then imaged at specific time intervals for up to 30 minutes. Scanned images were 
analysed using ImageJ; changes in scaffold surface area were used to determine 
the level of scaffold contraction. 
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5.3.10 Direct force measurement of RASM seeded GelMa scaffold 
contraction 
Rectangular crosslinked GelMa scaffolds (13 x 32 mm) were prepared and 
sterilised as described above. Scaffolds were seeded with RASM cells at a density 
of 2 x 105 cells cm-2. Scaffolds were then incubated (37°C, 5% CO2) for 10 days. 
Scaffolds were removed from culture media and washed twice with serum free 
DMEM. Scaffolds were individually placed in an 85 mm petri dish containing a 
strip of canning wax adhered to the dish surface. Scaffolds were cut away from 
the acetate frames along the long axis of the scaffold (parallel to fibre direction) 
using a scalpel and one end of the scaffold was pinned in place by passing a 
minuten pin through the acetate frame into the canning wax. Serum free DMEM 
(5 ml) was added to the dish and the acetate frame was cut away along the long 
axis to leave the scaffold free floating at one end. A minuten pin adhered to a 
glass bead was threaded through the underside of the scaffold at the free 
floating end which was then attached to a model 403A force transducer (Aurora 
Scientific, Dublin, Ireland) using canning wax. The force transducer was 
connected to a Powerlab 4/25T unit with associated software (AD Instruments, 
Oxford, UK). Force was measured at a frequency of 1 kHz. Once stable, the 
baseline force of the resting scaffolds was measured for 3 minutes before the 
addition of 500 µL of 1 mM UTP in serum free DMEM (500 µL serum free DMEM 
in control experiments) using a pipette. Contraction was then measured 
continuously for 60 minutes. 
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5.4 Results 
The overall aim of this chapter was to develop an in vitro model of contractile 
smooth muscle tissue. Smooth muscle cells were successfully cultured upon the 
electrospun PET scaffolds developed in the previous chapter. However, one 
noticeable feature of these scaffolds was that they were very stiff with Young’s 
moduli much higher than seen in vivo muscle tissue. Therefore, although HASM 
cells were seen to adhere to and proliferate upon the PET scaffolds, the scaffold 
fibres proved to be too stiff for cultured smooth muscle cells to contract. 
Consequently, the next stage of the investigation involves attempting to produce 
new scaffold material to achieve a contractile SM cell/ scaffold construct. This 
was achieved by electrospinning and cross-linking gelatin scaffolds. 
5.4.1 Electrospinning aligned gelatin scaffolds 
Gelatin was chosen to be electrospun as an alternative material to PET due to its 
more elastic properties and the fact that it is chemically similar to collagen, 
which was shown in chapter 3 to support the growth of contractile SM cells. 
Gelatin was electrospun from solutions ranging 6% to 10% (w/v) (Figure 5.5A, C 
and E). As gelatin is water soluble, scaffolds required crosslinking prior to use in 
cell culture. Scaffolds were successfully crosslinked using EDC and NHS in an 
ethanol and water mixture. Crosslinking was also attempted by incubating the 
scaffolds in glutaraldehyde vapour: the resultant scaffolds were still partially 
soluble in water (insoluble at room temperature but dissolved at higher 
temperatures necessary for cell culture) and were also very brittle. 
Consequently, glutaraldehyde crosslinked scaffolds were not further 
investigated. In both crosslinking methods, the gelatin scaffolds reduced to 
approximately 25-30% of their original size. This was prevented by holding the 
scaffolds in place either by using acetate frames or placing the scaffolds in trans-
well inserts or CellCrown™ inserts (Sigma). However, due to the eventual need to 
prepare rectangular constructs for force measurement studies, acetate frames  
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Gelatin Cross linked gelatin 
6% 
8% 
10% 
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Figure 5.5: Electrospun gelatin scaffolds pre and post crosslinking. Representative SEM 
images of gelatin scaffolds electrospun from 6%, 8% and 10% w/v gelatin solutions (A,C,E 
respectively). The scaffolds were then imaged after crosslinking with EDC and NHS (B,D,F) 
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were chosen as the method to secure the scaffolds during crosslinking. SEM 
images of the crosslinked gelatin scaffolds are shown in Figure 5.5 (B, D and F). 
In order to compare the stiffness of these gelatin scaffolds to the previously used 
PET scaffolds, tensile testing was performed on samples of the crosslinked 6%, 
8% and 10% (w/v) aligned gelatin scaffolds. Representative stress/ strain curves 
for each scaffold are displayed in Figure 5.6A. The gradients of these curves were 
used to calculate the Young’s modulus of each scaffold. The stiffest gelatin 
scaffold was the 10% gelatin scaffold with a mean Young’s modulus value of 3.80 
± 1.69 MPa (almost 100 times lower than the stiffest PET scaffold at 340 MPa). 
The mean Young’s modulus of the 8% and 6% gelatin scaffolds were 2.58 ± 0.72 
and 1.54 ± 0.79 MPa respectively (mean ± standard deviation). There was a 
statistical difference between the stiffness of the 10% and 6% gelatin scaffolds as 
shown in Figure 5.6B(P<0.05).  
In addition to the tensile properties of the gelatin scaffolds, the average fibre 
diameter and degree of fibre alignment were also analysed for each scaffold. 
Measurements were taken both before and after the scaffolds were crosslinked 
in order to assess the effect of crosslinking on the morphology of the gelatin 
scaffolds. As seen when electrospinning PET scaffolds, the fibre diameter of 
gelatin scaffolds increased with the concentration of the gelatin solution; 10% 
gelatin solutions produced fibres with an average diameter of 1.24 µm whereas 
8% and 6% produced scaffolds with average fibre diameters of 788 and 286 nm 
respectively. Crosslinking of these scaffolds significantly affected the average fibre 
diameter (P<0.0001), increasing the diameter in all cases. 10%, 8% and 6%  
gelatin scaffolds average fibre diameter increased to 1.49 µm, 978 nm and 746 
nm, an increase of 20.13%, 24.11% and 160.62% respectively (Figure 5.7A). 
All gelatin scaffolds were highly aligned with 57.71%, 65.21% and 42.50% of 
fibres within 10° of the mean fibre angle in 10%, 8% and 6% scaffolds 
respectively. In all cases fibre alignment significantly dropped (50.6%, 48.3% and 
23.0% respectively) after the crosslinking process although clear fibre alignment 
still remains (Figure 5.7B).  
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Figure 5.6: Mechanical properties of crosslinked electrospun gelatin 
scaffolds. Representative stress/ strain curves for three different gelatin 
scaffolds (A). This data was then used to calculate the average Young’s 
modulus for each scaffold (B) (error bars represent standard deviation; n= 6). 
One way ANOVA with Tukey’s multiple comparisons test was carried out 
between the Young’s modulus of all scaffolds (P<0.05) 
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Figure 5.7: Properties of aligned gelatin scaffolds. Average fibre diameters for 
each gelatin scaffold both before and after crosslinking (A), error bars represent 
standard deviation. Unpaired t-tests were carried out between the fibre 
diameters of each scaffold before and after crosslinking. Distribution curves 
illustrating the degree of alignment in each scaffold before and after crosslinking 
(B) and the alignment of RASM cells cultured on the crosslinked scaffolds (C). 
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5.4.2 Culture of RASM cells on gelatin scaffolds 
The differences seen in crosslinked gelatin scaffold alignment (10%> 8%> 6%) is 
reflected in the nuclear alignment of cells cultured upon the scaffolds; RASM cells 
were more aligned on 10% crosslinked gelatin scaffolds (37.9% within 10° of 
mean) than on 8% (27.3%)  and 6% (20.5%) scaffolds (Figure 5.7C). Due to the 
increased alignment of cells on 10% gelatin scaffolds and only slight increase in 
stiffness compared to the other gelatin scaffolds, the 10% gelatin scaffolds were 
chosen to be used for further cell culture studies. These scaffolds were seeded at 
a range of cell densities and fixed at various time points in order to determine the 
optimal seeding density and culture period required to produce an aligned 
confluent sheet of SM cells on the gelatin scaffolds (Figure 5.8A-I). Additionally, 
cell proliferation was monitored using the PrestoBlue assay (Figure 5.8J). Cell 
number appeared to increase steadily over the first 6 days of culture before a 
large increase between days 6 and 8. No decrease in cell activity was seen over 
the 10 day study. Confluency was achieved after 9 days when scaffolds were 
seeded at a density of 2 x 105 cells cm-2 (Figure 5.8I). When immunostained in 
order to confirm SM phenotype, SM cells cultured on gelatin scaffolds stained 
positive for SM markers SM22α (Figure 5.9A) and calponin (Figure 5.9C). Cells 
also stained positive for the gap junction protein connexin and negatively for the 
intermediate filament protein desmin (Figure 5.9B). Individual focal adhesions 
were observed in cells stained for vinculin (Figure 5.9D); cells possessed a 
spindle-like morphology with the majority of focal adhesions occurring at the 
spindle poles.  
5.4.3 Contraction of RASM seeded gelatin scaffolds 
Crosslinked 10% gelatin electrospun scaffolds were seeded with RASM cells at a 
density of 2 x 105 cells cm-2 and incubated for 10 days before scaffolds were cut 
away from the supporting acetate frames. Scaffolds were stimulated with 100 
µM UTP and imaged to assess the degree of scaffold contraction. Figure 5.10A  
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Figure 5.8: Culture of RASM cells on crosslinked gelatin scaffolds. ICC images of RASM 
cells seeded at various densities on crosslinked 10% gelatin scaffolds at day 3 (A,B,C), 6 
(D,E,F) and 9 (G,H,I). Cells were stained with fluorescently tagged phalloidin (green) 
and the nuclear stain Hoechst (blue). Cell metabolism was monitored using the 
PrestoBlue® assay for 10 days (J). Error bars represent SEM; n= 6. 
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Figure 5.9: Immunostaining of RASM cells on electrospun gelatin scaffolds. 
RASM cells were fixed and stained with SM22α (A), connexin (B), and calponin 
(C,D) (all green). Cells were also stained for desmin (B) and vinculin (C,D) (all 
red). All samples were additionally stained with the nuclear stain Hoechst 
33342 (blue). Scale bars = 100µm. 
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Figure 5.10: Contraction of RASM seeded gelatin scaffolds. Scanned images of 
a RASM seeded gelatin scaffold at T=0 (A) and T=20 minutes (B) following 
stimulation with UTP. Scale bar = 35 nm. To compare the scaffold at the two 
time points, A has been overlaid onto image B. Image analysis of the scaffolds 
at multiple time points was used to assess the level of scaffold contraction (C), 
error bars represent standard deviation (n=4). 
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and B displays images of a RASM seeded gelatin scaffold at times t=0 and t=20 
minutes respectively. By comparing the surface area of the scaffold across this 
time period, RASM contraction can be measured (Figure 5.10C). Over the 20 
minute period, scaffolds reduced to 90.5 ± 4.5% (mean ± standard deviation) of 
their original size, after 20 minutes no further contraction was seen. 
Unstimulated controls remained close to 100% their original size throughout the 
study. Although some scaffold contraction could be seen in this study, the 
amount of contraction (reduction in size) is still much lower than witnessed in 
the collagen hydrogels. By choosing an alternative, more controllable method of 
crosslinking the gelatin based scaffolds; it may be possible to alter the stiffness of 
the scaffolds to allow further cell mediated contraction. For this reason, the 
electrospinning of chemically modified (methacrylated) gelatin was investigated. 
5.4.4 Production of electrospun GelMa scaffolds 
Gelatin can be methacrylated via a nucleophilic substitution reaction with 
methacrylic anhydride. During this process, free amines found within lysine 
residues in the gelatin structure become methacrylated. The degree of 
methacrylation can be controlled by the ratio of gelatin: methacrylic anhydride in 
the initial reaction mixture. Once methacrylated, the gelatin methacrylate 
(GelMa) can be crosslinked under UV light in the presence of a photoinitiator. 
Therefore, the level of GelMa crosslinking can be controlled by the initial level of 
methacrylation, the amount of photoinitiator used, the amount of UV exposure 
and the solvents used in the crosslinking process. The methacrylation of gelatin 
was confirmed and degree of methacrylation calculated analysed using proton 
NMR spectroscopy (Figure 5.11). Comparing the 1HNMR spectrum of synthesised 
GelMa to that of gelatin, there are two clear additional peaks in the GelMa 
spectrum at approximately 5.3 and 5.6 ppm. These peaks are due to the two 
protons found on the methacrylate vinyl group. The degree of methacrylation 
was calculated using a previously published method (Ovsianikov et al. 2011). The 
peak at 0.84 ppm can be used as a reference peak ascribed to the hydrophobic 
side chains of valine, leucine and isoleucine; the integration of this peak (I0.84)  
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Figure 5.11: Analysis of synthesised gelatin methacrylate. Proton NMR spectra 
of gelatin (A) and synthesised gelatin methacrylate (B). Methacrylate vinyl 
peaks highlighted in blue rectangle. 
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corresponds to 0.3836 mol/ 100 g (sum of known composition of these amino 
acids in gelatin). The total amount of available amine groups in gelatin is equal to 
0.0385 mol/ 100g. Therefore the percentage of methacrylation within the 
synthesised GelMa can be expressed using the following equation: 
𝐷𝑀%=𝐼5.6𝑝𝑝𝑚×0.3836𝐼0.84𝑝𝑝𝑚×0.0385×100 
Using this equation the percentage of methacrylation was calculated to be 
81.01%. The synthesised GelMa was electrospun using a 10% (w/v) solution 
(Figure 5.12A) SEM image analysis was used to determine the average fibre 
diameter (297.4 ± 101.1 nm (mean ± standard deviation)) and degree of fibre 
alignment (49.79% of fibres within 10° of the mean fibre angle) of the 
electrospun scaffolds. Distribution curves of the fibre diameter and angle are 
displayed in Figure B and C respectively. 
GelMa scaffolds were cut and adhered to acetate frames before being 
crosslinked using UV light in the presence of a photoinitiator in solution (1% w/v 
solution of 2-Hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone). In order to 
prevent the GelMa scaffolds from dissolving during the crosslinking process, a 
number of solvent mixtures were investigated. These ranged from pure ethanol 
to a 9:1 ethanol: water mixture. Scaffolds would not crosslink in pure ethanol 
with the scaffolds dissolving when washed following the crosslinking process. 
Solutions with greater than 10% water content dissolved the scaffolds upon 
contact. Three different ethanol: water solutions were chosen to crosslink the 
GelMa scaffolds; these were 39:1 (2.5% H2O), 19:1 (5.0% H2O) and 9:1 (10% H2O). 
Tensile tests of the different crosslinked GelMa scaffolds were run to calculate 
the Young’s modulus of each. Young’s modulus increased with the increasing 
water content in the crosslinking solutions: average Young’s moduli were 142.2 ± 
25.39, 158.7 ± 95.33 and 451.5 ± 111.3 kPa (mean ± standard deviation) for 
scaffolds crosslinked in 2.5%, 5.0% and 10% water in ethanol solutions 
respectively (Figure 5.13A). Scaffolds crosslinked in 10% H2O were in ethanol 
significantly stiffer than those crosslinked in 5% and 2.5% H2O in ethanol  
 Page 
166 
 
  
F ib r e  d ia m e t e r  (n m )
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
)
0 2 0 0 4 0 0 6 0 0 8 0 0 1 0 0 0
0
1 0
2 0
3 0
D e v ia t io n  f r o m  m e a n  f ib r e  a n g le  (d e g r e e s )
R
e
la
ti
v
e
 f
re
q
u
e
n
c
y
 (
%
)
-5 0 0 5 0
1 0
2 0
3 0
Figure 5.12: Properties of electrospun GelMa scaffolds. SEM image of 
aligned electrospun GelMa spun from a 10% w/v solution before cross-
linking (A). Histograms and Gaussian distribution curves of fibre diameter 
(B) and fibre alignment (C) are presented. 
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Figure 5.13: Crosslinking electrospun GelMa scaffolds. Average Young’s moduli of 
GelMa scaffolds crosslinked in different H
2
O:EtOH mixtures (A). Error bars 
represent standard deviation (n=4). One way ANOVA with Tukey’s multiple 
comparisons test was carried out between the Young’s modulus of all scaffolds 
(P<0.01) Photographs of scaffolds crosslinked in 2.5%, 5.0% and 10.0% (v/v) H
2
O in 
ethanol show increasing scaffold opacity. SEM images of crosslinked GelMa 
scaffolds crosslinked in 5.0% (E) and 10.0% (F) H
2
O. 
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solutions (P<0.01). Scaffold opacity increased with increasing crosslinking water 
content (Figure 5.13B-D), in addition when crosslinking in 2.5% H2O in ethanol 
the failure rate of the scaffolds during post cross-linking washing was 
muchhigher. Scaffold fibre analysis post-crosslinking was not possible due to a 
lack of fibre resolution; fibres appeared to merge together during crosslinking 
although the aligned fibre morphology can still be seen when cross-linked in 5% 
and 10% H2O in ethanol solutions (Figure 5.13E-F respectively). Due to the high 
failure rates of 2.5% H2O in ethanol crosslinked scaffolds and the significantly 
higher Young’s modulus of the 10% H2O crosslinked scaffolds, the scaffolds 
crosslinked in 5% H2O in ethanol were chosen to be used for cell culture 
investigations. 
5.4.5 Culture of RASM cells on GelMa scaffolds 
RASM cells were cultured on crosslinked aligned GelMa scaffolds for a period of 
10 days. During that time cell metabolic activity was monitored using the 
PrestoBlue® assay. Cell metabolism increased steadily throughout the 10 day 
period (Figure 5.14A) indicating RASM proliferation over that time. Samples were 
fixed after the 10 day period and stained for the SM markers SM22α and 
calponin and stained for the gap junction protein connexin (Figure 5.15A, B and 
C respectively). Samples stained positive for all markers. In addition, the samples 
stained negatively for desmin. Unlike RASM cells cultured upon gelatin scaffolds, 
those cultured upon GelMa scaffolds did not stain positively for vinculin, with no 
clear focal adhesions present. RASM cell alignment on the GelMa scaffolds was 
similar to the degree of alignment achieved on 8% and 6% gelatin scaffolds with 
23.42% of nuclei oriented within 10° of the mean (Figure 5.14B). 
5.4.6  Contraction of RASM seeded GelMa scaffolds 
Crosslinked GelMa scaffolds were seeded with RASM cells at a density of 2 x 105 
cells cm-2 and incubated for 10 days before scaffolds were cut away from the 
supporting acetate frames. Scaffolds were stimulated with 100 µM UTP and 
imaged to assess the degree of scaffold contraction. Figures 13A and B display 
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Figure 5.14: Culture of RASM cells on crosslinked GelMa scaffolds. RASM cells 
were cultured on crosslinked GelMa scaffold for 10 days, cell metabolism was 
monitored periodically using the PrestoBlue® assay (A); error bars represent 
the standard error of the mean (n=6). Samples were fixed after 10 days and cell 
nuclei stained. Image analysis of stained samples was carried out in order to 
determine the alignment of the cells (B). 
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Figure 5.15: Immunostaining of RASM cells on electrospun GelMa scaffolds. RASM 
cells were fixed and stained with SM22α (A), calponin (B), and connexin (C) (all green). 
Cells were also stained for desmin (C) and vinculin (B) (both red). All samples were 
additionally stained with the nuclear stain Hoechst 33342 (blue). Scale bar = 100µm. 
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Figure 5.16: Contraction of RASM seeded GelMa scaffolds. Scanned 
images of a RASM seeded GelMa scaffold at T=0 (A) and T=30 minutes 
(B) following stimulation with UTP. Image analysis of the scaffolds at 
multiple time points was used to assess the level of scaffold contraction 
(C), error bars represent standard deviation (n=3). 
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images of a RASM seeded gelatin scaffold at times t=0 and t=30 minutes 
respectively, by comparing the surface area of the scaffold across this time 
period, RASM contraction can be measured (Figure 5.16C). Over the 30 minute 
period, scaffolds reduced to 78.0 ± 2.5% (mean ± standard deviation) of their 
original size (22% reduction in size), after 30 minutes no further contraction was 
observed. Unstimulated controls remained close to 100% their original size 
throughout the study. The level of scaffold contraction observed in this study 
was much closer to the level of contraction seen in collagen RASM constructs, 
the amount of contraction (reduction in size) was actually slightly higher than 
witnessed in the collagen hydrogels. Following these results, the direct force 
measurement of RASM seeded GelMa scaffold contraction was attempted using 
the same muscle physiology apparatus used to measure RASM collagen construct 
contraction described in chapter 3. 
RASM cells were cultured upon rectangular crosslinked GelMa scaffolds for 10 
days. Rectangular scaffolds were chosen to match the shape and dimensions of 
the previously developed collagen constructs. After the 10 day culture period, 
scaffolds were removed from their acetate frames and attached to the force 
transducer (Figure 5.17A); once attached the force was allowed to stabilise 
before recording started. The stable force reading was measured for 3 minutes 
before the constructs were stimulated with 100 µM UTP. Control studies were 
stimulated with serum free DMEM. An increase in force was detected within 
seconds of adding the agonist solution and continued to rise quickly for 20 
minutes before slowing. Force continued to increase for a further 30 minutes 
before beginning to plateau (Figure 5.17B). The maximal force generated by the 
RASM constructs ranged from 755.22 µN to 1356.37 µN with the average max 
force being 1008.12 ± 251.59 µN (mean ± standard deviation). The majority of 
contraction occured within the first 5 minutes following stimulation with 42.46 ± 
2.85% of the maximal force measured occurring within this time; 59.89 ± 3.65% 
measured 10 minutes following stimulation and 94.69 ± 1.55% after 40 minutes 
stimulation. As shown in Figure 5.17C, the contractile forces generated by the  
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Figure 5.17: Direct force measurement of RASM contraction on electrospun 
GelMa scaffolds. Photograph of a RASM seeded GelMa scaffold contracting 
whilst attached to the force transducer. Force vs. time curves comparing the 
average contractile force of stimulated GelMa scaffolds against unstimulated 
controls (B) and RASM seeded collagen gels (C). Error bars represent standard 
deviation (n=4). 
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RASM cells on the GelMa scaffolds was over 2.5 times greater than those 
generated by RASM cells in the collagen constructs (1008 vs 394 µN at T= 60). 
Furthermore, the results generated when using the GelMa scaffolds were less 
variable than when using the collagen constructs. This is shown by 
representingthe standard deviation as a percentage of the mean max force 
(24.96% vs 37.47%; GelMa scaffolds vs collagen constructs). 
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5.5 Discussion 
The mechanical properties of materials used to develop scaffolds for tissue 
engineering purposes have a great impact on the behaviour of the cells cultured 
upon/ within them. Given the wide range of polymers available when 
electrospinning, the potential fibrous scaffolds can possess Young’s moduli 
ranging from a few hundred kPa (Kharaziha et al. 2013) to several hundred MPa 
(Hadjizadeh et al. 2011b). This wide range in stiffness will greatly impact on the 
attachment (Haugh et al. 2011), proliferation (Skotak et al. 2010), movement 
(Keogh et al. 2010) and even differentiation (Breuls et al. 2008; Park et al. 2012) 
of the cells. It is therefore important to choose a material with mechanical 
properties that match the mechanical properties that the cells experience in vivo. 
This will be a more effective way of producing tissue engineered constructs with 
functional outputs (such as contraction) that match the functionality of the in 
vivo tissue. Of course, other material properties such as surface chemistry, 
biodegradability and biocompatibility all need to be considered when choosing 
materials for tissue engineering applications. In this chapter of work, the 
contractile behaviour of RASM cells cultured upon electrospun scaffolds that 
greatly differ in their mechanical properties was explored. In addition, using the 
scaffold that best facilitated SM contraction, the physical force generated during 
agonist induced SM contraction was actively measured using muscle physiology 
apparatus. 
In the previous chapter HASM cells were cultured upon electrospun PET scaffolds 
for up to 14 days and expressed markers of a contractile SM phenotype. When 
stimulated with bradykinin or histamine however no visible contraction was 
measured. Scaffolds did not change in size or shape indicating that either the 
cells were not contracting or that the scaffold fibres were too stiff for the SM 
cells to displace. Due to the presence of the same markers seen in the collagen 
gel model (which did contract), it was hypothesised that the scaffolds were 
restricting SM contraction given that the Young’s modulus of in vivo SM is much 
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lower than the Young’s moduli of the PET scaffolds (200-300 MPa). For example, 
the Young’s moduli of human arteries and porcine bronchi range from 0.1 to 1.0 
MPa and 0.35 to 1.35 MPa respectively (Riley et al. 1992; Wang, Patrick 
Mesquida, et al. 2011). These values are 100 to 1000 times smaller than the 
values obtained for the PET scaffolds. As a result, a much less stiff material was 
required to provide suitable mechanical properties that would facilitate SM 
contraction. The first material investigated was gelatin, which was chosen as it is 
possible to electrospin, is biocompatible, is chemically similar to collagen and 
inexpensive, in addition to its favourable mechanical properties. 
5.5.1 Production of electrospun gelatin fibre scaffolds and their use 
as scaffolds for the culture of contractile SM cells 
Gelatin fibre scaffolds were electrospun from gelatin solutions ranging from 6% 
to 10% w/v in concentration. Scaffold fibre diameter increased with gelatin 
concentration and ranged from 286 nm to 1.24 µm, a diameter range similar to 
previously published work when similar concentrations of gelatin in fluorinated 
alcohols were electrospun (Tsai et al. 2012; Skotak et al. 2010). When gelatin has 
been electrospun using aqueous solutions however, much greater 
concentrations (30-40% w/v) have been used to achieve similar sized fibres 
(Zhang et al. 2008; Panzavolta et al. 2011). This once again illustrates the effect 
that different electrospinning parameters (such as the solvent used) can have on 
the resultant fibres. Scaffold fibre alignment was high for all scaffolds. 
Cross-linking of the gelatin scaffolds was attempted using both glutaraldehyde 
vapour and EDC and NHS although glutaraldehyde cross-linked scaffolds failed to 
produce reproducible results. This is possibly because the glutaraldehyde cross-
links the scaffolds in the vapour phase. As the level of glutaraldehyde vapour in 
the chamber can be affected by environmental parameters such as temperature 
and humidity; that would mean that the level of cross-linking would not 
necessarily be the same for different batches. The EDC and NHS cross-linking 
method on the other hand, is carried out in a temperature controlled refrigerator 
in the liquid phase resulting in a more reliable method. Image analysis of the 
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scaffolds after cross-linking shows that the scaffolds appear slightly less uniform 
and that the degree of alignment had decreased slightly. This is due to several 
fibres merging together during cross-linking as cross-links formed between 
fibres, this also lead to a reduction in visible pores between fibres but the aligned 
fibrous topography of the scaffolds remained. Cross-linking also resulted in an 
increase in fibre diameter in all of the gelatin scaffolds; this has also been 
reported by Zhang et al. (Zhang et al. 2008) who crosslinked gelatin scaffolds 
with EDC and NHS at 25mM EDC. Fibre swelling has also been reported when 
cross-linking gelatin scaffolds with genipin (Panzavolta et al. 2011). The fibre 
swelling is thought to be due to the absorption of water. In this case, the cross-
linked scaffolds appear to behave like a hydrogel, swelling in size with reduced 
stiffness, but retain their fibrous structure. Zhang et al. also found that when 
wet; the Young’s modulus of crosslinked gelatin scaffolds dramatically decreases 
(Zhang et al. 2008). As the scaffolds produced in this study were to be used for 
cell culture, only the wet state Young’s modulus was measured, this ranged from 
3.80 to 1.54 MPa, values similar in magnitude to those measured by Zhang for 
similar sized fibre scaffolds. 
RASM cells were seeded onto the 10% cross-linked gelatin scaffolds to assess cell 
attachment, proliferation and phenotype. Scaffolds spun from 10% w/v gelatin 
solutions were chosen for further experiments due to the high alignment that 
RASM cells displayed upon them. Cells achieved confluency quickest when 
seeded at a density of 2x105 cells ml-1 and cultured for 9 days. Parallel 
PrestoBlue® tests showed a steady rise in metabolic activity over the same time 
period; indicating that cells were proliferating on the scaffolds. Immunostaining 
of fixed confluent scaffolds for SM markers SM22α and calponin showed that 
both proteins were present within the cells in addition to illustrating the aligned, 
spindle-shaped morphology of the cells. All of which are indicative of a 
contractile SM phenotype. In addition, the cells stained positive for the gap 
junction protein connexin, with gap junctions seen between cells. Focal 
adhesions were also seen on the scaffolds with cells staining positive for vinculin. 
Once again, cells stained negative for desmin. 
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RASM cells were grown to confluency on cross-linked 10% gelatin scaffold 
squares before contraction of the scaffolds was attempted. Scaffolds were 
stimulated with 100 µM UTP and imaged periodically to measure any visible 
scaffold contraction. Scaffolds reduced in size by an average of 9.5% over 20 
minutes following stimulation in comparison to unstimulated controls. Although 
the level of contraction was only small compared to the previously established 
hydrogels, this showed an improvement on the level of contraction compared to 
PET scaffolds. By reducing the scaffold stiffness further, it may be possible to 
create RASM seeded electrospun aligned scaffold constructs that contract to a 
similar degree as the RASM seeded hydrogels. 
5.5.2 Production of electrospun GelMa scaffolds and their use as 
scaffolds for the culture of contractile SM cells 
Due to the multiple ways in which the mechanical properties of GelMa hydrogels 
can be manipulated, as discussed previously, GelMa was considered as an 
attractive material that could potentially produce electrospun scaffolds with 
Young’s moduli lower than those seen in the electrospun gelatin scaffolds. 
GelMa was successfully synthesised following a previously published method 
(Van Den Bulcke et al. 2000; Nichol et al. 2010; Nikkhah et al. 2012). Following 
synthesis, the degree of methacrylation of the gelatin was calculated using the 
NMR spectra of the GelMa; methacrylation was calculated to be approximately 
80%. This level of methacrylation matches previously published calculated values 
for the same gelatin: methacrylic anhydride ratio (Nichol et al. 2010; Hosseini et 
al. 2012; Nikkhah et al. 2012). Hence, 80% of the once free amino groups now 
possess the methacrylamide functional group and are available during UV cross-
linking. 
The synthesised GelMa was electrospun at a concentration of 10% w/v 
generating aligned fibres around 300 nm in diameter. When compared to gelatin 
fibres electrospun from the equivalent concentration (average diameter of 1.24 
µm), the GelMa fibres were much thinner. This is most probably due to a change 
in the net charge during GelMa synthesis whereby consumption of the majority 
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of free amines by methacrylation (and no change to the number of free 
carboxylate groups) will lead to an increased negative charge at neutral pH due 
to deprotonated carboxylic acid groups (Zhou et al. 2014). This will affect the 
conductivity of the electrospinning solution, leading to the thinner fibres. As 
there is no published literature on electrospun GelMa scaffolds a cross-linking 
method had to be developed where the scaffolds retained their fibrous 
architecture whilst submerged in a photoinitiator solution. In order to work the 
photoinitiator needs to be in an aqueous solution. Previous studies have cross-
linked GelMa hydrogels in PBS (Nichol et al. 2010; Nikkhah et al. 2012; 
Ovsianikov et al. 2011), but this was not possible with the electrospun scaffolds 
due to the high solubility of GelMa (the scaffolds dissolve instantly on contact 
with water). In order to overcome this issue, the EDC and NHS gelatin 
crosslinking method (Zhang et al. 2008) was adapted. This method uses a 9:1 
ethanol: water mix, in this solution the scaffolds do not dissolve but are 
crosslinked. Therefore a selection of ethanol: water mixtures were investigated 
for use as the solvent for the photoinitiator solution. Any mixture with a water 
content higher than 10% (v/v) caused the scaffolds to dissolve and a water 
content less than 2.5% failed to sufficiently cross-link the scaffolds under UV 
light, leading to dissolution of the scaffolds upon washing with PBS.  By changing 
the ethanol to water ratio it was possible to partially control the level of GelMa 
cross-linking and, as a result, the mechanical properties of the scaffolds. Young’s 
moduli of the scaffolds ranged from 142 kPa (2.5% water) to 451 kPa (10% 
water); in addition the scaffolds became more opaque as the level of cross-
linking increased. SEM images of cross-linked scaffolds suggested that during 
cross-linking, scaffolds appeared to lose their porous structure due to fibre 
swelling however, the aligned fibrous topography of the scaffolds was still visible. 
RASM cells were cultured upon GelMa scaffolds cross-linked in a 5% water: 
ethanol solution. These scaffolds were chosen for further cell culture 
experiments due to their low Young’s modulus and high cross-linking success 
rate when compared to the 10% and 2.5% (cross-linking solution water in 
ethanol ratio) respectively. As with the gelatin scaffolds, RASM cells attached to 
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and proliferated on the surface of the GelMa scaffolds over a 10 day period, cells 
aligned upon the scaffolds indicating that the surface topography of the scaffolds 
remained intact after cross-linking. However it is worth noting that the degree of 
nuclear alignment was lower on the GelMa scaffolds than on the PET scaffolds 
(23.42 vs 48.78% (10% w/v PET scaffolds, 7 days of culture) of cells within 10° of 
the mean), this correlates with the loss of alignment seen when cross-linking the 
electrospun gelatin scaffolds. RASM cells once again stained positive for SM22α, 
calponin and connexin. Unlike the gelatin scaffolds however, RASM cells on 
GelMa scaffolds showed no clear positive staining for vinculin, meaning no focal 
adhesion points could be identified. It has been previously documented that the 
level of vinculin bound to the cytoskeleton, and the amount of vinculin localizing 
at focal adhesions is larger on stiffer surfaces than on more elastic ones 
(Yamashita et al. 2014; Discher 2005). The difference in stiffness between the 
GelMa and gelatin scaffolds could be the reason why no vinculin localisation was 
seen on the GelMa scaffolds. 
As previously attempted with the gelatin scaffolds, RASM cells were cultured 
upon square cross-linked electrospun GelMa scaffolds for 10 days prior to 
contraction studies. When stimulated to contract with 100 µM UTP, the RASM 
seeded GelMa scaffolds reduced in surface area by an average of 22% due to 
RASM contraction. This level of contraction is even greater than the gel length 
reduction of RASM collagen constructs seen in chapter 3.  For this reason, and 
that this level of contraction was higher than that seen on gelatin and PET 
scaffolds, GelMa scaffolds were chosen to be used to measure the physical force 
exerted by SM cells during contraction. 
5.5.3 Measuring the physical contractile force of SM cells cultured 
upon electrospun scaffolds 
RASM cells were seeded upon cross-linked GelMa scaffolds and cultured for 10 
days to achieve a confluent layer of cells. Scaffolds were rectangular in shape 
with dimensions matching the previously established collagen gel constructs. 
After the 10 days the scaffolds were attached to the muscle physiology 
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apparatus (isometric force transducer) that was used to measure the contractile 
force generated by the collagen constructs. Scaffolds were designed and 
attached to the transducer so that scaffold (and therefore cell) alignment was 
along the length of the rectangular scaffolds and parallel to the direction of force 
measurement. Scaffolds that were stimulated with 100 µM UTP contracted 
instantly and generated average maximal forces that were over 2.5 times greater 
than those achieved by collagen constructs. This could be due to several factors 
such as greater cell alignment and much more uniform distribution on the 
scaffolds than in the collagen gels. This will lead to more uniaxial force generated 
by the scaffolds. Also, collagen gels have been shown to restrict the proliferation 
of cells (Jones et al. 1997) compared to denatured collagen, arresting the cell 
cycle in G1 (Koyama et al. 1996). A study by Li et al. showed that vascular SM 
cells cultured in a 3D collagen matrix display an increased expression of p21 (Li et 
al. 2002), a cyclin-dependent kinase inhibitor known to inhibit SM proliferation 
(Chang et al. 1995; Tanner et al. 2000). Additionally, they also found that there 
were a significantly lower proportion of cells in the S phase and more in the 
G0/G1 phase in a 3D collagen matrix than a 2D one; suggestive of a lower 
proliferation rate in 2D. Therefore, whilst reaching confluency, the number of 
cells on the scaffolds could very well have increased to a number much greater 
than the number within the gels. This greater number of cells would logically 
produce a greater force. The actual change in cell number during the 10 day 
incubation will have to be assessed in future work.  Although electrospun gelatin 
scaffolds have been used to produce contractile tissues such as cardiac 
(Kharaziha et al. 2013) and skeletal (Ostrovidov et al. 2014) muscle previously, 
this is the first time that SM contraction has been assessed using electrospun 
scaffolds. In addition, this is also the first time that the physical force of 
contraction from any cell type has been directly measured on electrospun 
scaffolds. With their greater cell alignment and distribution uniformity, force 
generation and reproducibility when compared to collagen gels, the electrospun 
GelMa scaffolds are a promising platform for direct measurement of contractile 
tissue engineered constructs. 
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5.5.4 Chapter Summary 
Within this chapter of work, both gelatin and GelMa scaffolds were successfully 
electrospun and cross-linked using different cross-linking methods. The two 
materials produced scaffolds with different mechanical properties and including 
the PET scaffolds, Young’s moduli of the scaffolds ranged from around 100 kPa to 
300 MPa. The mechanical properties of the GelMa scaffolds can be manipulated 
by controlling the amount of water in the photoinitiator solution (which 
predominantly consisted of ethanol). SM cells readily attached to and 
proliferated upon both gelatin and GelMa scaffolds, expressing expected 
contractile SM markers in all cases. When cultured upon GelMa scaffolds 
however, no localised vinculin could be seen; a potential indicator of the 
scaffolds’ low stiffness. SM cells were able to contract both gelatin and GelMa 
scaffolds with greater contraction seen on the less stiff GelMa scaffolds. The 
GelMa scaffolds were attached to force monitoring equipment and stimulated to 
contract with an agonist. Immediately following agonist stimulation scaffolds 
produced forces much greater than seen in collagen hydrogels. Limitations of the 
GelMa scaffolds are that they are fragile and require careful handling. Also, the 
method of attachment to the force transducer still requires the use of a minuten 
pin which adds variability into the setup, albeit less variability than when using 
collagen gels. This work represents the first time that GelMa has been 
electrospun and cross-linked using the methods described here. Additionally, the 
first time that the contractile forces generated by a confluent, aligned sheet of 
SM cells cultured upon an electrospun scaffold have been directly measured. 
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6. General Discussion 
The experimental data collected and presented in this thesis illustrate the steps 
taken towards developing a tissue engineered in vitro model of contractile 
smooth muscle tissue using electrospun scaffolds. The role of the electrospun 
scaffolds is to provide a matrix with a surface topography that can support the 
growth of an aligned, confluent population of SM cells. In addition to this, the 
scaffolds provide a mechanical environment akin to what the cells experience in 
vivo (Wang, P Mesquida, et al. 2011). This allows the scaffolds to facilitate the 
functional output of the SM cells (contraction), producing a functional, 
contractile model of SM. By attaching the scaffolds to an appropriate force 
measurement apparatus, the physical force of this contraction can be measured. 
The ultimate goal of this work was to provide a tissue engineered alternative to 
traditional ex vivo models such as bronchial segments and TCLS during drug 
screening studies and when studying SM physiology and the pathophysiology of 
diseases such as asthma and atherosclerosis. The work described here has taken 
steps towards reaching that goal, resulting in a functional cell/ scaffold construct 
designed to be attached to traditional muscle physiology apparatus. With some 
refinement of the scaffold design and validation studies with primary human 
cells; further development of the model could easily take place. 
SM plays a key role in the modulation of airway tone; in airway diseases such as 
asthma excessive contraction of the ASM tissue leads to increased airway 
resistance and shortness of breath. Models studying the role of ASM in these 
diseases generally involve the use of animals, be that in vivo (Zosky & Sly 2007)  
or ex vivo (Gunst & Mitzner 1981; Bergner & Sanderson 2002a). The use of 
animals in the study of human disease however raises several issues that a tissue 
engineered model would hope to solve. Firstly, although hypersensitivity (a key 
symptom of asthma) can be induced in many animal models (Johnson et al. 2004; 
Shinagawa & Kojima 2003), asthma is a disease that only affects humans. 
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Therefore, all animal models of asthma lack some elements of the disease 
(Holmes et al. 2011; Krug & Rabe 2008), raising questions over their accuracy. 
Similarly, due to genetic differences between species, drugs that produce 
positive effects in animal models may not necessarily be replicated in humans 
(Henig et al. 2000; Bryan et al. 2000). By using the approach developed in this 
thesis, human ASM cells could be cultured upon the electrospun scaffolds. 
Furthermore, by obtaining the cells from donors with asthma or COPD, the 
behaviour of the diseased ASM could be closely studied without the need for an 
induced disease phenotype. This would overcome the issue of different drug 
interactions between species and will also allow for studies into variation 
between human donors. 
Another issue that a tissue engineered model would combat is the ethical 
concerns expressed towards animal models (Levy 2012). Although the majority 
of work done in this thesis used aortic SM cells from rats, the number of cells 
obtained from one donor (cultured through 3 passages) could provide enough 
cells for at least 20-30 individual scaffolds. This is working towards the 3R’s 
guidelines (https://www.gov.uk/guidance/research-and-testing-using-animals) 
and EU regulation (REACH) (NC3Rs 2014), reducing the number of animals used 
in research. Furthermore, if the model is used with primary human cells as 
intended, the need for animal donors would be removed completely. 
6.1 Key findings 
Although there has been much work previously published where SM cells have 
been seeded onto/ into various materials for tissue engineering purposes (Baker 
et al. 2006; Nivison-Smith & Weiss 2012; De Filippo et al. 2003; Rayatpisheh et al. 
2012; Schaner et al. 2004), few of these studies actually study the contractile 
force generated by the seeded SM cells (Grosberg et al. 2012; Nesmith et al. 
2014; Alford et al. 2011; West et al. 2013). Very few have directly measured this 
force, and those that did were carried out in collagen hydrogels (Oishi et al. 
2000) or required prior implantation in vivo (Lai et al. 2002; De Filippo et al. 
2003). In this thesis, RASM cells were successfully isolated from sacrificed rats 
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and characterised in vitro, staining positive for expected contractile SM markers. 
When seeded into collagen hydrogels both RASM and human ASM cells were 
found to contract in response to chemical stimuli as previously reported 
(Matsumoto et al. 2007; Sakota et al. 2014). Using the design of an established 
C2C12 model (Sharples et al. 2012; Cheema et al. 2003), RASM constructs were 
developed and cultured for 3 days prior to contraction studies. During this time, 
the cells remodelled the collagen matrix and aligned parallel to the tension lines 
formed in the construct. Constructs were stimulated to contract whilst both free 
floating and attached to force measurement apparatus. During contraction 
studies using a force transducer, the forces generated by RASM construct 
contraction were measured and found to be agonist concentration dependant. 
Additionally, the contraction could be inhibited by L-type Ca2+ channel inhibition. 
Electrospinning offers an attractive method to develop fibrous matrices for the 
culture of many different cell types (Nandakumar et al. 2013; Chew et al. 2008; 
Yan et al. 2012). By altering the many electrospinning parameters and the 
polymers used, the morphological and mechanical properties of these fibres can 
be tuned to match the properties of the desired tissue (Pham et al. 2006). Here, 
PET fibres were electrospun whilst varying the electrospinning parameters in 
order to produce multiple scaffolds varying in fibre diameter. PET was initially 
chosen due to its biocompatibility, its stability (not biodegradable; long shelf life) 
and its low cost. As previously reported, the key parameters controlling the fibre 
diameter were the polymer concentration and the flow rate (Hadjizadeh et al. 
2011b; Veleirinho et al. 2007). Lowering the surface tension and increasing the 
conductivity of the PET solutions by adding an anionic surfactant reduced the 
amount of beading observed when spinning low concentrations of PET. Beading 
was also reduced by spinning through a narrower needle which increased 
solution velocity at the same flow rates. Altering the source of PET dramatically 
changed the morphology of the resultant fibres; this is highly likely due to 
differences in the purity and the polymer molecular weight (Kim et al. 2004; 
Gupta et al. 2005) in each source. By electrospinning nanofibres directly onto 
microfibre scaffolds it was possible to create a bi-phasic scaffold providing 
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different matrices for the co-culture of different cell types. Electrospinning onto 
a rapidly rotating mandrel made the production of highly aligned polymer fibres 
possible.  Aligned PET scaffolds were used for the culture of HASM cells. Cells 
aligned along the direction of the fibres with greater alignment seen on thicker 
fibres. Cells proliferated on the surface of the scaffolds and formed a highly 
aligned, confluent layer of HASM after 14 days in culture.  
When attempting to replicate the contraction studies carried out in collagen 
hydrogels on the PET scaffolds, no visual contraction was recorded. It was 
proposed that this was due to the stiffness’ of the PET scaffolds which were 
much greater than SM would experience in vivo. As a result, gelatin and for the 
first time, GelMa, scaffolds were electrospun and cross-linked. The two materials 
produced scaffolds which were approximately 100 to 1000 times (respectively) 
less stiff than the PET scaffolds. The mechanical properties of the GelMa 
scaffolds were manipulated by controlling the water content of the 
photoinitiator solution. RASM cells attached to and proliferated upon gelatin and 
GelMa scaffolds, expressing characteristic contractile SM markers in all cases. 
Loss of localised vinculin, associated with less stiff extracellular environments 
(Yamashita et al. 2014; Discher 2005) was seen on GelMa scaffolds highlighting 
the difference in stiffness between the scaffolds. Contraction of RASM cells could 
be seen visually (change in scaffold shape/size) upon both of these scaffolds; 
more so on GelMa scaffolds than on gelatin scaffolds which were more stiff than 
the GelMa scaffolds.. 
Finally, the GelMa scaffolds were attached to force monitoring equipment and 
stimulated with a contractile agonist, representing the first time that SM 
contraction studies have been carried out with smooth muscle cells on 
electrospun scaffolds. Immediately following agonist stimulation, cell seeded 
scaffolds produced forces much greater than seen in collagen hydrogels 
demonstrating that electrospun GelMa scaffolds could be a more suitable 
scaffold to use for contraction studies than the previously developed hydrogel 
models due to their greater uniformity in alignment and their ability to 
proliferate upon the scaffolds (Jones et al. 1997; Koyama et al. 1996). This in 
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turn, provides a much more confluent, uniaxial population of cells than what is 
achieved in collagen gels, even with the addition of uniaxial tension. 
6.2 Current limitations 
Due to a limited supply of primary human cells, the development and 
optimisation of this model was  carried out using SM cells from rats. Therefore, it 
is unknown how human cells will respond when cultured upon GelMa scaffolds 
and whether they would produce similar force readings in response to agonist 
stimulation. In chapters 3 and 5, collagen gels and GelMa scaffolds were 
attached to an isometric force transducer to measure the force of SM 
contraction. Although this proved to be successful and provided interesting 
results, all results were highly variable. This is thought to be due to the method 
of attachment which is quite rudimentary in nature, and a major source of 
variability. In order to increase the accuracy of experiments in future work, this 
experimental design will need to be addressed. It is worth mentioning though, 
that less variability was seen with cell seeded GelMa scaffolds; this was most 
probably due to the positioning of a thin strip of acetate at the end of each 
scaffold to prevent the pin tearing through the scaffold. As this strip was in a 
similar position each time, this meant that attachment of the scaffolds to the 
transducer was slightly more reproducible than when attaching gels. Also, the 
fragile nature of the GelMa scaffolds made them difficult to handle during cell 
culture and contraction studies; however, any attempt to strengthen the 
scaffolds would be of detriment to the scaffolds’ mechanical properties. 
Another important point is that this model uses only SM cells and is devoid of 
any diffusion barrier that would be present in vivo. Therefore, if this model is to 
be used to study the effects of drugs on airway or blood vessel physiology, it will 
need to be incorporated into a more complex model that (or need further 
development itself so that it) includes an epithelial/ endothelial layer to form this 
barrier. The presence of an epithelium can cause significantly different reactions 
to molecules and cross-communication between the tissues is of great 
importance when understanding disease mechanisms (Miyagi et al. 1996; White 
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et al. 1990; Gourgoulianis et al. 1998). This will therefore provide results that 
better represent drug response in vivo. 
6.3 Future work 
This model of SM can be used to assess the level of contractile forces generated 
in response to agonist stimulation. In order to validate the model further, there 
are several experiments that need to be carried out. Firstly, the sensitivity of the 
model should be tested by performing a dose-response experiment similar to 
those carried out on the collagen constructs. Ideally, these experiments could be 
carried out in a perfused chamber, removing the need for constant volume 
changes within the vessel. Also, it is unknown whether the scaffolds return to 
their original state following contraction as the cells relax; this could be 
investigated by adding cytochalasin D to the cells to disrupt the actin 
cytoskeleton, causing relaxation of the SM (Saito et al. 1996; Mortensen & 
Larsson 2003). This is an important question as it could enable long term or 
multiple contraction studies using the same scaffold. 
An important step in developing the model further would be the transition from 
primary rat cells to those from human donors. By using SM cells from both 
diseased and normal human donors, the role of SM in different diseases could be 
investigated with comparisons made between donors. One example would be 
comparing the forces generated by asthmatic ASM cells with those from healthy 
donors, indicating whether excessive ASM contraction in asthma is due to ASM 
dysfunction or other facets of the disease such as airway remodelling. The 
complexity of the model could be increased by co-culture of SM cells with other 
cell types such as epithelial or fibroblast cells. This could be achieved using the 
biphasic scaffolds described in chapter 4, although potentially using gelatin or 
GelMa instead of PET. Another co-culture model to investigate would be SM cells 
co-cultured with immune cells such as mast cells, which are thought to embed 
themselves in the ASM bundle in asthma sufferers (Brightling et al. 2002; 
Woodman et al. 2008). By co-culturing ASM cells and mast cells from both 
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asthmatic and non-asthmatic donors, the interaction between ASM and mast 
cells could be investigated further. 
6.4 Final conclusions 
A key product of the work represented in this thesis is a contractile model of SM 
tissue that can be used to physically measure the forces generated by the SM 
cells during contraction. Using aligned electrospun scaffolds, an aligned 
population of cells is produced as the cells use the topographical cues provided 
by the fibrous scaffold. By using aligned electrospun scaffolds, cells are 
morphologically similar to their in vivo state and contract uniaxially. The 
presence of gap junctions between the cells also suggests they are behaving as a 
syncytium. Hopefully, this model can go some way to help shift the focus of pre-
clinical studies from animals to tissue engineered alternatives and aid in the 
development of new drugs for diseases such as asthma and atherosclerosis. The 
benefits of this model over existing models are that; the contractile force can be 
directly measured, no extra load (other than the scaffold) is applied to the 
system, and it can be used for the study of single cell types and multiple cell 
types (with some modification such as the use of a biphasic scaffold). Finally, the 
successful use of GelMa as a material for electrospinning opens up avenues for 
the future study of other soft or contractile tissues such as cardiac and skeletal 
muscle in addition to further studies investigating SM biology. 
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